{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "b54d75ca-bebb-4661-99f4-572385a1e12d",
   "metadata": {},
   "source": [
    "Drug Review Dataset"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "262f47c6-dd96-49e9-a65c-5ef28a43a91b",
   "metadata": {},
   "source": [
    "In this dataset, I aim to understand which drugs and conditions are listed. I will map the drug with the condition and then tally drugs and conditions. \n",
    "\n",
    "I will attempt to answer:\n",
    "\n",
    "1. Which are the most and least popular drugs\n",
    "2. Is any one drug used for more than one clinical indication? \n",
    "3. Which drugs are used for a wide range of clinical conditions?\n",
    "\n",
    "The stages to this review include:\n",
    "- data preprocessing. The intent of this stage will be to remove NAs, duplicates, and unwanted values.\n",
    "  \n",
    "\n",
    "If I have an opportunity, I will attempt to take a deeper dive into the findings. I will employ NLP and tokenize reviews. I will perform a sentiment analysis on the tokens. \n",
    "\n",
    "Sentiments will be grouped as either:\n",
    "\n",
    "1. positive,\n",
    "2. neutral or\n",
    "3. negative reviews\n",
    "\n",
    "From this I will then look to see if certain drugs or even conditions more likely to yield a particular sentiment?"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c365a669-7c20-4e80-b434-97c82ec5a207",
   "metadata": {},
   "source": [
    "In the first instance I will conduct data preprocessing. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "3a86f49a-ca1b-4275-8c00-52c1b98a17dd",
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import seaborn as sns\n",
    "\n",
    "import math\n",
    "import matplotlib.pyplot as plt\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "837389fa-c436-407f-843a-ff39ca91d838",
   "metadata": {},
   "outputs": [],
   "source": [
    "drug_data_df=pd.read_csv(\"/Users/sunuber/Desktop/drugsdata.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "id": "e326a644-3d80-47a5-b361-8cbb66da800d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>uniqueID</th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>163740</td>\n",
       "      <td>Mirtazapine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>\"I&amp;#039;ve tried a few antidepressants over th...</td>\n",
       "      <td>10</td>\n",
       "      <td>28-Feb-12</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>206473</td>\n",
       "      <td>Mesalamine</td>\n",
       "      <td>Crohn's Disease, Maintenance</td>\n",
       "      <td>\"My son has Crohn&amp;#039;s disease and has done ...</td>\n",
       "      <td>8</td>\n",
       "      <td>17-May-09</td>\n",
       "      <td>17</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>159672</td>\n",
       "      <td>Bactrim</td>\n",
       "      <td>Urinary Tract Infection</td>\n",
       "      <td>\"Quick reduction of symptoms\"</td>\n",
       "      <td>9</td>\n",
       "      <td>29-Sep-17</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>39293</td>\n",
       "      <td>Contrave</td>\n",
       "      <td>Weight Loss</td>\n",
       "      <td>\"Contrave combines drugs that were used for al...</td>\n",
       "      <td>9</td>\n",
       "      <td>5-Mar-17</td>\n",
       "      <td>35</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>97768</td>\n",
       "      <td>Cyclafem 1 / 35</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>\"I have been on this birth control for one cyc...</td>\n",
       "      <td>9</td>\n",
       "      <td>22-Oct-15</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   uniqueID         drugName                     condition  \\\n",
       "0    163740      Mirtazapine                    Depression   \n",
       "1    206473       Mesalamine  Crohn's Disease, Maintenance   \n",
       "2    159672          Bactrim       Urinary Tract Infection   \n",
       "3     39293         Contrave                   Weight Loss   \n",
       "4     97768  Cyclafem 1 / 35                 Birth Control   \n",
       "\n",
       "                                              review  rating       date  \\\n",
       "0  \"I&#039;ve tried a few antidepressants over th...      10  28-Feb-12   \n",
       "1  \"My son has Crohn&#039;s disease and has done ...       8  17-May-09   \n",
       "2                      \"Quick reduction of symptoms\"       9  29-Sep-17   \n",
       "3  \"Contrave combines drugs that were used for al...       9   5-Mar-17   \n",
       "4  \"I have been on this birth control for one cyc...       9  22-Oct-15   \n",
       "\n",
       "   usefulCount  \n",
       "0           22  \n",
       "1           17  \n",
       "2            3  \n",
       "3           35  \n",
       "4            4  "
      ]
     },
     "execution_count": 57,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_data_df.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "id": "de746967-23f6-46d1-bade-9f3dd2a6fed0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(53766, 7)"
      ]
     },
     "execution_count": 58,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_data_df.shape"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9faff9a0-8160-4729-bac2-82a0d5d5c2a2",
   "metadata": {},
   "source": [
    "This dataset contains over 53 thousand rows and seven columns."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "d91187f9-f840-4cca-8c31-ad12336055e9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<bound method DataFrame.info of        uniqueID         drugName                     condition  \\\n",
       "0        163740      Mirtazapine                    Depression   \n",
       "1        206473       Mesalamine  Crohn's Disease, Maintenance   \n",
       "2        159672          Bactrim       Urinary Tract Infection   \n",
       "3         39293         Contrave                   Weight Loss   \n",
       "4         97768  Cyclafem 1 / 35                 Birth Control   \n",
       "...         ...              ...                           ...   \n",
       "53761    159999        Tamoxifen     Breast Cancer, Prevention   \n",
       "53762    140714     Escitalopram                       Anxiety   \n",
       "53763    130945   Levonorgestrel                 Birth Control   \n",
       "53764     47656       Tapentadol                          Pain   \n",
       "53765    113712        Arthrotec                      Sciatica   \n",
       "\n",
       "                                                  review  rating       date  \\\n",
       "0      \"I&#039;ve tried a few antidepressants over th...      10  28-Feb-12   \n",
       "1      \"My son has Crohn&#039;s disease and has done ...       8  17-May-09   \n",
       "2                          \"Quick reduction of symptoms\"       9  29-Sep-17   \n",
       "3      \"Contrave combines drugs that were used for al...       9   5-Mar-17   \n",
       "4      \"I have been on this birth control for one cyc...       9  22-Oct-15   \n",
       "...                                                  ...     ...        ...   \n",
       "53761  \"I have taken Tamoxifen for 5 years. Side effe...      10  13-Sep-14   \n",
       "53762  \"I&#039;ve been taking Lexapro (escitaploprgra...       9   8-Oct-16   \n",
       "53763  \"I&#039;m married, 34 years old and I have no ...       8  15-Nov-10   \n",
       "53764  \"I was prescribed Nucynta for severe neck/shou...       1  28-Nov-11   \n",
       "53765                                      \"It works!!!\"       9  13-Sep-09   \n",
       "\n",
       "       usefulCount  \n",
       "0               22  \n",
       "1               17  \n",
       "2                3  \n",
       "3               35  \n",
       "4                4  \n",
       "...            ...  \n",
       "53761           43  \n",
       "53762           11  \n",
       "53763            7  \n",
       "53764           20  \n",
       "53765           46  \n",
       "\n",
       "[53766 rows x 7 columns]>"
      ]
     },
     "execution_count": 59,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_data_df.info"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "ae8795b9-83ce-4c0a-bcb0-f58b7a478acc",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "       uniqueID  drugName  condition  review  rating   date  usefulCount\n",
      "0         False     False      False   False   False  False        False\n",
      "1         False     False      False   False   False  False        False\n",
      "2         False     False      False   False   False  False        False\n",
      "3         False     False      False   False   False  False        False\n",
      "4         False     False      False   False   False  False        False\n",
      "...         ...       ...        ...     ...     ...    ...          ...\n",
      "53761     False     False      False   False   False  False        False\n",
      "53762     False     False      False   False   False  False        False\n",
      "53763     False     False      False   False   False  False        False\n",
      "53764     False     False      False   False   False  False        False\n",
      "53765     False     False      False   False   False  False        False\n",
      "\n",
      "[53766 rows x 7 columns]\n"
     ]
    }
   ],
   "source": [
    "missing_values= drug_data_df.isnull()\n",
    "print(missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "id": "1758bb35-fb44-44e7-a1a3-bb5afdcbbe9d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "uniqueID         0\n",
      "drugName         0\n",
      "condition      295\n",
      "review           0\n",
      "rating           0\n",
      "date             0\n",
      "usefulCount      0\n",
      "dtype: int64\n"
     ]
    }
   ],
   "source": [
    "missing_values=drug_data_df.isnull().sum()\n",
    "print(missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "644ed24c-a2c9-475f-a9db-fe0376b45d64",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "uniqueID       0.000000\n",
       "drugName       0.000000\n",
       "condition      0.548674\n",
       "review         0.000000\n",
       "rating         0.000000\n",
       "date           0.000000\n",
       "usefulCount    0.000000\n",
       "dtype: float64"
      ]
     },
     "execution_count": 62,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_data_df.isna().sum()*100/len(drug_data_df)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5b614737-5b65-4861-9a60-2ede7ee71632",
   "metadata": {},
   "source": [
    "I've used a few ways to determine the number and percentage of null values in the dataset. Over 0.5% of null values are attributable to the conditons row."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "id": "e71ed260-4108-41bc-b347-e51a28a9f272",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>uniqueID</th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>163740</td>\n",
       "      <td>Mirtazapine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>\"I&amp;#039;ve tried a few antidepressants over th...</td>\n",
       "      <td>10</td>\n",
       "      <td>28-Feb-12</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>206473</td>\n",
       "      <td>Mesalamine</td>\n",
       "      <td>Crohn's Disease, Maintenance</td>\n",
       "      <td>\"My son has Crohn&amp;#039;s disease and has done ...</td>\n",
       "      <td>8</td>\n",
       "      <td>17-May-09</td>\n",
       "      <td>17</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>159672</td>\n",
       "      <td>Bactrim</td>\n",
       "      <td>Urinary Tract Infection</td>\n",
       "      <td>\"Quick reduction of symptoms\"</td>\n",
       "      <td>9</td>\n",
       "      <td>29-Sep-17</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>39293</td>\n",
       "      <td>Contrave</td>\n",
       "      <td>Weight Loss</td>\n",
       "      <td>\"Contrave combines drugs that were used for al...</td>\n",
       "      <td>9</td>\n",
       "      <td>5-Mar-17</td>\n",
       "      <td>35</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>97768</td>\n",
       "      <td>Cyclafem 1 / 35</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>\"I have been on this birth control for one cyc...</td>\n",
       "      <td>9</td>\n",
       "      <td>22-Oct-15</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53761</th>\n",
       "      <td>159999</td>\n",
       "      <td>Tamoxifen</td>\n",
       "      <td>Breast Cancer, Prevention</td>\n",
       "      <td>\"I have taken Tamoxifen for 5 years. Side effe...</td>\n",
       "      <td>10</td>\n",
       "      <td>13-Sep-14</td>\n",
       "      <td>43</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53762</th>\n",
       "      <td>140714</td>\n",
       "      <td>Escitalopram</td>\n",
       "      <td>Anxiety</td>\n",
       "      <td>\"I&amp;#039;ve been taking Lexapro (escitaploprgra...</td>\n",
       "      <td>9</td>\n",
       "      <td>8-Oct-16</td>\n",
       "      <td>11</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53763</th>\n",
       "      <td>130945</td>\n",
       "      <td>Levonorgestrel</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>\"I&amp;#039;m married, 34 years old and I have no ...</td>\n",
       "      <td>8</td>\n",
       "      <td>15-Nov-10</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53764</th>\n",
       "      <td>47656</td>\n",
       "      <td>Tapentadol</td>\n",
       "      <td>Pain</td>\n",
       "      <td>\"I was prescribed Nucynta for severe neck/shou...</td>\n",
       "      <td>1</td>\n",
       "      <td>28-Nov-11</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53765</th>\n",
       "      <td>113712</td>\n",
       "      <td>Arthrotec</td>\n",
       "      <td>Sciatica</td>\n",
       "      <td>\"It works!!!\"</td>\n",
       "      <td>9</td>\n",
       "      <td>13-Sep-09</td>\n",
       "      <td>46</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>53471 rows Ã— 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       uniqueID         drugName                     condition  \\\n",
       "0        163740      Mirtazapine                    Depression   \n",
       "1        206473       Mesalamine  Crohn's Disease, Maintenance   \n",
       "2        159672          Bactrim       Urinary Tract Infection   \n",
       "3         39293         Contrave                   Weight Loss   \n",
       "4         97768  Cyclafem 1 / 35                 Birth Control   \n",
       "...         ...              ...                           ...   \n",
       "53761    159999        Tamoxifen     Breast Cancer, Prevention   \n",
       "53762    140714     Escitalopram                       Anxiety   \n",
       "53763    130945   Levonorgestrel                 Birth Control   \n",
       "53764     47656       Tapentadol                          Pain   \n",
       "53765    113712        Arthrotec                      Sciatica   \n",
       "\n",
       "                                                  review  rating       date  \\\n",
       "0      \"I&#039;ve tried a few antidepressants over th...      10  28-Feb-12   \n",
       "1      \"My son has Crohn&#039;s disease and has done ...       8  17-May-09   \n",
       "2                          \"Quick reduction of symptoms\"       9  29-Sep-17   \n",
       "3      \"Contrave combines drugs that were used for al...       9   5-Mar-17   \n",
       "4      \"I have been on this birth control for one cyc...       9  22-Oct-15   \n",
       "...                                                  ...     ...        ...   \n",
       "53761  \"I have taken Tamoxifen for 5 years. Side effe...      10  13-Sep-14   \n",
       "53762  \"I&#039;ve been taking Lexapro (escitaploprgra...       9   8-Oct-16   \n",
       "53763  \"I&#039;m married, 34 years old and I have no ...       8  15-Nov-10   \n",
       "53764  \"I was prescribed Nucynta for severe neck/shou...       1  28-Nov-11   \n",
       "53765                                      \"It works!!!\"       9  13-Sep-09   \n",
       "\n",
       "       usefulCount  \n",
       "0               22  \n",
       "1               17  \n",
       "2                3  \n",
       "3               35  \n",
       "4                4  \n",
       "...            ...  \n",
       "53761           43  \n",
       "53762           11  \n",
       "53763            7  \n",
       "53764           20  \n",
       "53765           46  \n",
       "\n",
       "[53471 rows x 7 columns]"
      ]
     },
     "execution_count": 63,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_data_df.dropna(axis=0) #it will go through whole dataframe, and delete missing values "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "id": "b4bc471a-4f5e-4756-a2dc-b002eb33c417",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "uniqueID       0\n",
       "drugName       0\n",
       "condition      0\n",
       "review         0\n",
       "rating         0\n",
       "date           0\n",
       "usefulCount    0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 64,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#sanity check\n",
    "drug_data_df.dropna(axis=0).isna().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "id": "d7d1ea51-3d17-4fad-81b2-3741424ced64",
   "metadata": {},
   "outputs": [],
   "source": [
    "drug_data_df=drug_data_df.dropna(axis=0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "0463466e-4bca-40b2-b64c-b4e721447e25",
   "metadata": {},
   "outputs": [],
   "source": [
    "drug_data_df=drug_data_df.drop('uniqueID', axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "id": "d78da0b0-1d32-44a2-9eb9-bf93b7c7b1ee",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Mirtazapine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>\"I&amp;#039;ve tried a few antidepressants over th...</td>\n",
       "      <td>10</td>\n",
       "      <td>28-Feb-12</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Mesalamine</td>\n",
       "      <td>Crohn's Disease, Maintenance</td>\n",
       "      <td>\"My son has Crohn&amp;#039;s disease and has done ...</td>\n",
       "      <td>8</td>\n",
       "      <td>17-May-09</td>\n",
       "      <td>17</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Bactrim</td>\n",
       "      <td>Urinary Tract Infection</td>\n",
       "      <td>\"Quick reduction of symptoms\"</td>\n",
       "      <td>9</td>\n",
       "      <td>29-Sep-17</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Contrave</td>\n",
       "      <td>Weight Loss</td>\n",
       "      <td>\"Contrave combines drugs that were used for al...</td>\n",
       "      <td>9</td>\n",
       "      <td>5-Mar-17</td>\n",
       "      <td>35</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Cyclafem 1 / 35</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>\"I have been on this birth control for one cyc...</td>\n",
       "      <td>9</td>\n",
       "      <td>22-Oct-15</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Zyclara</td>\n",
       "      <td>Keratosis</td>\n",
       "      <td>\"4 days in on first 2 weeks.  Using on arms an...</td>\n",
       "      <td>4</td>\n",
       "      <td>3-Jul-14</td>\n",
       "      <td>13</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Copper</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>\"I&amp;#039;ve had the copper coil for about 3 mon...</td>\n",
       "      <td>6</td>\n",
       "      <td>6-Jun-16</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Amitriptyline</td>\n",
       "      <td>Migraine Prevention</td>\n",
       "      <td>\"This has been great for me. I&amp;#039;ve been on...</td>\n",
       "      <td>9</td>\n",
       "      <td>21-Apr-09</td>\n",
       "      <td>32</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Methadone</td>\n",
       "      <td>Opiate Withdrawal</td>\n",
       "      <td>\"Ive been on Methadone for over ten years and ...</td>\n",
       "      <td>7</td>\n",
       "      <td>18-Oct-16</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Levora</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>\"I was on this pill for almost two years. It d...</td>\n",
       "      <td>2</td>\n",
       "      <td>16-Apr-11</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          drugName                     condition  \\\n",
       "0      Mirtazapine                    Depression   \n",
       "1       Mesalamine  Crohn's Disease, Maintenance   \n",
       "2          Bactrim       Urinary Tract Infection   \n",
       "3         Contrave                   Weight Loss   \n",
       "4  Cyclafem 1 / 35                 Birth Control   \n",
       "5          Zyclara                     Keratosis   \n",
       "6           Copper                 Birth Control   \n",
       "7    Amitriptyline           Migraine Prevention   \n",
       "8        Methadone             Opiate Withdrawal   \n",
       "9           Levora                 Birth Control   \n",
       "\n",
       "                                              review  rating       date  \\\n",
       "0  \"I&#039;ve tried a few antidepressants over th...      10  28-Feb-12   \n",
       "1  \"My son has Crohn&#039;s disease and has done ...       8  17-May-09   \n",
       "2                      \"Quick reduction of symptoms\"       9  29-Sep-17   \n",
       "3  \"Contrave combines drugs that were used for al...       9   5-Mar-17   \n",
       "4  \"I have been on this birth control for one cyc...       9  22-Oct-15   \n",
       "5  \"4 days in on first 2 weeks.  Using on arms an...       4   3-Jul-14   \n",
       "6  \"I&#039;ve had the copper coil for about 3 mon...       6   6-Jun-16   \n",
       "7  \"This has been great for me. I&#039;ve been on...       9  21-Apr-09   \n",
       "8  \"Ive been on Methadone for over ten years and ...       7  18-Oct-16   \n",
       "9  \"I was on this pill for almost two years. It d...       2  16-Apr-11   \n",
       "\n",
       "   usefulCount  \n",
       "0           22  \n",
       "1           17  \n",
       "2            3  \n",
       "3           35  \n",
       "4            4  \n",
       "5           13  \n",
       "6            1  \n",
       "7           32  \n",
       "8           21  \n",
       "9            3  "
      ]
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_data_df.head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "id": "e48275a9-0fda-4150-81ad-b40394551b4d",
   "metadata": {},
   "outputs": [],
   "source": [
    "count=pd.Series('drugName')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "93dbd9d5-fd0c-435e-a78a-1577735b29e9",
   "metadata": {},
   "source": [
    "The intent of this code is to look at whether removing the nulls has indeed worked in the drugName column."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "id": "a235c6c6-b50b-4ed9-83a0-b60673d95ecf",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0    drugName\n",
      "dtype: object\n"
     ]
    }
   ],
   "source": [
    "print(count)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b6a5f95b-4cb8-494e-a449-ec5652db8619",
   "metadata": {},
   "source": [
    "After the preprocessing of data, my intent is to look at the commonly used drugs in this dataset and map this to the conditions. \n",
    "\n",
    "1. Which drugs are used for the greatest number of conditions?\n",
    "2. How many entries are there for each drug?\n",
    "3. For which conditions is each drug used for? \n",
    "4. Is there any overlap between drugs treating a condition - have three drugs been used to treat the same, identical condition?\n",
    "\n",
    " "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "id": "13230836-ee2b-4306-a1fb-ba7b93a0d933",
   "metadata": {},
   "outputs": [],
   "source": [
    "df=pd.DataFrame(drug_data_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "id": "5b4352a3-5821-41cb-b228-de8881f88f05",
   "metadata": {},
   "outputs": [],
   "source": [
    "popular_drugs=df['drugName'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "id": "331a3ba6-a2d8-47a1-b418-20571d0492af",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Most popular drugs in dataset:\n",
      "drugName\n",
      "Levonorgestrel                       1265\n",
      "Etonogestrel                         1081\n",
      "Ethinyl estradiol / norethindrone     869\n",
      "Nexplanon                             736\n",
      "Ethinyl estradiol / norgestimate      649\n",
      "                                     ... \n",
      "Stromectol                              1\n",
      "Loestrin Fe 1 / 20                      1\n",
      "Onfi                                    1\n",
      "Nimotop                                 1\n",
      "FluMist                                 1\n",
      "Name: count, Length: 2635, dtype: int64\n"
     ]
    }
   ],
   "source": [
    "print('Most popular drugs in dataset:')\n",
    "print(popular_drugs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "id": "7ec43eb6-c130-422b-9401-951751ede088",
   "metadata": {},
   "outputs": [],
   "source": [
    "popular_conditions=df['condition'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "id": "84cd52ff-c9bc-420d-8802-63b84bcba45c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Most popular conditions in this dataset:\n",
      "condition\n",
      "Birth Control                                  9648\n",
      "Depression                                     3095\n",
      "Pain                                           2100\n",
      "Anxiety                                        1908\n",
      "Acne                                           1847\n",
      "                                               ... \n",
      "Gender Dysphoria                                  1\n",
      "83</span> users found this comment helpful.       1\n",
      "Meningococcal Meningitis Prophylaxis              1\n",
      "Tympanostomy Tube Placement Surgery               1\n",
      "Strongyloidiasis                                  1\n",
      "Name: count, Length: 708, dtype: int64\n"
     ]
    }
   ],
   "source": [
    "print('Most popular conditions in this dataset:')\n",
    "print(popular_conditions)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4e3548ca-2a32-4c81-8680-5ff74e6d93a3",
   "metadata": {},
   "source": [
    "The five most popular 'conditions', or symptoms treated in this dataset are:\n",
    "\n",
    "1. drugs which provide suitable birth control\n",
    "2. drugs used to treat certain depressive states\n",
    "3. drugs used to provide pain relief\n",
    "4. drugs used to treat certain anxiety states\n",
    "5. and lastly acne"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "221f83f1-bd82-44b2-8e66-5e39bcfdd727",
   "metadata": {},
   "source": [
    "Lets' explore what the top drugs might be from this dataset. \n",
    "\n",
    "I will plot a bar chart to see which drugs are the most commonly used in this dataset."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "id": "962f7667-dce2-43cb-9864-0e15446234c4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Mirtazapine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>\"I&amp;#039;ve tried a few antidepressants over th...</td>\n",
       "      <td>10</td>\n",
       "      <td>28-Feb-12</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Mesalamine</td>\n",
       "      <td>Crohn's Disease, Maintenance</td>\n",
       "      <td>\"My son has Crohn&amp;#039;s disease and has done ...</td>\n",
       "      <td>8</td>\n",
       "      <td>17-May-09</td>\n",
       "      <td>17</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Bactrim</td>\n",
       "      <td>Urinary Tract Infection</td>\n",
       "      <td>\"Quick reduction of symptoms\"</td>\n",
       "      <td>9</td>\n",
       "      <td>29-Sep-17</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Contrave</td>\n",
       "      <td>Weight Loss</td>\n",
       "      <td>\"Contrave combines drugs that were used for al...</td>\n",
       "      <td>9</td>\n",
       "      <td>5-Mar-17</td>\n",
       "      <td>35</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Cyclafem 1 / 35</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>\"I have been on this birth control for one cyc...</td>\n",
       "      <td>9</td>\n",
       "      <td>22-Oct-15</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          drugName                     condition  \\\n",
       "0      Mirtazapine                    Depression   \n",
       "1       Mesalamine  Crohn's Disease, Maintenance   \n",
       "2          Bactrim       Urinary Tract Infection   \n",
       "3         Contrave                   Weight Loss   \n",
       "4  Cyclafem 1 / 35                 Birth Control   \n",
       "\n",
       "                                              review  rating       date  \\\n",
       "0  \"I&#039;ve tried a few antidepressants over th...      10  28-Feb-12   \n",
       "1  \"My son has Crohn&#039;s disease and has done ...       8  17-May-09   \n",
       "2                      \"Quick reduction of symptoms\"       9  29-Sep-17   \n",
       "3  \"Contrave combines drugs that were used for al...       9   5-Mar-17   \n",
       "4  \"I have been on this birth control for one cyc...       9  22-Oct-15   \n",
       "\n",
       "   usefulCount  \n",
       "0           22  \n",
       "1           17  \n",
       "2            3  \n",
       "3           35  \n",
       "4            4  "
      ]
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "id": "c466af12-a53d-41fc-b05a-97d3432a5ea3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Text(0.5, 1.0, 'Top10 Drugs: Number of drugs used')"
      ]
     },
     "execution_count": 76,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1400x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# \n",
    "temp_df=drug_data_df.groupby('drugName')['condition'].nunique().sort_values(ascending=False)[0:10]\n",
    "temp_df.sort_values(ascending=True).plot(kind=\"barh\", figsize=(14,6), fontsize=10, color=\"purple\")\n",
    "plt.xlabel(\" \", fontsize=20)\n",
    "plt.ylabel(\" \", fontsize=20)\n",
    "plt.title(\"Top10 Drugs: Number of drugs used\", fontsize=20)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "91348ade-3042-4f09-9650-f5b29cd5cefc",
   "metadata": {},
   "source": [
    "The top five drugs are:\n",
    "\n",
    "1. gabapentin,\n",
    "2. prednisolone,\n",
    "3. amitryptylline,\n",
    "4. venlafaxine,\n",
    "5. doxycycline \n",
    "\n",
    "What is interesting is that these drugs are commonly used to treat certain types of pain, depression. Doxycycline is an antibiotic used to treat a range of infections, it is also clinically indicated for the use of acne.\n",
    "\n",
    "Out of interest, I will list the bottom drugs used in this dataset."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "id": "ece1b4eb-cf7a-4cb4-931e-8b4cd1ff706f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Text(0.5, 1.0, 'Lowest 10: Number of drugs used per condition')"
      ]
     },
     "execution_count": 77,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1400x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "temp_df=drug_data_df.groupby('drugName')['condition'].nunique().sort_values(ascending=True)[0:10]\n",
    "temp_df.plot(kind=\"barh\", figsize=(14,6), fontsize=10, color=\"pink\")\n",
    "plt.xlabel(\" \", fontsize=20)\n",
    "plt.ylabel(\" \", fontsize=20)\n",
    "plt.title(\"Lowest 10: Number of drugs used per condition\", fontsize=20)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "223a1e81-2c0b-44be-b926-fedb311c535e",
   "metadata": {},
   "source": [
    "The least commonly used used in this dataset are:\n",
    "\n",
    "1. Metrogel Vaginal (metronidazole generic name, used to treat vaginal infections)\n",
    "2. Mevacor (lovastatin, generic name, for high cholesterol)\n",
    "3. Miacalcin Nasal (calcitonin, generic, for osteoporosis prevention in post menopausal women)\n",
    "4. Mibelas 24 Fe (norethindrone acetate, ethinyl estradiol and ferrous fumarate, birth control)\n",
    "5. Micardis HCT (telmesartan and hydrochlorotiazide, angiotensin receptor blocker and a thiazide-diuretic, for essential high blood pressure)\n",
    "6. miconazole/zinc oxide topical application (usually used to treat nappy rash in babies and yeast infections in adults)\n",
    "7. Microgestin 1.5/3.0 (norethindrone and ehtinyl estradiol, birth control)\n",
    "8. Microzide (hydrochlorothiazide, used to treat high blood pressure)\n",
    "9. Migergot (ergotamine and caffeine suppository, used to treat migraines or vascular headaches)\n",
    "10. A/B Otic (antipyrine and benzocaine, used to treat and relief symptoms of ear infections)\n",
    "\n",
    "These drugs are used to treat more obscure conditions. Perhaps users are less likely to provide a review for something which is more difficult to tell whether it's treated a symptom. For example, how can a lay person 'feel healthier' after having taken a drug for high cholesterol? Maybe the benefits to taking these medications cannot be limited to a positive review insisting an immediate beenfit to its use. For these reasons, if I have more time, I intend to employ some kind of NLP, looking more closely at sentiment analysis."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "id": "3af28165-da5a-49a4-a858-00aa5df33a92",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2635\n"
     ]
    }
   ],
   "source": [
    "#how many drugs from the dataset only treat one condition?\n",
    "pop_drugs_conditions=df.groupby(by='drugName')['condition'].nunique()\n",
    "single_condition_drugs=pop_drugs_conditions[pop_drugs_conditions ==1]\n",
    "count_single_condition_drugs=pop_drugs_conditions.count()\n",
    "print(count_single_condition_drugs)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "da638405-be29-498a-b83e-49c0481fe635",
   "metadata": {},
   "source": [
    "From this dataset, there are 2635 drugs used to treat one clinical indication."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "id": "a4221db1-e8db-4b7e-b1ff-e0be19652c65",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "drugName\n",
       "A / B Otic                               1\n",
       "Abacavir / dolutegravir / lamivudine     1\n",
       "Abacavir / lamivudine                    1\n",
       "Abatacept                                1\n",
       "Abilify                                 11\n",
       "Name: condition, dtype: int64"
      ]
     },
     "execution_count": 79,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#which drugs are used for the greatest number of conditions?\n",
    "pop_drugs_conditions=df.groupby(by='drugName')['condition'].nunique()\n",
    "pop_drugs_conditions.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "id": "202541bb-67cb-4ba8-bf2d-3871a8dc9557",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "drugName\n",
       "Gabapentin             26\n",
       "Prednisone             26\n",
       "Amitriptyline          19\n",
       "Venlafaxine            18\n",
       "Doxycycline            17\n",
       "                       ..\n",
       "Galantamine             1\n",
       "Gadoxetate disodium     1\n",
       "Gabitril                1\n",
       "Gabarone                1\n",
       "pHisoHex                1\n",
       "Name: condition, Length: 2635, dtype: int64"
      ]
     },
     "execution_count": 80,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pop_drugs_conditions.sort_values(ascending=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "id": "29f85b24-bf2d-45f4-aa34-e4344a2377f0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>Gabapentin</td>\n",
       "      <td>Bipolar Disorde</td>\n",
       "      <td>\"I started taking gabapentin experimentally to...</td>\n",
       "      <td>8</td>\n",
       "      <td>24-Sep-14</td>\n",
       "      <td>75</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>193</th>\n",
       "      <td>Gabapentin</td>\n",
       "      <td>ibromyalgia</td>\n",
       "      <td>\"It honestly helps a lot for my nerve pain, I ...</td>\n",
       "      <td>9</td>\n",
       "      <td>17-May-16</td>\n",
       "      <td>43</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>229</th>\n",
       "      <td>Gabapentin</td>\n",
       "      <td>Pain</td>\n",
       "      <td>\"I have a bulging disc and low back that has d...</td>\n",
       "      <td>9</td>\n",
       "      <td>9-May-10</td>\n",
       "      <td>37</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>245</th>\n",
       "      <td>Gabapentin</td>\n",
       "      <td>Anxiety</td>\n",
       "      <td>\"Ok,   its funny i found this page because  it...</td>\n",
       "      <td>8</td>\n",
       "      <td>9-May-16</td>\n",
       "      <td>66</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>259</th>\n",
       "      <td>Gabapentin</td>\n",
       "      <td>Anxiety</td>\n",
       "      <td>\"I was prescribed this for Anxiety never shoul...</td>\n",
       "      <td>1</td>\n",
       "      <td>24-Nov-16</td>\n",
       "      <td>40</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53200</th>\n",
       "      <td>Gabapentin</td>\n",
       "      <td>Restless Legs Syndrome</td>\n",
       "      <td>\"I have been suffering from Restless legs synd...</td>\n",
       "      <td>10</td>\n",
       "      <td>25-Nov-13</td>\n",
       "      <td>126</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53436</th>\n",
       "      <td>Gabapentin</td>\n",
       "      <td>Anxiety</td>\n",
       "      <td>\"I can&amp;#039;t tolerate SSRI&amp;#039;s.  I&amp;#039;ve...</td>\n",
       "      <td>10</td>\n",
       "      <td>31-Oct-13</td>\n",
       "      <td>64</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53584</th>\n",
       "      <td>Gabapentin</td>\n",
       "      <td>Restless Legs Syndrome</td>\n",
       "      <td>\"I feel that this medication has given my life...</td>\n",
       "      <td>6</td>\n",
       "      <td>30-Dec-15</td>\n",
       "      <td>48</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53607</th>\n",
       "      <td>Gabapentin</td>\n",
       "      <td>Peripheral Neuropathy</td>\n",
       "      <td>\"This is the only drug that works for me. I us...</td>\n",
       "      <td>7</td>\n",
       "      <td>25-Jul-09</td>\n",
       "      <td>30</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53657</th>\n",
       "      <td>Gabapentin</td>\n",
       "      <td>Anxiety</td>\n",
       "      <td>\"Gabapentin is the most liberating medicine I ...</td>\n",
       "      <td>10</td>\n",
       "      <td>17-Jul-11</td>\n",
       "      <td>67</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>367 rows Ã— 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "         drugName               condition  \\\n",
       "41     Gabapentin         Bipolar Disorde   \n",
       "193    Gabapentin             ibromyalgia   \n",
       "229    Gabapentin                    Pain   \n",
       "245    Gabapentin                 Anxiety   \n",
       "259    Gabapentin                 Anxiety   \n",
       "...           ...                     ...   \n",
       "53200  Gabapentin  Restless Legs Syndrome   \n",
       "53436  Gabapentin                 Anxiety   \n",
       "53584  Gabapentin  Restless Legs Syndrome   \n",
       "53607  Gabapentin   Peripheral Neuropathy   \n",
       "53657  Gabapentin                 Anxiety   \n",
       "\n",
       "                                                  review  rating       date  \\\n",
       "41     \"I started taking gabapentin experimentally to...       8  24-Sep-14   \n",
       "193    \"It honestly helps a lot for my nerve pain, I ...       9  17-May-16   \n",
       "229    \"I have a bulging disc and low back that has d...       9   9-May-10   \n",
       "245    \"Ok,   its funny i found this page because  it...       8   9-May-16   \n",
       "259    \"I was prescribed this for Anxiety never shoul...       1  24-Nov-16   \n",
       "...                                                  ...     ...        ...   \n",
       "53200  \"I have been suffering from Restless legs synd...      10  25-Nov-13   \n",
       "53436  \"I can&#039;t tolerate SSRI&#039;s.  I&#039;ve...      10  31-Oct-13   \n",
       "53584  \"I feel that this medication has given my life...       6  30-Dec-15   \n",
       "53607  \"This is the only drug that works for me. I us...       7  25-Jul-09   \n",
       "53657  \"Gabapentin is the most liberating medicine I ...      10  17-Jul-11   \n",
       "\n",
       "       usefulCount  \n",
       "41              75  \n",
       "193             43  \n",
       "229             37  \n",
       "245             66  \n",
       "259             40  \n",
       "...            ...  \n",
       "53200          126  \n",
       "53436           64  \n",
       "53584           48  \n",
       "53607           30  \n",
       "53657           67  \n",
       "\n",
       "[367 rows x 6 columns]"
      ]
     },
     "execution_count": 81,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_name='Gabapentin'\n",
    "filter=df['drugName']==drug_name\n",
    "df[filter]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "id": "1a37cdb8-a731-4d0c-90c4-b94428cbfd06",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['Bipolar Disorde', 'ibromyalgia', 'Pain', 'Anxiety',\n",
       "       'Peripheral Neuropathy', 'Migraine',\n",
       "       'Diabetic Peripheral Neuropathy', 'Restless Legs Syndrome',\n",
       "       'Occipital Neuralgia', 'Postherpetic Neuralgia', 'Insomnia',\n",
       "       'Neuropathic Pain', 'Hot Flashes', 'Alcohol Withdrawal', 'Hiccups',\n",
       "       'Epilepsy', 'Reflex Sympathetic Dystrophy Syndrome',\n",
       "       'Spondylolisthesis', 'Not Listed / Othe', 'Vulvodynia', 'Cough',\n",
       "       'Trigeminal Neuralgia', 'Pruritus',\n",
       "       'Periodic Limb Movement Disorde',\n",
       "       'Nausea/Vomiting, Chemotherapy Induced', 'Benign Essential Trem'],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 82,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[filter]['condition'].unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "id": "9c2e51ce-c48c-4a6c-b7f0-c5c6c2da6fa2",
   "metadata": {},
   "outputs": [],
   "source": [
    "gabapentin_conditions=df[filter][['condition']].value_counts().rename_axis('unique_values').reset_index(name='counts')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "id": "8c94b513-7bf1-487c-976c-f109b61890c6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>unique_values</th>\n",
       "      <th>counts</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Anxiety</td>\n",
       "      <td>67</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Pain</td>\n",
       "      <td>63</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>ibromyalgia</td>\n",
       "      <td>38</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Peripheral Neuropathy</td>\n",
       "      <td>33</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Restless Legs Syndrome</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "            unique_values  counts\n",
       "0                 Anxiety      67\n",
       "1                    Pain      63\n",
       "2             ibromyalgia      38\n",
       "3   Peripheral Neuropathy      33\n",
       "4  Restless Legs Syndrome      21"
      ]
     },
     "execution_count": 84,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "gabapentin_conditions.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "id": "5a225835-63e8-485f-ba5b-c1f2bb89cc76",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# draw a bar chart, y axis conditions, x axis drug\n",
    "\n",
    "#import pandas as pd\n",
    "#import matplotlib.pyplot as plt\n",
    "\n",
    "#df=pd.DataFrame(drug_data_df)\n",
    "#filter=df[filter]['condition'].value_counts()\n",
    "#value_counts.plot(kind='bar', color='skyblue')\n",
    "#plt.xlabel('Gabapentin')\n",
    "#plt.ylabel('condition')\n",
    "#plt.title(\"conditions treated using Gabapentin\")\n",
    "\n",
    "#plt.show()\n",
    "\n",
    "sns.barplot(gabapentin_conditions, x=\"counts\", y=\"unique_values\").set(title=\"'Conditions' treated using Gabapentin\");"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fe5cb05c-e7ff-4e64-a2ab-3019a7ef5e0b",
   "metadata": {},
   "source": [
    "From the graph above, gabapentin is treated for a wide range of clinical indications. The top five common uses for gabapentin are:\n",
    "\n",
    "1. anxiety\n",
    "2. pain management\n",
    "3. fibromylagia\n",
    "4. peripheral neuropathy\n",
    "5. restless legs syndrome\n",
    "\n",
    "The five least commonly used indications of gabapentin are:\n",
    "1. vulvodynia\n",
    "2. spondylolisthesis\n",
    "3. benign essential tremor\n",
    "4. pruritus\n",
    "5. cough"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "id": "aa3798c4-ab43-4d57-ba75-2bb6bb2e71f9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2784</th>\n",
       "      <td>Prednisolone</td>\n",
       "      <td>Postoperative Ocular Inflammation</td>\n",
       "      <td>\"Experiencing muscle pain and weakness, poor s...</td>\n",
       "      <td>2</td>\n",
       "      <td>17-Dec-16</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13425</th>\n",
       "      <td>Prednisolone</td>\n",
       "      <td>Bullous Pemphigoid</td>\n",
       "      <td>\"I was sliding downhill very fast with Pemphig...</td>\n",
       "      <td>9</td>\n",
       "      <td>28-Sep-15</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14522</th>\n",
       "      <td>Prednisolone</td>\n",
       "      <td>Postoperative Ocular Inflammation</td>\n",
       "      <td>\"Caused the eye to burn afterwards.\"</td>\n",
       "      <td>2</td>\n",
       "      <td>28-May-15</td>\n",
       "      <td>14</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19858</th>\n",
       "      <td>Prednisolone</td>\n",
       "      <td>Iritis</td>\n",
       "      <td>\"I am a 75 year old male, and have reoccurring...</td>\n",
       "      <td>8</td>\n",
       "      <td>25-Aug-16</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40041</th>\n",
       "      <td>Prednisolone</td>\n",
       "      <td>Inflammatory Conditions</td>\n",
       "      <td>\"First time taking pred and was on 40mg for Ul...</td>\n",
       "      <td>6</td>\n",
       "      <td>7-Sep-16</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43885</th>\n",
       "      <td>Prednisolone</td>\n",
       "      <td>Inflammatory Conditions</td>\n",
       "      <td>\"I had post nasal drip with a cough.  It helpe...</td>\n",
       "      <td>5</td>\n",
       "      <td>13-Sep-15</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46215</th>\n",
       "      <td>Prednisolone</td>\n",
       "      <td>Dermatitis</td>\n",
       "      <td>\"Had itching, redness and rashes between finge...</td>\n",
       "      <td>7</td>\n",
       "      <td>25-Sep-17</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           drugName                          condition  \\\n",
       "2784   Prednisolone  Postoperative Ocular Inflammation   \n",
       "13425  Prednisolone                 Bullous Pemphigoid   \n",
       "14522  Prednisolone  Postoperative Ocular Inflammation   \n",
       "19858  Prednisolone                             Iritis   \n",
       "40041  Prednisolone            Inflammatory Conditions   \n",
       "43885  Prednisolone            Inflammatory Conditions   \n",
       "46215  Prednisolone                         Dermatitis   \n",
       "\n",
       "                                                  review  rating       date  \\\n",
       "2784   \"Experiencing muscle pain and weakness, poor s...       2  17-Dec-16   \n",
       "13425  \"I was sliding downhill very fast with Pemphig...       9  28-Sep-15   \n",
       "14522               \"Caused the eye to burn afterwards.\"       2  28-May-15   \n",
       "19858  \"I am a 75 year old male, and have reoccurring...       8  25-Aug-16   \n",
       "40041  \"First time taking pred and was on 40mg for Ul...       6   7-Sep-16   \n",
       "43885  \"I had post nasal drip with a cough.  It helpe...       5  13-Sep-15   \n",
       "46215  \"Had itching, redness and rashes between finge...       7  25-Sep-17   \n",
       "\n",
       "       usefulCount  \n",
       "2784             7  \n",
       "13425            2  \n",
       "14522           14  \n",
       "19858            2  \n",
       "40041            7  \n",
       "43885            1  \n",
       "46215            0  "
      ]
     },
     "execution_count": 86,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_name2='Prednisolone'\n",
    "filter=df['drugName']==drug_name2\n",
    "df[filter]\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 87,
   "id": "dc05a094-20bb-4b57-9cd1-8ded8d4efac4",
   "metadata": {},
   "outputs": [],
   "source": [
    "prednisolone_conditions=df[filter][['condition']].value_counts().rename_axis('unique_values').reset_index(name='counts')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 88,
   "id": "d9fb1eb5-01b9-4f27-9306-6a10068735cc",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>unique_values</th>\n",
       "      <th>counts</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Inflammatory Conditions</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Postoperative Ocular Inflammation</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Bullous Pemphigoid</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Dermatitis</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Iritis</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                       unique_values  counts\n",
       "0            Inflammatory Conditions       2\n",
       "1  Postoperative Ocular Inflammation       2\n",
       "2                 Bullous Pemphigoid       1\n",
       "3                         Dermatitis       1\n",
       "4                             Iritis       1"
      ]
     },
     "execution_count": 88,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "prednisolone_conditions.head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "id": "0e0b0c52-2661-4e24-bfe0-7479217faeff",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "#bar chart\n",
    "sns.barplot(prednisolone_conditions, x=\"counts\", y=\"unique_values\").set(title=\"'Conditions' treated with Prednisolone\");"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "186fb224-1b44-45de-bdb5-b4f3644d0acb",
   "metadata": {},
   "source": [
    "Prednisolone is commonly used to treat a range of inflammatory conditions. From this dataset, it is used to treat a group of unclassified and ubiquitous \"inflammatory conditions\", and also:\n",
    "1. post surgical ocular inflammation\n",
    "2. bullous pemphigoid\n",
    "3. dermatitis\n",
    "4. iritis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 90,
   "id": "88bd862e-2827-49dd-a367-9af222064dd9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Amitriptyline</td>\n",
       "      <td>Migraine Prevention</td>\n",
       "      <td>\"This has been great for me. I&amp;#039;ve been on...</td>\n",
       "      <td>9</td>\n",
       "      <td>21-Apr-09</td>\n",
       "      <td>32</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117</th>\n",
       "      <td>Amitriptyline</td>\n",
       "      <td>ibromyalgia</td>\n",
       "      <td>\"I am a 66 year old post-premenopausal female ...</td>\n",
       "      <td>1</td>\n",
       "      <td>30-Nov-17</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>395</th>\n",
       "      <td>Amitriptyline</td>\n",
       "      <td>Anxiety and Stress</td>\n",
       "      <td>\"I&amp;#039;ve only been taking this for a month. ...</td>\n",
       "      <td>4</td>\n",
       "      <td>13-Feb-14</td>\n",
       "      <td>62</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>404</th>\n",
       "      <td>Amitriptyline</td>\n",
       "      <td>ibromyalgia</td>\n",
       "      <td>\"I was just diagnosed with Fibromyalgia, was b...</td>\n",
       "      <td>2</td>\n",
       "      <td>17-Jan-11</td>\n",
       "      <td>46</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1000</th>\n",
       "      <td>Amitriptyline</td>\n",
       "      <td>ibromyalgia</td>\n",
       "      <td>\"I had unrefreshing sleep, and needed a lot of...</td>\n",
       "      <td>9</td>\n",
       "      <td>9-May-12</td>\n",
       "      <td>122</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53292</th>\n",
       "      <td>Amitriptyline</td>\n",
       "      <td>Migraine Prevention</td>\n",
       "      <td>\"I had been taking propranolol for migraine pr...</td>\n",
       "      <td>9</td>\n",
       "      <td>20-Sep-13</td>\n",
       "      <td>64</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53444</th>\n",
       "      <td>Amitriptyline</td>\n",
       "      <td>Migraine Prevention</td>\n",
       "      <td>\"I have chronic Lyme disease and one of the wo...</td>\n",
       "      <td>10</td>\n",
       "      <td>4-Sep-14</td>\n",
       "      <td>65</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53490</th>\n",
       "      <td>Amitriptyline</td>\n",
       "      <td>Anxiety and Stress</td>\n",
       "      <td>\"Started for sleep. No difference with headach...</td>\n",
       "      <td>3</td>\n",
       "      <td>2-Feb-17</td>\n",
       "      <td>10</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53520</th>\n",
       "      <td>Amitriptyline</td>\n",
       "      <td>Pain</td>\n",
       "      <td>\"Took it for a few days but could not stay awa...</td>\n",
       "      <td>1</td>\n",
       "      <td>27-Nov-15</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53524</th>\n",
       "      <td>Amitriptyline</td>\n",
       "      <td>Migraine Prevention</td>\n",
       "      <td>\"Husband has turned in to a angry hulk. I know...</td>\n",
       "      <td>1</td>\n",
       "      <td>4-Sep-15</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>225 rows Ã— 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "            drugName            condition  \\\n",
       "7      Amitriptyline  Migraine Prevention   \n",
       "117    Amitriptyline          ibromyalgia   \n",
       "395    Amitriptyline   Anxiety and Stress   \n",
       "404    Amitriptyline          ibromyalgia   \n",
       "1000   Amitriptyline          ibromyalgia   \n",
       "...              ...                  ...   \n",
       "53292  Amitriptyline  Migraine Prevention   \n",
       "53444  Amitriptyline  Migraine Prevention   \n",
       "53490  Amitriptyline   Anxiety and Stress   \n",
       "53520  Amitriptyline                 Pain   \n",
       "53524  Amitriptyline  Migraine Prevention   \n",
       "\n",
       "                                                  review  rating       date  \\\n",
       "7      \"This has been great for me. I&#039;ve been on...       9  21-Apr-09   \n",
       "117    \"I am a 66 year old post-premenopausal female ...       1  30-Nov-17   \n",
       "395    \"I&#039;ve only been taking this for a month. ...       4  13-Feb-14   \n",
       "404    \"I was just diagnosed with Fibromyalgia, was b...       2  17-Jan-11   \n",
       "1000   \"I had unrefreshing sleep, and needed a lot of...       9   9-May-12   \n",
       "...                                                  ...     ...        ...   \n",
       "53292  \"I had been taking propranolol for migraine pr...       9  20-Sep-13   \n",
       "53444  \"I have chronic Lyme disease and one of the wo...      10   4-Sep-14   \n",
       "53490  \"Started for sleep. No difference with headach...       3   2-Feb-17   \n",
       "53520  \"Took it for a few days but could not stay awa...       1  27-Nov-15   \n",
       "53524  \"Husband has turned in to a angry hulk. I know...       1   4-Sep-15   \n",
       "\n",
       "       usefulCount  \n",
       "7               32  \n",
       "117              0  \n",
       "395             62  \n",
       "404             46  \n",
       "1000           122  \n",
       "...            ...  \n",
       "53292           64  \n",
       "53444           65  \n",
       "53490           10  \n",
       "53520           20  \n",
       "53524           19  \n",
       "\n",
       "[225 rows x 6 columns]"
      ]
     },
     "execution_count": 90,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_name3='Amitriptyline'\n",
    "filter=df['drugName']==drug_name3\n",
    "df[filter]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 91,
   "id": "31a88af9-e18e-439d-bbba-3e6ae6d329f8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "condition\n",
       "Migraine Prevention                      56\n",
       "Pain                                     42\n",
       "Insomnia                                 39\n",
       "ibromyalgia                              25\n",
       "Anxiety and Stress                       20\n",
       "Depression                               13\n",
       "Irritable Bowel Syndrome                 10\n",
       "Interstitial Cystitis                     5\n",
       "Cyclic Vomiting Syndrome                  4\n",
       "Post Traumatic Stress Disorde             2\n",
       "Reflex Sympathetic Dystrophy Syndrome     1\n",
       "Chronic Myofascial Pain                   1\n",
       "m Pain Disorde                            1\n",
       "Vulvodynia                                1\n",
       "Cough                                     1\n",
       "Not Listed / Othe                         1\n",
       "Somat                                     1\n",
       "Hyperhidrosis                             1\n",
       "Pudendal Neuralgia                        1\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 91,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[filter]['condition'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 92,
   "id": "4db67d8e-150e-4378-9623-bd8586394fe3",
   "metadata": {},
   "outputs": [],
   "source": [
    "#barchart\n",
    "amitriptyline_conditions=df[filter][['condition']].value_counts().rename_axis('unique_values').reset_index(name='counts')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 93,
   "id": "b8724626-1861-40aa-bc00-0034ed1d8951",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>unique_values</th>\n",
       "      <th>counts</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Migraine Prevention</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Pain</td>\n",
       "      <td>42</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Insomnia</td>\n",
       "      <td>39</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ibromyalgia</td>\n",
       "      <td>25</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Anxiety and Stress</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         unique_values  counts\n",
       "0  Migraine Prevention      56\n",
       "1                 Pain      42\n",
       "2             Insomnia      39\n",
       "3          ibromyalgia      25\n",
       "4   Anxiety and Stress      20"
      ]
     },
     "execution_count": 93,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "amitriptyline_conditions.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 94,
   "id": "a450ab9c-2a1f-48b4-bbc4-f642248bc0aa",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.barplot(amitriptyline_conditions, x=\"counts\", y=\"unique_values\").set(title=\"'Conditions' treat using Amitryptylline\");"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8edce0fe-d464-44e3-bdd6-fe66ea4e65b5",
   "metadata": {},
   "source": [
    "In this datatset, amitriptyline is commonly used for:\n",
    "\n",
    "1. treating symptoms of depression\n",
    "2. treating symptoms of anxiety\n",
    "3. treating 'anxiety and stress'\n",
    "4. fibromyalgia\n",
    "5. and major despressive disorder\n",
    "\n",
    "It is less commonly used to treat:\n",
    "1. bulimia\n",
    "2. 'other' conditions\n",
    "3. muscular pain disorder\n",
    "4. irritable bowel syndrome\n",
    "5. and dissociative identity disorder\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6bc2b128-ef64-40ec-a346-2b1471e4113c",
   "metadata": {},
   "source": [
    "There might be overlap here, and thus duplicated entries. 'Anxiety' and 'anxiety and stress' might be the same clinical indications."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 95,
   "id": "837b0a07-670d-41d2-9830-11f16f6724ff",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>\"I was first prescribed Effexor 13 years ago a...</td>\n",
       "      <td>8</td>\n",
       "      <td>13-Dec-10</td>\n",
       "      <td>36</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>\"I took Effexor for the first and last time ye...</td>\n",
       "      <td>1</td>\n",
       "      <td>12-Oct-17</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>223</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>\"Horrible side effects! I tried Ciprelex (esci...</td>\n",
       "      <td>1</td>\n",
       "      <td>15-Jun-16</td>\n",
       "      <td>24</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>586</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Major Depressive Disorde</td>\n",
       "      <td>\"I&amp;#039;ve been on Effexor xr for 2 weeks and ...</td>\n",
       "      <td>10</td>\n",
       "      <td>8-Jul-16</td>\n",
       "      <td>30</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>712</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Anxiety</td>\n",
       "      <td>\"I suffered with severe anxiety, especially in...</td>\n",
       "      <td>9</td>\n",
       "      <td>23-Dec-13</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52286</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Generalized Anxiety Disorde</td>\n",
       "      <td>\"Changes my life for the better!\"</td>\n",
       "      <td>10</td>\n",
       "      <td>10-Mar-14</td>\n",
       "      <td>62</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52683</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Anxiety and Stress</td>\n",
       "      <td>\"I have multiple health issues and am very anx...</td>\n",
       "      <td>8</td>\n",
       "      <td>24-Apr-11</td>\n",
       "      <td>13</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52904</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>\"Though the medication helped my depression, I...</td>\n",
       "      <td>3</td>\n",
       "      <td>22-Jan-17</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52953</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>\"this med did its job reasonably. Didn&amp;#039;t ...</td>\n",
       "      <td>6</td>\n",
       "      <td>16-Aug-16</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53618</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Generalized Anxiety Disorde</td>\n",
       "      <td>\"I&amp;#039;m on 75mg venlafaxine but I&amp;#039;m goi...</td>\n",
       "      <td>5</td>\n",
       "      <td>10-Aug-17</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>320 rows Ã— 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "          drugName                    condition  \\\n",
       "79     Venlafaxine                   Depression   \n",
       "81     Venlafaxine                   Depression   \n",
       "223    Venlafaxine                   Depression   \n",
       "586    Venlafaxine     Major Depressive Disorde   \n",
       "712    Venlafaxine                      Anxiety   \n",
       "...            ...                          ...   \n",
       "52286  Venlafaxine  Generalized Anxiety Disorde   \n",
       "52683  Venlafaxine           Anxiety and Stress   \n",
       "52904  Venlafaxine                   Depression   \n",
       "52953  Venlafaxine                   Depression   \n",
       "53618  Venlafaxine  Generalized Anxiety Disorde   \n",
       "\n",
       "                                                  review  rating       date  \\\n",
       "79     \"I was first prescribed Effexor 13 years ago a...       8  13-Dec-10   \n",
       "81     \"I took Effexor for the first and last time ye...       1  12-Oct-17   \n",
       "223    \"Horrible side effects! I tried Ciprelex (esci...       1  15-Jun-16   \n",
       "586    \"I&#039;ve been on Effexor xr for 2 weeks and ...      10   8-Jul-16   \n",
       "712    \"I suffered with severe anxiety, especially in...       9  23-Dec-13   \n",
       "...                                                  ...     ...        ...   \n",
       "52286                  \"Changes my life for the better!\"      10  10-Mar-14   \n",
       "52683  \"I have multiple health issues and am very anx...       8  24-Apr-11   \n",
       "52904  \"Though the medication helped my depression, I...       3  22-Jan-17   \n",
       "52953  \"this med did its job reasonably. Didn&#039;t ...       6  16-Aug-16   \n",
       "53618  \"I&#039;m on 75mg venlafaxine but I&#039;m goi...       5  10-Aug-17   \n",
       "\n",
       "       usefulCount  \n",
       "79              36  \n",
       "81               5  \n",
       "223             24  \n",
       "586             30  \n",
       "712             22  \n",
       "...            ...  \n",
       "52286           62  \n",
       "52683           13  \n",
       "52904            2  \n",
       "52953            1  \n",
       "53618            1  \n",
       "\n",
       "[320 rows x 6 columns]"
      ]
     },
     "execution_count": 95,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_name4='Venlafaxine'\n",
    "filter=df['drugName']==drug_name4\n",
    "df[filter]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 96,
   "id": "69f686f2-5e0d-4c5d-8e78-f1023d177781",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "condition\n",
       "Depression                       137\n",
       "Anxiety                           46\n",
       "Anxiety and Stress                26\n",
       "Generalized Anxiety Disorde       24\n",
       "ibromyalgia                       14\n",
       "Major Depressive Disorde          14\n",
       "Bipolar Disorde                   14\n",
       "Hot Flashes                       12\n",
       "Social Anxiety Disorde            11\n",
       "Panic Disorde                      7\n",
       "Postpartum Depression              4\n",
       "Post Traumatic Stress Disorde      4\n",
       "Obsessive Compulsive Disorde       2\n",
       "Irritable Bowel Syndrome           1\n",
       "Not Listed / Othe                  1\n",
       "m Pain Disorde                     1\n",
       "Dissociative Identity Disorde      1\n",
       "Bulimia                            1\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 96,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[filter]['condition'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "id": "e2eb08a7-5063-4c9a-899f-603b89b114a0",
   "metadata": {},
   "outputs": [],
   "source": [
    "#barchart\n",
    "venlafaxine_conditions=df[filter][['condition']].value_counts().rename_axis('unique_values').reset_index(name='counts')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "id": "a9b24c7f-497d-4707-b65b-673fd4c9b582",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>unique_values</th>\n",
       "      <th>counts</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Depression</td>\n",
       "      <td>137</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Anxiety</td>\n",
       "      <td>46</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Anxiety and Stress</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Generalized Anxiety Disorde</td>\n",
       "      <td>24</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ibromyalgia</td>\n",
       "      <td>14</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                 unique_values  counts\n",
       "0                   Depression     137\n",
       "1                      Anxiety      46\n",
       "2           Anxiety and Stress      26\n",
       "3  Generalized Anxiety Disorde      24\n",
       "4                  ibromyalgia      14"
      ]
     },
     "execution_count": 98,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "venlafaxine_conditions.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "id": "2e1cfc2a-62da-4f74-abde-2d31c484700d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.barplot(venlafaxine_conditions, x=\"counts\", y=\"unique_values\").set(title=\"'Conditions' treated using Venlafaxine\");"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "dda6ce0a-53fa-40bf-9fda-c8cea6fded1c",
   "metadata": {},
   "source": [
    "Venlafxaine is commonly used to treat:\n",
    "\n",
    "1. depression\n",
    "2. anxiety\n",
    "3. stress\n",
    "4. generalised anxiety disorder\n",
    "5. and fibromylagia\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "id": "6966f4f5-267f-4b13-b585-113f3cda937b",
   "metadata": {},
   "outputs": [],
   "source": [
    "#are there any drugs used to treat more than one condition?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "id": "b02a4160-3ef4-46a6-8201-e37fa21fb01b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "drugName\n",
       "Levonorgestrel                       1265\n",
       "Etonogestrel                         1081\n",
       "Ethinyl estradiol / norethindrone     869\n",
       "Nexplanon                             736\n",
       "Ethinyl estradiol / norgestimate      649\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 101,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "popular_drugs.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "id": "2fc787a5-ab8f-4e1c-8926-a930757e8c64",
   "metadata": {},
   "outputs": [],
   "source": [
    "top_drugs=popular_drugs.to_frame().reset_index()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 103,
   "id": "6ae67372-230d-4ed7-a9b0-d95d8bca6bd3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugName</th>\n",
       "      <th>count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Levonorgestrel</td>\n",
       "      <td>1265</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Etonogestrel</td>\n",
       "      <td>1081</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Ethinyl estradiol / norethindrone</td>\n",
       "      <td>869</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Nexplanon</td>\n",
       "      <td>736</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Ethinyl estradiol / norgestimate</td>\n",
       "      <td>649</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                            drugName  count\n",
       "0                     Levonorgestrel   1265\n",
       "1                       Etonogestrel   1081\n",
       "2  Ethinyl estradiol / norethindrone    869\n",
       "3                          Nexplanon    736\n",
       "4   Ethinyl estradiol / norgestimate    649"
      ]
     },
     "execution_count": 103,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "top_drugs.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7488e07b-7ea8-483c-91fd-078494576a68",
   "metadata": {},
   "source": [
    "The most common drugs in this dataset are:\n",
    "\n",
    "1. levonorgestrel\n",
    "2. etonogestrel\n",
    "3. ethninyl estradiol/northindrone\n",
    "4. nexplanon\n",
    "5. ethinyl estradiol/norgestimate\n",
    "\n",
    "All five drugs are hormones used for birth control. One drug is listed by its brand name - Nexplanon. The other four are listed by their generic names.\n",
    "\n",
    "There may be overlap in this dataset of drugs used. The brand and the generic drug names are used but haven't been tidied up. Nexplanon is the same drug as etonogestrel."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "id": "24f954e7-15f9-41d3-87c4-60cf4023c9e9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Axes: ylabel='condition'>"
      ]
     },
     "execution_count": 104,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "drug_data_df.groupby('condition')['drugName'].nunique().sort_values(ascending=False)[:10].plot(kind=\"barh\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b4f999e7-e4e3-432b-ab95-960cd4c1ad7b",
   "metadata": {},
   "source": [
    "From this dataset, clincial indications such as pain, birth control and high blood pressure are treated or managed by more than one drug."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c7e0a67e-9cef-4a2f-a385-02cee4ac45fa",
   "metadata": {},
   "source": [
    "CONCLUSION!\n",
    "\n",
    "For my preliminary anaylsis I can identify the most commonly used drugs and the most common clinical indications for which these drugs are used for. \n",
    "\n",
    "The top five drugs used based on the number of 'conditions' treated:\n",
    "1. gabapentin,\n",
    "2. prednisolone\n",
    "3. amitryptylline\n",
    "4. venlafaxine\n",
    "5. doxycycline\n",
    "\n",
    "The least popular drugs used as per count:\n",
    "1. Metrogel\n",
    "2. Mevacor\n",
    "3. Miacalcin\n",
    "4. Micardis HCT\n",
    "5. Miconazole/zinc oxide\n",
    "\n",
    "Gabapentin is used to treat:\n",
    "1. anxiety,\n",
    "2. pain,\n",
    "3. fibromyalgia\n",
    "4. peripheral neuropathy\n",
    "5. restless leg syndrome\n",
    "\n",
    "Prednisolone is used to treat:\n",
    "1. inflammatory conditions\n",
    "2. postoperative ocular inflammation\n",
    "3. bullous periphigold\n",
    "4. dermatitis\n",
    "5. iritis\n",
    "\n",
    "Amitryptylline is used to treat:\n",
    "1. migraine\n",
    "2. pain\n",
    "3. insomnia\n",
    "4. fibromyalgia\n",
    "5. anxiety and stress\n",
    "\n",
    "Venlafaxine is used to treat:\n",
    "1. depression\n",
    "2. anxiety\n",
    "3. anxiety and stress\n",
    "4. generalised anxiety disorder\n",
    "5. fibromyalgia\n",
    "\n",
    "\n",
    "I've identified some further data cleaning required to reduce cases of synonomy in this dataset:\n",
    "\n",
    "1. to unify brand names and generic names. For this I would ideally need to know from which country this dataset is from and that would detwermine which generic and brane names the country would have access to.\n",
    "2. Spelling mistakes of data entries - for example 'fibromyalgia' and 'ibromaylgia'\n",
    "3. data entry of a range of clinical conditoons which may mean the same thing, but are called different things. An example of this is heart attack, mycardial infarction, cardiac arrest.\n",
    "\n",
    "Further analysis will include removing duplicates."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2a060519-48e7-4e92-ab90-94a6ec7c712f",
   "metadata": {},
   "source": [
    "Tokenization.\n",
    "\n",
    "This is the first step in many NLP processes. This process pulls apart text into small chunks of words or sentences. We label these as tokens. By analysing words in a sentence we can find meaning in large volumes of data - the data being reviews from a drug subset."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "id": "67a8bd30-a0b4-4140-b041-f349d895c1ac",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>\"I was first prescribed Effexor 13 years ago a...</td>\n",
       "      <td>8</td>\n",
       "      <td>13-Dec-10</td>\n",
       "      <td>36</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>\"I took Effexor for the first and last time ye...</td>\n",
       "      <td>1</td>\n",
       "      <td>12-Oct-17</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>223</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>\"Horrible side effects! I tried Ciprelex (esci...</td>\n",
       "      <td>1</td>\n",
       "      <td>15-Jun-16</td>\n",
       "      <td>24</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>586</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Major Depressive Disorde</td>\n",
       "      <td>\"I&amp;#039;ve been on Effexor xr for 2 weeks and ...</td>\n",
       "      <td>10</td>\n",
       "      <td>8-Jul-16</td>\n",
       "      <td>30</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>712</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Anxiety</td>\n",
       "      <td>\"I suffered with severe anxiety, especially in...</td>\n",
       "      <td>9</td>\n",
       "      <td>23-Dec-13</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52286</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Generalized Anxiety Disorde</td>\n",
       "      <td>\"Changes my life for the better!\"</td>\n",
       "      <td>10</td>\n",
       "      <td>10-Mar-14</td>\n",
       "      <td>62</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52683</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Anxiety and Stress</td>\n",
       "      <td>\"I have multiple health issues and am very anx...</td>\n",
       "      <td>8</td>\n",
       "      <td>24-Apr-11</td>\n",
       "      <td>13</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52904</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>\"Though the medication helped my depression, I...</td>\n",
       "      <td>3</td>\n",
       "      <td>22-Jan-17</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52953</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>\"this med did its job reasonably. Didn&amp;#039;t ...</td>\n",
       "      <td>6</td>\n",
       "      <td>16-Aug-16</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53618</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Generalized Anxiety Disorde</td>\n",
       "      <td>\"I&amp;#039;m on 75mg venlafaxine but I&amp;#039;m goi...</td>\n",
       "      <td>5</td>\n",
       "      <td>10-Aug-17</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>320 rows Ã— 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "          drugName                    condition  \\\n",
       "79     Venlafaxine                   Depression   \n",
       "81     Venlafaxine                   Depression   \n",
       "223    Venlafaxine                   Depression   \n",
       "586    Venlafaxine     Major Depressive Disorde   \n",
       "712    Venlafaxine                      Anxiety   \n",
       "...            ...                          ...   \n",
       "52286  Venlafaxine  Generalized Anxiety Disorde   \n",
       "52683  Venlafaxine           Anxiety and Stress   \n",
       "52904  Venlafaxine                   Depression   \n",
       "52953  Venlafaxine                   Depression   \n",
       "53618  Venlafaxine  Generalized Anxiety Disorde   \n",
       "\n",
       "                                                  review  rating       date  \\\n",
       "79     \"I was first prescribed Effexor 13 years ago a...       8  13-Dec-10   \n",
       "81     \"I took Effexor for the first and last time ye...       1  12-Oct-17   \n",
       "223    \"Horrible side effects! I tried Ciprelex (esci...       1  15-Jun-16   \n",
       "586    \"I&#039;ve been on Effexor xr for 2 weeks and ...      10   8-Jul-16   \n",
       "712    \"I suffered with severe anxiety, especially in...       9  23-Dec-13   \n",
       "...                                                  ...     ...        ...   \n",
       "52286                  \"Changes my life for the better!\"      10  10-Mar-14   \n",
       "52683  \"I have multiple health issues and am very anx...       8  24-Apr-11   \n",
       "52904  \"Though the medication helped my depression, I...       3  22-Jan-17   \n",
       "52953  \"this med did its job reasonably. Didn&#039;t ...       6  16-Aug-16   \n",
       "53618  \"I&#039;m on 75mg venlafaxine but I&#039;m goi...       5  10-Aug-17   \n",
       "\n",
       "       usefulCount  \n",
       "79              36  \n",
       "81               5  \n",
       "223             24  \n",
       "586             30  \n",
       "712             22  \n",
       "...            ...  \n",
       "52286           62  \n",
       "52683           13  \n",
       "52904            2  \n",
       "52953            1  \n",
       "53618            1  \n",
       "\n",
       "[320 rows x 6 columns]"
      ]
     },
     "execution_count": 105,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_name4='Venlafaxine'\n",
    "filter=df['drugName']==drug_name4\n",
    "df[filter]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 106,
   "id": "bb9db55f-e3af-4fad-b51f-86c1f9e2179e",
   "metadata": {},
   "outputs": [],
   "source": [
    "nlp_drug=df[filter]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 107,
   "id": "0c515e23-4d16-49dd-80b7-658573a866fd",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>\"I was first prescribed Effexor 13 years ago a...</td>\n",
       "      <td>8</td>\n",
       "      <td>13-Dec-10</td>\n",
       "      <td>36</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>\"I took Effexor for the first and last time ye...</td>\n",
       "      <td>1</td>\n",
       "      <td>12-Oct-17</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>223</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>\"Horrible side effects! I tried Ciprelex (esci...</td>\n",
       "      <td>1</td>\n",
       "      <td>15-Jun-16</td>\n",
       "      <td>24</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>586</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Major Depressive Disorde</td>\n",
       "      <td>\"I&amp;#039;ve been on Effexor xr for 2 weeks and ...</td>\n",
       "      <td>10</td>\n",
       "      <td>8-Jul-16</td>\n",
       "      <td>30</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>712</th>\n",
       "      <td>Venlafaxine</td>\n",
       "      <td>Anxiety</td>\n",
       "      <td>\"I suffered with severe anxiety, especially in...</td>\n",
       "      <td>9</td>\n",
       "      <td>23-Dec-13</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        drugName                 condition  \\\n",
       "79   Venlafaxine                Depression   \n",
       "81   Venlafaxine                Depression   \n",
       "223  Venlafaxine                Depression   \n",
       "586  Venlafaxine  Major Depressive Disorde   \n",
       "712  Venlafaxine                   Anxiety   \n",
       "\n",
       "                                                review  rating       date  \\\n",
       "79   \"I was first prescribed Effexor 13 years ago a...       8  13-Dec-10   \n",
       "81   \"I took Effexor for the first and last time ye...       1  12-Oct-17   \n",
       "223  \"Horrible side effects! I tried Ciprelex (esci...       1  15-Jun-16   \n",
       "586  \"I&#039;ve been on Effexor xr for 2 weeks and ...      10   8-Jul-16   \n",
       "712  \"I suffered with severe anxiety, especially in...       9  23-Dec-13   \n",
       "\n",
       "     usefulCount  \n",
       "79            36  \n",
       "81             5  \n",
       "223           24  \n",
       "586           30  \n",
       "712           22  "
      ]
     },
     "execution_count": 107,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "nlp_drug.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 122,
   "id": "7c3bad84-585e-4f9b-ad0d-aa114cc59cfa",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Index: 320 entries, 79 to 53618\n",
      "Data columns (total 7 columns):\n",
      " #   Column        Non-Null Count  Dtype \n",
      "---  ------        --------------  ----- \n",
      " 0   drugName      320 non-null    object\n",
      " 1   condition     320 non-null    object\n",
      " 2   review        320 non-null    object\n",
      " 3   rating        320 non-null    int64 \n",
      " 4   date          320 non-null    object\n",
      " 5   usefulCount   320 non-null    int64 \n",
      " 6   tokens_count  320 non-null    object\n",
      "dtypes: int64(2), object(5)\n",
      "memory usage: 20.0+ KB\n"
     ]
    }
   ],
   "source": [
    "nlp_drug.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 131,
   "id": "8ac29260-2add-4113-bbd7-fbf05788b187",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['\"I was first prescribed Effexor 13 years ago and was taking 225 mg. I was on it for a few years and stopped taking when I was pregnant with my first child. I was put on Paxil (gained so much weight) and then Zoloft. I took the Zoloft off and on for years until it just wasn&#039;t working for me anymore. I was then put on Welbutrin while still taking 25mg of Zoloft. I quit smoking (had no desire to smoke) but then became suicidal. My doctor then put me back on Effexor and I currently only take 75 mg. I feel amazing. Yeah the side effects are bad, I&#039;ve gained weight (lost weight the first time I was on it), have sexual side effects, and get quite shaky/jittery if I&#039;m late on a dose. But I&#039;m finally the mom I&#039;ve always wanted to be.\"',\n",
       "       '\"I took Effexor for the first and last time yesterday around 7:41 am . At first I couldn&#039;t feel my arms or face and then it felt like fire works were going off in my head . I yawned all day long and each time I did I felt like my own tongue was gagging me . The worst of it was around 3:45 am I woke up shaking uncontrollably falling over couldn&#039;t see straight it felt like I was being electrocuted it was to the point I either wanted to be knocked out or die . My husband found me shaking and rocking back and forth in our living room floor . This drug for me personally was horrific .\"',\n",
       "       '\"Horrible side effects! I tried Ciprelex (escitalopram), but made me so tried all the time. My doc switched me to Pristiq (desvenlafaxine), I had 0 side effects, but I couldn&#039;t afford the $105 price each month without a generic brand or drug plan. Doc switched me to Effexor claiming it was &quot;very similar to Pristiq, and available in a generic&quot; however I had the WORST insomnia at night. Trouble falling and staying asleep at night- would wake up every hour with mind racing. Dry mouth throughout the day no matter how much water I drank. Also, very fidgety feet and legs while sitting or laying in bed. I was exhausted all day everyday, yet continued waking up several times throughout the night. Went back to my doc, and switched back to Pristiq.\"',\n",
       "       '\"I&#039;ve been on Effexor xr for 2 weeks and it&#039;s great. I had been on Zoloft before and it pooped out on me so my doc switched me to Effexor xr and after 2 days I started feeling good again. I take 37.5 mg per day. I come back to write here because I wanna give back to this forum and give hope for anybody that suffer from this like me. keep to try the med that suit for you. best wish!\"',\n",
       "       '\"I suffered with severe anxiety, especially in social situations. I think mine was linked to coming off my pill and my hormones going crazy. I tried sertraline for two days and felt horrid - flu like symptoms, depression, nausea, fatigue! I then tried venlafaxine and after two weeks my anxiety had gone. It came back around the time of the month but this medicine has truly fixed me. I understand that different medicines work for different people but this saved my life.\"',\n",
       "       '\"Improves my mood, less stressed but nauseous and sweaty.\"',\n",
       "       '\"I have tried every SSRI except luvox and this is the only one that did anything. However it takes at least a month to work.  However I went out of country and had my carotid veins widened and this extra blood flow has taken away all mental health issues or need for drugs...\"',\n",
       "       '\"Effexor was the first medicine given to me when I started having panic attacks. It helped me with my depression and stopped the crying spells. But I still continued to have panic attacks.\"',\n",
       "       '\"I was diagnosed with postpartum depression after the birth of my 3rd son. I&#039;m on venlafaxine for the 2nd time. The 1st time I disliked it because it seemed to have weird side effects. Now, I&#039;m almost 3 weeks into it and I feel like a million bucks! My depersonalization seems to be so much better, my mood is better, I&#039;m playing with my kids more than I have been. Starting to care about myself, have motivation to workout, more patient and able to handle my kids again! Venlafaxine gave me my life back. Not looking forward to tapering but that&#039;s a long way down the road. But I&#039;ve found taking it at night is the best. I don&#039;t seem to have any side effects beside weight loss but who is going to hate that!\"',\n",
       "       '\"I&rsquo;ve been dealing with a lot lately that is out of my control and have admittedly been depressed most of my life (I am 29 years old). A breakup reeked havoc on my mental health and I consulted a psychiatrist. Was prescribed generic 37.5mg for 2 weeks then was instructed to double dose. \\r\\nFirst pill took around 11am yesterday, by 2pm I was nauseous, dry heaving, had incredibly bad diarrhea, double vision, back pain, and was becoming very lethargic. My jaw was clenched most of the day and I was grinding my teeth all night. I didn&rsquo;t sleep well, woke up pacicking and having racing thoughts. \\r\\nDoctor said to quit taking it. One pill was enough. Never again.\"',\n",
       "       '\"I like venlafaxine, although I think Cymbalta helped more with the pain of my fibromyalgia.  I&#039;m hoping venlafaxine will start helping with the pain in the next month or two.  Side effects are little, and I tolerate the medicine well.\"',\n",
       "       '\"Didn&#039;t find it a whole lot different from SSRIs other than a couple weeks of jitters. Starts off with a contented, floaty feeling and then after a month subsides to having a minor, yet meaningful effect in helping me recover from recurrent depressive episodes. It helps, but only marginally. The withdrawal effects I&#039;ve experienced going cold turkey off it numerous times are strange. A couple months of severe flu-like symptoms and I&#039;ll cry very easily over anything even remotely sad. Also causes me to start rapid-cycling between euphoria, mixed and extreme depression. Also lasts a couple months. Going off of it abruptly is quite terrifying. I recommend titrating off it.\"',\n",
       "       '\"Started Venlafazine 37.5mg - 150mg over a 6 weeks period for Anxiety and PMDD but had to stop. Previous to this I was on Mirtazapine 15mg to help with sleep and appetite but it did nothing for my &#039;feelings&#039;. \\r\\nVENLAFAXINE- PROs-  Slightly more confident, didn&#039;t blush, more energy, less body pain.\\r\\nCONs- INSOMNIA, no appetite at all started losing weight, muted feelings, had no empathy anymore, like a I don&#039;t give a shit attitude, NO LIBIDO and couldn&#039;t orgasm! \\r\\nI decided to quit this garbage and return to the mild Mirtazapine for good. Some of the weeks I was on venlafazxine I actually also took the Mirt (the combo known as Californian rocket fuel) so I could get some sleep although doctors did not allow me to do this! Effects after stopping Venlafaxine -3days\"',\n",
       "       '\"I have been taking Effexor XR for approximately 6 months now.  My hot flashes were very severe.  I would be soaked and wet from top of my head down to my legs.  Cold glass of water hardly touched it.  After taking Effexor I only have little sweating around my head and neck maybe two to five times a month.  It is a great relief.\"',\n",
       "       '\"I tried Paroxetine, Prozac and Celexa and had no positive results so my doctor advised I try Effexor XR given it is a SNRI or different class of drug. Almost immediately &lt; 1 Week I felt a positive mood change, my social anxiety and mild stuttering seem to dissipate and I felt balanced. I have been taking Effexor XR now for almost a month now and my anxiety has dropped right off that I feel my normal self again, I am a lot more social and I stutter hardly ever and I think more logically. The only down sides are that I do sleep more and find it harder getting up in the mornings for work and have noticed fluid retention around my abdomen. I do not mind these small side effects because this drug has really helped me get my life together. :)\"',\n",
       "       '\"Burned areas on the tongue with discoloration and blisters\"',\n",
       "       '\"I have been on Effexor XR for approximately 7 years now. I was started off at 75mg and have since been raised to 225mg over the years. I have had good results on this medication. One downfall is the terrible withdrawals that I experience if I miss a dose. These effects happen within the first couple of hours of not taking it. Terrible headache, foggy feeling, and extreme eye sensitivity. Within a day of a skipped dose I become agitated, argumentative, and defiant. I do not look forward to switching from this medicine to a different one, which my doctor has suggested, due to the withdrawal symptoms.\"',\n",
       "       '\"I have been on Effexor XR for 17 years now. I take 150mg once a day. My biggest negative side effect is extreme, excessive  sweating. I tried going off it earlier this year because I was fed up with this issue and thinking that maybe I really didn&#039;t need  it any longer. Bad mistake. Within 2 month&#039;s I was back at my Doctors a mental mess and was put back on it. I guess you have to take the good with the bad. Does anyone else have a issue like this while taking this med? It can be very embarrassing and makes me very self conscious.\"',\n",
       "       '\"I took this for a few years in my late teens for severe depression and self harm tendencies.  It worked well for me.  The only downfall is the effects one experiences if one forgets a dose or stops taking the medicine without approval from one&#039;s medical provider. \\r\\n\\r\\n  In my opinion the honest truth is this:  it can be a wonderful, miracle for severe depression and anxiety.  It can make a person more outgoing in their environment and provide someone with more energy.  \\r\\n\\r\\nThe only downfall I ever experienced with it was the withdrawal effects if I forgot a dose.  Brain zaps, nausea, general ill feeling.  If one takes it as directed, however, they shouldn&#039;t experience these.\\r\\n\\r\\nNever quit this medicine on your own without talking to your doctor.\"',\n",
       "       '\"I have been on Effexor XR for 2 days now for anxiety panic agoraphobia. So far not to bad. Not to many side affects. Tired and a bit fuzzy but I hope this medicine is as good as everyone has said. I just want my life back.\"',\n",
       "       '\"I&#039;ve been on this for 9 yrs, i take 150mg 3 times a day, i&#039;ve missed sometimes up to 2 doses with no side effects. i would be dead today if it weren&#039;t for this pill, that&#039;s the god&#039;s honest truth. Only side effect I can think of is I&#039;ve gained a few pounds. Love Love this medication\"',\n",
       "       '\"We moved to VA after 3 years on orders and my Anxiety came back. My anxiety was situational. I had a refill left on my Zoloft. I filled it but it didn&#039;t work like the first time. Everything felt constricted. Nothing seemed clear to me. I tried Venlafaxine after crying to my doctor and I have been extremely happy. I will say, just like the other reviews mentioned, if you miss a dose, it&#039;s horrible. The dizziness, anxiety, foggy thoughts are severe. I&#039;m on 75 mg and feel great.\"',\n",
       "       '\"I have been taking Effexor 300mg for 2 years, and it has saved my life. I didn&#039;t care if I died prior to taking it. I never get sleepy or tired, and I can concentrate much better than I used too. My depression is gone.\"',\n",
       "       '\"I started taking Venlafaxine a week ago. I already feel more at ease and comfortable in situations that used to make me panic already. My anxiety was making me feel breathless and even ended up at A&amp;E twice, thinking I couldn&#039;t breathe. My doctor was sure it was due to anxiety so put me on this medicine. The first couple of days I was very tired and dizzy but that soon passes. Anxiety is an awful thing but hopefully this is working for me. Best of luck.\"',\n",
       "       '\"Was in College when I treated. At high doses (approximately 225mg), I was lethargic, cloudy headed and angry. Drug caused SSRI-induced sexual dysfunction. It aggravated stress levels. But for my mom, this medication has given her life back to her, &quot;curing&quot; depression, lowering anxiety, and inspiring creativity.\"',\n",
       "       '\"As with all antidepressants, I tend to peak after about 5 years and my medication begins to lose its efficacy. This is the third time I have had Effexor prescribed, and each time the results have been better than with any other antidepressant. I actually enjoy parts of my life and sleep like a baby, which is a true blessing, because I have Fibromyalgia and the accompanying insomnia so common with Fibromyalgia. Several years ago my brother-in-law was having trouble with his depression medications so I told him to ask his doctor about Effexor. He has gone from suicidal to a fairly happy fellow. This medicine has literally been a life saver in our family.\"',\n",
       "       '\"Venlafaxine turned out to help my irritable bowel syndrome a lot in addition to the psychological part. I take 225mg a day at the moment, and the days I sometimes forget to take them it gets noticeable worse.\"',\n",
       "       '\"I believe this medication saved my life. I did feel extremely sleepy at first while my dosage was being raised but that went away quickly. I have a new feeling of wanting to get up and do things that wasn&#039;t there before. I also feel a sense of calm and peacefulness. The only side effects so far that were troublesome is constipation and sometimes it&#039;s hard to concentrate if someone is speaking.\"',\n",
       "       '\"I was on Effexor XR for almost a year. I started out on 75 mg a day, and it slowly progressed to 300 mg per day. I was 16, and weighed 105 pounds, while my 300  lb grandfather was only on 75 mg. While it helped with the depression (no suicidal ideas, not sleeping all day, etc.) it aggravated my moods. I had manic episodes that I would not remember, hallucinations, trouble sleeping, and when I did get depressed, it was very severe. The worst part was the withdrawal. It made me feel like I had the flu, and had been hit by a train. I ended up weaning myself off of it, with the help of 25 mg of Benadryl twice a day (it cut down on the nausea). I am now about to start Cymbalta, and I hope that it is a better experience.\"',\n",
       "       '\"Tried several antidepressants before going on Effexor XR and have received excellent results with this medication.\"',\n",
       "       '\"I only give it two stars because it did relieve some depression while I was on it.  After being on it for about 2 months, I realized that I wasn&#039;t feeling like myself at all.  I felt like I was losing my personality and ambition.  So I decided to taper off, and my doctor had me decrease 37.5 mg per week until I was off the med.  During the tapering I didn&#039;t notice anything major side-effect-wise, but the second day I was completely off of it, everything kicked in.  I felt like I was going to die, with major brain zaps and horrible migraines being consistent for a week. I also gained 15 pounds in what seemed like a few days.  It&#039;s now been a month since I&#039;ve been off of this awful drug, and I still have brain zaps, and the weight gain too.\"',\n",
       "       '\"I find the drug good, my doses go up and down depending on how I am feeling. I have put on weight at 225mg and I was told that you are not supposed to exceed 225mg. I will go back down to 150mg for the summer. I usually go up in the winter months.\"',\n",
       "       '\"I have CPTSD. Currently taking the &quot;California Rocket Fuel&quot; combo of Effexor and Remeron. (Also taking prazosin, propranolol, lorazepam, and saphris)\\r\\n\\r\\nI found that the Effexor helped with my anxiety/flashbacks/depression a little bit. I noticed headaches at first and an increase in blood pressure. I cannot miss my dose or I get bad withdrawal symptoms (headaches, flu-like symptoms, diarrhea, brain zaps, dizziness, weakness, and fatigue) which only subside 6 to 12 hours after I take the missed dose.\"',\n",
       "       '\"I am a 21 year old female. I was on Prozac for ten years (40 mg at the end) before switching to Effexor (37.5 mg at first, 262.5 mg now) because I was having issues with anxiety. I was ok for a while then I became extremely depressed and suicidal. My doctor increased my dose and although it did take away the misery and suicidal thoughts, I wouldn&#039;t describe myself as happy. I feel constantly tired, sleeping up to 16 hours a day. I can&#039;t work and social situations exhaust me. It took me a while to realize Effexor might be responsible for some of these symptoms. I am talking to a psychiatrist about changing my medication but I&#039;m very worried about the infamous withdrawl from Effexor.\"',\n",
       "       '\"I&#039;ve been on Lexapro 20mg and Vistiril 100mg for about 2 years. They worked at first but I kept having to take higher doses without any results (those were the ending doses). Went to my doctor and she gave me Effexor 75mg in place of Lexapro and it&#039;s working wonders! Absolutely 0 anxiety. She gave me the benzo Klonopin as well, but I barely have to use it because Effexor is doing the trick. It&#039;s wonderful to have my life back again, and I thank God for giving me a medication that works.\"',\n",
       "       '\"Effexor helped me see the reality of my life when I couldn&#039;t. I took Zoloft for a while (up to 150mg) and I felt more numb than &quot;happy&quot;. When I switched to a family doctor from my psychiatrist, they recommended Effexor XR; I&#039;ve been taking 75 mg a day for the past four months and my life has done a complete 180. No depression, very little anxiety, and I finally have CONFIDENCE. I have more friends now than I ever did, a wonderful new relationship that I could never have foreseen myself happening, and I&#039;m performing really well academically. Best decision of my life was taking Effexor- I can immediately see a difference in my thought processes when I forget to take it for two days at a time.\"',\n",
       "       '\"I was on this medication for 2 years and I felt great..no anxiety.. I weaned off over 3 months and have totally been off for 3 month.. All my issues came back. Just started back today fingers crossed it works again. I should have never stopped taking. It was a life changer\"',\n",
       "       '\"Started Effexor after other anti-depressants gave me too many side effects. I&#039;m four months in now and so far it has been great. I do have times where I&#039;m very sleepy, have vivid dreams, and some weight gain but those are minor to me compared to how miserable I was before. Sexually it&#039;s been helpful as I&#039;m not on edge all the time and can relax easier.  It&#039;s up to the individual to decide what side effects are deal breakers. I have accidentally missed a dose here and there but haven&#039;t experienced any of the withdrawals that others have.\"',\n",
       "       '\"Venlafaxine is a good drug.  It helps with depression and anxiety.  What it doesn&#039;t work so well with is the mania.  If anything, it can make the mania worse.  I find adjusting my dose works the best.  So anywhere from 150mg to 200mg.  I know that is not the wisest course, but it does help keep the mania from being too strong.  Olanzapine also helps me.\"',\n",
       "       '\"Effexor XR has helped a lot and I&#039;ve stayed at 75 mg. but others may need more.  Also, a few people have mentioned that they fear getting off of it because of withdrawal.  Your doctor can help if you ever need to get off.  I believe the technical term is &quot;Effexor - Prozac bridge.&quot;  In other words, you take the longer acting medication (like Prozac) to counteract the short half-life of Effexor.  A doctor could explain it better than I can, but hopefully that will alleviate any concerns.\"',\n",
       "       '\"I was switched from Prozac to this (150mg) and it is amazing! It really helped me but I will say DO NOT FORGET TO TAKE IT! my side effects of missing one day were these really weird dreams and horrible headache but if I was off of it for more than a day I felt super dizzy.\"',\n",
       "       '\"I was prescribed Effexor after a really bad anxiety attack about 3 years ago. At first, it was really great. Less suicidal thoughts, my anxiety wasn&#039;t as bad, but I wasn&#039;t eating. I had absolutely no appetite whatsoever, I starved myself until I lost 20 lbs and they increased my dosage from 37.5 to 150 mg. It&#039;s years later and I now suffer from an eating disorder that I didn&#039;t before. The side effects; dizziness, bad coordination, insomnia, headaches, lightheadedness, and especially the fatigue, all impacted my life to the point where I dropped out of high school. The withdrawals, which occur after 24 hours of not taking the pill, make you feel inhuman. I was better before.\"',\n",
       "       '\"I took Effexor for three years due to depression. I loved the fact that I was no longer depressed but I was tired all the time. I could sleep for 10 hours get up and two hours later I was ready to sleep again. If I missed taking a dose I would get a horrible headache. The only reason I stopped taking Effexor was due to being tired all the time. Getting off of the medication was awful. I have never been so sick in my life. If you are going to take this medicine the rest of your life I highly recommend it. It did wonders for my depression.\"',\n",
       "       '\"Effexor XR is effective in low dose for hot flashes. Sadly the doctors follow the guidelines presented by the pharmaceutical companies for dosing and everyone is different. DO NOT take 75 mg a day! . \\r\\r\\n LOW DOSE is effective for both hot flashes and mild depression . I mean open up the capsule, count out 10 of the small balls of medicine and take that daily. After 2 weeks less effective and  can increase to 15 to 20 balls a day.  Track HFs  on a calendar. Never stop without tapering down! COUNTER WITHDRAWAL WITH VALIUM, XANAX, ATAVAN, any benzos will do. These will stop brain jolts or vertigo withdrawal symptoms!!!!  This med Iis strong. If this dosnt work for you, you can always increase. With my plan you can avoid withdrawal completely!\"',\n",
       "       '\"This drug was prescribed after several attempts on my life in a short period. I was prescribed 75mg for 2 weeks, then 150mg for 4 weeks and finally 300mg for 2 1/2 years. (Daily dosages)\\r\\r\\nWithin the first two weeks I could no longer &quot;climax&quot;, I began getting paranoid and went from mild social phobia to debilitating agoraphobia. I became distant from my wife and kids and regular attempts on my life had me in and out of hospital during the entire time on this drug. I tried to withdraw myself as my doctor was reluctant to assist and tried to assure me it was better than not taking it. The withdrawals where like someone letting off fire crackers in my skull, within 72 hours it even effected my vision pulsing white light with every &quot;spark&quot;. AVOID\"',\n",
       "       '\"Prevents dwelling on missed loved ones, crying, irritability, feeling left out, self-pity, resentment, bitterness.\\r\\nHas either hurt or failed to help low energy  level, motivation, task initiation, and focus\\r\\nWorth it and would not want to try to live without it.\\r\\nIf I miss a dose all that first paragraph stuff comes back but the worst is the physical brain zaps and dizziness upon standing &amp; walking.   If I miss it for 2 days or more, I get a fever and flu symptoms.\"',\n",
       "       '\"Apart from wanting to sleep a lot in afternoon finding great results found it best taking it at 10pm\"',\n",
       "       '\"I&#039;ve been taking Effexor XR since 2004.  The side effects that I experience are loss of appetite/weight loss and sexual side effects.  However, every time I try another medicine or try to &quot;get off&quot; my medicines, I crash and I always go back to Effexor and it works really well.  So it is a consistently reliable drug for me and I am very thankful for it.\"',\n",
       "       '\"Terrible med. for me like it was for a lot of people.  I used it for 6 weeks (enough time to get into my system).  It caused panic attacks, which was not fun.  I would have several each day.  I was taking this med. for anxiety and depression.  I cried every single day, and several times a day on this med. and I did not sleep a full nights sleep for the entire duration. I felt way more sad, and felt like I was in a zombie like state daily.  I read reviews of this drug and prayed that I would soon start to feel better, and wouldn&#039;t be one of those that this drug did not work for.  Alas, I was one of those.  I stopped taking Effexor, cold turkey 5 days ago.  Best thing I ever did.  I experienced some withdrawal symptoms, like severe brain zaps\"',\n",
       "       '\"I am a 60 year old male who has suffered with depression and panic attacks. In my late 30s, I decided to seek help.  Like many others, the list of medications my doctors tried would fill a dictionary.  Some worked for a while.  I refused to take Lithium.  In my late 40s, I was also diagnosed with ADD.\\r\\n\\r\\nI now use 4 medications successfully: Effexor XR 450 mg daily, Xanax 1 mg daily, Adderall XR 60 mg daily, and Strattera 25 mg daily.\\r\\n\\r\\nI am now free of both depression and panic attacks for nearly 10 years!  I am comfortable in public speaking and find that I love the adrenalin-rush!\\r\\n\\r\\nI&#039;ve tried to stop using Effexor XR but always restarted because of the horrible depression.  Withdrawal is like a bad acid trip.  Use Effexor to stay alive!\"',\n",
       "       '\"Psych prescribed Venlafaxine, Neulactil + Mirtazapine (have been on Mirtazapine for 2 years). So far taking Venlafaxine I am energetic, I am thinking clearly, feel more confident &amp; I am not emotional at all. I also noticed my appetite has reduced severely (I gained 16kgs on Mirtazapine). 5 days in I still have very minimal appetite, I am finding that I have a day where I am energetic and days where I am not. I often get a bit of euphoria but I am so far pleased with everything. I expect I will up the dosage eventually. Suicidal thoughts have been minimal but they&#039;re occur sporadically. I also have moments where I zone out but this may be because I am still getting used to the medication.\"',\n",
       "       '\"At 3 months post partum I started experiencing slight symptoms of PPD. I handled it and worked myself through it, thought I had it under control until I found myself uncontrollably crying, panic attacks, insomnia, excessive anger, lots of feelings of self worthlessness. My Dr first proscribed me Zoloft at 5 months post partum, for 3 weeks I had no luck. She then switched me to Effexor xr 37.5mg, as they say, the &quot;light bulb&quot; came back on after 2 weeks. I have had very bad anxiety since I was 14, I am now currently taking Effexor xr 75mg daily and am at 7 months post partum. Depression, the horrible self feelings I experienced were not anything I have ever felt with prior to this experience. Effexor changed my life!\"',\n",
       "       '\"I have been on this drug for about a year. I went up to the highest dose I could (225mg). A year later, I started feeling better. Little did I know, that this drug would give me bad headaches, night terrors, constant over sweating and weight gain. The over sweating is unbearable, if its hot outside, don&#039;t bother wearing make up, it will come right off. You&#039;ll be sweating buckets while no one else has shed a single drop. The weight gain ruined my self esteem as well. If I would have known these side effects, I would have never started it. I am currently going off the drug and I am bracing my self for the days following my dose going to 0mg.\"',\n",
       "       '\"This medication was God awful to me. I was on Lexapro for 3 years when they suddenly switched me to Effexor while slowly weaning me of the Lexapro. The first few days were hell. I couldn&#039;t sleep for more than a few hours each night and became irritable and physically ill because of it. When I finally did sleep and wake up I had one of the worst panic attacks I&#039;ve ever experienced in my life. It was to the point where my family and I were afraid I would need to be hospitalized. I will NEVER EVER TAKE THIS DRUG AGAIN. I had only been taking it for 3 weeks when I had the horrible panic attack, the worst one I&#039;ve ever experimeced and which the meds were supposed to be helping me with, and I am back on 20 mg of Lexapro.\"',\n",
       "       '\"I have a patient who was a wreck until he was started on Effexor. He has to take a large dose, but it works.\"',\n",
       "       '\"This medicine worked great for the first 3 or 4 years but now I am not feeling as well and am taking 300 mg per day.\"',\n",
       "       '\"Effexor was a mixed bag for me -  it was very numbing, and the side effects (which lingered for years after I stopped taking it) were awful. I attempted suicide a few weeks after starting it, because I was still depressed but was more numbed to the guilt I would usually feel. Be careful of this, make sure someone is aware if you feel at risk. It took a few months, but I began to feel positive things again, but eventually I was stuck in a zombie state where the side effects outweighed the good. I tried it on a few occasions with the same result: taking myself off them because I wanted to feel again. The best advice I can give is to see a psychiatrist, not a GP. There is a range of medicines, make sure you get the one that is tailored to YOU.\"',\n",
       "       '\"I started taking Effexor 3 weeks ago after finding no success with Wellbutrin or Zoloft. It causes some initial bad side effects (nausea, dizziness, tiredness) but I cant emphasize enough how wonderful I feel now! I thought I would never find a solution. Most effective medication I&#039;ve encountered this far!\"',\n",
       "       '\"I&#039;ve been on 75 mg for two months now, started at a baby dose of 37.5 about 3 months ago. I can honestly say I woke up feeling the difference and the burst of energy. Only complaints are if you forget to take a dose you&#039;re not in for a good day until you take your next dose. I vomit and have a terrible headache, and also with the medication I found that I had a couple bad lows while getting used to it. But as long as you keep up with your dose and don&#039;t mess around with taking it you should be very satisfied with the result.\"',\n",
       "       '\"Be smart about getting off of this medicine. Follow doctors instructions, it is very important.\"',\n",
       "       '\"I was taken off Lexapro and put on this. It&#039;s made me extremely angry. I can&#039;t do my school work or anything. I want off this NOW.\"',\n",
       "       '\"Effexor has helped me more than other antidepressants I&#039;ve taken. I have severe depression and take 75 mg twice a day. On occasion, my doctor increased the dose to 75 mg 3 x day.  \\r\\n\"',\n",
       "       '\"I started this medicine in nursing school. Very much so needed. I started seeing myself with less worry, and a more of a &quot;whatever&quot; type of mentality. I figured that worked for me. However, my biggest problem has been the weight gain. Before I knew it I gained atleast 25 lbs. I&#039;m a very active person and I do what wait I eat, especially since I am a cardiac nurse. Also make sure you NEVER miss a day of the medication. My side effects would be vertigo and shooting nerve pains in my head. I just upped my dosage to 150mg hoping it will increase my energy and help with weight loss. I was really bad off emotionally before so besides everything above, I have my life back.\"',\n",
       "       '\"I started at a low dosage of about 30mg (little more) and that first week I felt high 24/7. I noticed immediately that my anxiety would not surface. It was like it was trapped. After that week I went up to 75mg. Slept a lot the first month. Always tired going straight to sleep after work and sleeping all not. Never woke up tired though. It&#039;s been 2 months and I think it&#039;s safe to say that I am stress and anxiety free. The only thing I hate about it is the dry mouth all the time.\"',\n",
       "       '\"I have been on several meds since I can remember. Altven medication works BUT the night sweating is unbearable. What can I do about it?\"',\n",
       "       '\"My life has gotten better and brighter since I started taking this medication.  It has helped me get through a very hard time after losing three family members in a car wreck.\"',\n",
       "       '\"I have been on Venlafaxine for 10 years now and couldn&#039;t be happier. I see all the negative comments on here but you need to remember that these reviews are our experiences, how our bodies reacted, your body may react different. How many times have you changed meds in order to find the right one? It&#039;s no different with this one, well maybe a little because you need to lower your dosage slowly or you will get violently ill. I didn&#039;t refill my prescription in time and I was so miserable I had to go to the ER. I gained weight on Paxil but not on Effexor but some people do. Take all these reviews, evaluate, make a list of questions for your doctor and then decide if you want to give it a try.\"',\n",
       "       '\"MY EXPERIENCE with Effexor XR vs Prozac\\r\\r\\n\\r\\r\\n1) EXR eliminates ALL PANIC ATTACKS\\r\\r\\n2) Prozac eliminates ALL OBSESSIVE THINKING\\r\\r\\n3) Prozac made me sleep like a fat cat even tho I RARELY ate, and I gained a ton of weight when I was only 106 lbs to start.\\r\\r\\n4) EXR did not cause me weight gain (or loss) however it made me very irritable and I caught myself clenching my jaw all day, however had a lot more energy than Prozac.\\r\\r\\n5) BOTH meds I used over 12 weeks to make a fair comparison.\\r\\r\\n\\r\\r\\n6) I saw a bio-identical hormones therapist to see what&#039;s going on.  No clear cut answers.  So here is my thought.  You&#039;re a normal person being a normal life with a normal energy level. You take Prozac and Wham! You&#039;re  sleeping 10 hours a day.............................\"',\n",
       "       '\"I started with the 37 mg dose for mild-moderate depression I had experienced this past year.  I felt calm and peaceful for the first few weeks.  The doctor had me increase the dose to 75mg.  I tried for a month to adjust to it, but all I wanted to do was sleep.  It took away my energy and I fought fatigue.  I reduced back down to 37 mg and felt pretty good for a couple of months, but started to notice trouble responding to people around me.  It felt like being in a daze that took some effort to break.  I also started to feel out of sorts and frenzied.  I decided to stop the medicine a few weeks ago and feel 100% better.  No more confusion or anxiety!  This medicine was definitely not a good match for my body chemistry.\"',\n",
       "       '\"Effexor is the only antidepressant that has helped my Obsessive Compulsive Disorder, and I have tried quite a few. It is the only one that has had very few side effects as long as you take it regularly. It has greatly helped me deal with my OCD and has greatly improved my overall mood and outlook on life. I take it in conjunction with Pimozide which has eliminated the intrusive unwanted thoughts and also Dextrostat which helped eliminate the tiredness associated with with taking the previous medications.  These 3 medications have given me a new lease on life.  Prior to this mix of medicines I must have tried a couple dozen that either didn&#039;t work for me or had too many side effects.\"',\n",
       "       '\"Just starting 37.5mg Venlafaxine, and I am at day 13. At same time weaning down from 50mg Prozac. At day 7 I began feeling more nervous, anxious, no drive, I awake and want to stay in bed because if I get up I don&#039;t know what I should do. Tomorrow I increase dose to 75mg. I hope the medication begins to take hold soon and what I am feeling are short term side effects. I hope in a week or so I can update and give a higher rating.\"',\n",
       "       '\"It was efficient to have no anxiety. \\r\\n\\r\\nExcept 2 weeks before my final exams, I&quot;froze&quot; = I had anxiety attacks.\\r\\nThe big side effect was that it was extremely difficult to reach an orgasm / ejaculation + I lost more than 50 % of sex pleasure. Not good for couple life. Also I sweat A LOT during the night + big traumatizing nightmares if you forget your pills +  I think I did sleep apnea + sleep paralysis. All those things at 75 mg. An other bad effect was that I became over confident / maniac.\\r\\n\\r\\nAlso better to use Effexor than generics. The real brand seemed better for me\"',\n",
       "       '\"I was prescribed effexor for GAD with severe mood swings - im a busy person and have always said a &quot;slow you down&quot; type of antidepressant would not work for me I&#039;ve tried ones that have left me feeling like a zombie (numb and lethargic) effexor is not like that, it really lifts my mood and keeps me stable.  I experience little to no side effects. I have a good insight to my moods and work with my gp changing dosage when required I can be on anything from 75mg-225mg. I&#039;ve also worked out I cannot take any dosage later in the day as I would go to bed feeling wired and not tired so I take them in the morning only.  Only negative is if I miss 1 dose I&#039;m ok, miss 2 and the withdrawals are so shocking! If you come off effexor it must be controlled\"',\n",
       "       '\"My doctor put me on this medicine for hot flashes and the roller coaster emotions that come along with pre-menopause. 37.5mg. After I took the first dose I started sweating, shaking,  got nauseous and started violently vomiting, along with diarrhea. I had the dry heaves for 4 hours. Very scary. I almost went to the ER. I will not be taking this medicine! I&#039;d rather have the hot flashes!!\"',\n",
       "       '\"I am amazed at how this medication changed my life. I often compare myself to a duck in water, where the problems just glide right over me, which never used to be the case.  Issues that may have cause depression or anxiety in the past are now handled without confusing emotions.  The only reason I give it a 9 are the horrific side effects if I miss even one dose.  Strange nightmares, shaking, confusion and even an odd ability to sleep for more than 10 hours straight. Does it deter me from continuing with this medication? Absolutely not.\"',\n",
       "       '\"I&#039;ve been taking 25mg twice a day for about 6 weeks and have experienced no side effects whatsoever. I feel normal and competent for the first time in years. Prozac and Celexa both gave me such bad dreams that I had to discontinue them. That being said, I consider my anxiety and depression to be largely situational and temporary, and I hope eventually to be drug-free.\"',\n",
       "       '\"After completely stopping my antidepressant and then making a disappointing career change, I slipped into a permanent state of anxiety. I couldn&rsquo;t sleep, eat or function. Unfortunately there were not any reliable mental health resources available. I was not in the state of mind to make any decisions regarding my care and unfortunately all mind altering meds take time to work. My unbearable anxiety turned into the darkest depression I have ever experienced. I felt completely worthless, hopeless and suicidal. I would spend the days ruminating. The simplest of tasks felt like a marathon. I became afraid of everything with no explainable reason. The Effexor helped but it takes time. Be patient. Withdrawals are bad but I&rsquo;m alive.\"',\n",
       "       '\"I never had depression in my life. Then I went through a major depression episode 2 years ago. I tried 7 different antidepressants none worked some made me even worse my doctor decided efexor  I was very reluctant after reading horror stories about coming off of Efexor well I&#039;m happy to say it worked for year-and-a-half, it had made me better within two weeks of taking it however I started to experience depression while taking it I decided to wean myself off and had no problems coming off of it. I did it slowly and it&#039;s been a month with no side effects of coming off this drug saved me from the deep dark hell of depression. Every drug is different from everybody this drug work for me I only took it for a year-and-a-half 37.5 mg.\"',\n",
       "       '\"I&#039;ve been on this medication for almost a month. My doctor told me it could easily take a month to get used to it.  I started out with headaches, extreme tiredness and excessive sweating.  The tiredness was gone after about 10 days.  The sweating is the worst side effect and I still suffer with it daily, though I am no longer dripping with sweat like I was when I began the medication.  I get occasional headaches, but nothing more than a slight headache to remind me that I have one.  I do feel better and am less stressed.\"',\n",
       "       '\"I have tried everything I can read about to alleviate hot flashes. I&#039;m 47 and have had them for years but still have regular period so I can&#039;t try HRTs yet. Nothing over the counter has ever worked. What has worked for me (birth control, Effexor 37.5 &amp; Effexor 75) work for about a year and then the hot flashes come back as strong as ever, all day every day. I&#039;m scared to up my Effexor to 150. Right now, I am trying combination birth control and Effexor 75. It&#039;s been a week and no improvement yet.  But Effexor did work for me and I&#039;m thankful for the years it did. I had no side effects. It helped my anxiety too.\"',\n",
       "       '\"I have been on this medication for over 4 years. I changed to Celexa during that time for a short time but soon had to get back on it. It is true that if you go off it you won&#039;t be pleasant to deal with. You become irritable and emotional sort of like the way you were before you started the medication. Overall it really works and I have suffered from depression since my teens.\"',\n",
       "       '\"I can&#039;t believe how much this medicine helps.  Something tramatic happened to me last May which made me very anxious and my doctor tried to prescribe this but my insurance company is notorious for turning down any medicine that does not have a generic. Finally in October (after trying many other medicines) I was prescribed Effexor.  Although the underlying issues are still there for me, I am myself again.\"',\n",
       "       '\"I started suffering very badly from hot flashes about 2 years ago. When I would work out and do cardio, I would literally leave puddles. It was scary because I didn&#039;t know what was going on at the time. Someone I met recommended I try it. I was suffering so bad, I didn&#039;t want to be on antidepressants, but I was desperate. I didn&#039;t have to wait long, I went from having about six hot flashes a day, lasting about two to three minutes, to having three or four mini flashes. I was incredibly grateful, was able to sleep through the night as well. Just recently, they started to become unbearable again, so they increased the dosage. Really does work. Currently on 150 milligrams. I may have one or two flashes during the day and and maybe two at night\"',\n",
       "       '\"Started on celexa 8 yrs ago.  It was tremendously successful at 60mg, so much so that I nicknamed it routine Xanax.  Then FDA directed lower dose to 40mg for senior citizens due to small possibility of dropping dead from altered heart rhythm.  So my shrink and I tried Zoloft(I felt zombified).  Lost two Drs. cause they transferred to different departments, then we tried adding wellbutrin to cover the side effects, but that simulated taking a strong stimulant, shakey and anxious.  Was was then carefully switched to effexor  SR.  Once completely off the wellbutrin and Zoloft, and taking Effexor  SR caps 150mg, I&#039;m now, after a few days, approaching benefits of celexa, with side effects decreasing or gone.  Will ask for 1 more slight dose increase.\"',\n",
       "       '\"I wanted to leave my experience on here because this drug has changed my life!! I read all the bad experiences people have had and was worried this would happen to me too. Back in December 2016 for some reason I just lost it. Heart racing constant (although most my life I have had heart racing at times...anxiety) panicking over nothing, crying, depressed, lost interest in hanging out with my friends, wanted to just lay in bed all day, expecting the worst to happen, scared to drive anywhere past my town, dreading my husband coming home from work...etc...No logical reason for any of this. My doctor started me out on Zoloft and it helped a little at first. The side effects for Zoloft were awful for me the first week. 7 months in my doctor had me on 100 mg and at that point it felt like it wasn&#039;t working at all anymore. In August he switched me to Effexor (generic) The only side effects was an occasional dizzy feeling a couple times the first few days. I literally felt a change by the 2 day. Heart started beating normal, happy, lots of energy, driving everywhere!!! The best part, other then my heart not racing, is wanting to hang out with friends again and talking to complete strangers without sweating and panicking thinking they are judging me!! I did have to raise my dosage to 150 mg because 75 mg was only working half the day. I do hear when you do want to come off of these it is not fun but at this point I hope I never have to.\"',\n",
       "       '\"I&#039;ve had depression, dissociation, mild OCD, &amp; bad anxiety my entire life. After I found out my ex GF was triggering my dissociation to have odd sexual fantasies with me, my dis grew into dissociative identity disorder &amp; my mild OCD grew into a terrible 3 type OCD. Cleaning, Counting, &amp; Pure O. My dr prescribed me 1 Venlafaxine 150xr/day. Within a month, my 2 alts were gone, my anxiety was far less (almost non existent), my OCD was gone, and my depression was way less. When I go more than 2 days without my Ven, I get brain zaps &amp; terrible anger. I have to hide away. It&#039;s masking my issues but I want to fix them. I also get night sweats and have trouble waking up. Both started when I started taking Ven. I don&#039;t recommend these. Avoid SNRIs!\"',\n",
       "       '\"Was so excited to try Effexor XL and did for the past 6 years.  Well, I didn&#039;t realize that it made me anhedonia, or without feeling towards a lot of things.  I just went on my merry way, but would do nothing....sat and watched TV, couldn&#039;t get anything done.  Everything was just Great!.....that is what I thought....then I started gaining weight......gradually, but I mean 60-70# over the past 6 years or so.....but just kept on eating.   Then I thought I have to do something about this.  I gradually took myself off, but WOW the side effects of the withdrawl was unbelievable.  My son told me never to do that again...and I told him see.....this medication has so changed me.....and I will never take that again....!Trying to lose this weight now\"',\n",
       "       '\"After a month of taking 37.5mg of venlafaxine a day I began to experience palpitations, breathlessness, fast pulse rate and other unpleasant but less serious side effects, occasional staring spells, jerky movements and strange sensations in my neck and head. My GP told me to discontinue the drug straight away. I&#039;ve been off venlafaxine for 2 weeks, although the breathlessness eased after a few days I&#039;m still have fast pulse(over 100bpm), palpitations and an overall unwell feeling with aches/pains and strange &quot;turning&quot; sensation in my head which leaves me feeling spaced out for a minute or two after. My mood is currently worse than it was before taking the medicine.\"',\n",
       "       '\"Hi I was on cymbalta for 6 weeks  gained 17 lbs.  I started back to Effexor. Have lost 4 lbs in a week of coming off cymbalta and going back on Effexor. Cymbalta made me retain fluid. I was miserable on cymbalta.  Rheumatologist wanted me to try cymbalta so I gave it a try for fibromyalgia    I went through a little electric feeling for about 3 days coming off cymbalta. Can anyone tell me what else is good to take for the fibromyalgia pain. Effexor seems to help some , but still having some pain.\"',\n",
       "       '\"HORRID. Weight gain 130lb to 165lb, I&#039;m 5&#039;3. Night sweats. Ice cold hand and feet. Severe dizziness, blurred vision. Constipation. Diarrhea, nausea, headaches, rapid pounding heartbeats edema, achy legs that wake me up they hurt so bad. Can&#039;t concentrate or focus at work. Black out while driving. Felt like was going to faint at work.\"',\n",
       "       '\"I was put on a lot of meds for 9 years - I even overdosed on one wanting to die after 3 months. In the lock down ward they found out I had Dissociative Identity Disorder and put me on Effexor XR 150mg. I have been taking for 10 years now. In the beginning I felt like a zombie but then when it got into my system I was not raging on people and I have not lost time. I was going to sleep and waking up days or months later not know where I&#039;d been or who I was with I had to give up my children so I would not hurt them. It doesn&#039;t matter if you are for or against this if you have a problem you should get help and let someone close to you know so they can watch if something changes.\"',\n",
       "       '\"I had hot flashes every 2 hours. My face would turn beet red my glasses would fog up and always at an inappropriate time. Took my first dose of Effexor 37.5mg, my hot flashes are basically non- existent. Mood is also awesome now.\"',\n",
       "       '\"I am 140 lb, 29 year old woman. I was prescribed 150 mg of Venlafaxine XR. I only took it for 5 days due to the horrendous side effects. I experienced dry mouth, excessive sweating, blurred vision, constipation, and increased heart rate. I wasn&#039;t on it long enough to determine its effectiveness; I wasn&#039;t willing to deal with side effects. My doctor switched me to Wellbutrin and I have not experienced any withdrawal symptoms.\"',\n",
       "       '\"Possibly the best medication I have ever been given. Miracle for my father too. I take 187.5mg and notice the difference with the last 37.5mg capsule that got added. Only downside is that missing a dose is extremely sickening for an entire day, so it is good to carry a dose or two in my purse so I can take it around the same time daily.\"',\n",
       "       '\"I have been on Effexor for about 6 months now. I was prescribed it for anxiety and social anxiety. My social anxiety is basically gone. I still get a little bit of anxiety but it is way better than it used to be. However, if I forget to take it I get very bad withdraw symptoms. But, I consider it worth it.\"',\n",
       "       '\"I&#039;m on Effexor 150mg. I was on 75mg but my doctor upped it as I was still not feeling good. Feel better now but don&#039;t advise coming off yourself as the coming down effects of it aren&#039;t good.\"',\n",
       "       '\"In response to Natalie- why didn&#039;t your doctor wean you off this medication? By just  cutting your dose by half-if that&#039;s what he/she did here,  no wonder you&#039;re experiencing such horrific side effects - speak up! My daughter just started taking this for panic disorder brought about by MIf the RX only comes in capsule form at those two doses- then there needs to be advocacy to change this so there is a way to wean off this med! So many people report negative side effects- withdrawal shouldn&#039;t be torture and you might need to find a more compassionate doctor- it astonishes me the lack of empathy some professionals have- considering their career choice- if they can&#039;t be compassionate, they should stay AWAY from patients and stick to reearch!\"',\n",
       "       '\"While this medication calmed my stress, I wish I had never gone on it.  I have been trying to go off it for two years.  The withdrawal symptoms are horrendous. Brain zaps, anxiety ten times worse than before meds, isolation, low energy, extreme irritability, very quick to anger.  No joy.  I used to be a very happy and caring person. No more.  I would never wish this on anyone else...\"',\n",
       "       '\"I&#039;ve never been so happy in my life. It&#039;s not a fake, life is strangely perfect happiness. It&#039;s not the &quot;I&#039;m in my head, three feet away from everything and no one knows me&quot; feeling I&#039;ve gotten from previous antidepressants. I feel balanced and for the first time in my life (I&#039;m 28, female) feel like I am actually coming from a well-grounded place. As others have said, when a dose is late or missed, the effects are pretty awful. The longer I&#039;ve been on it though they are getting less intense. The first few times I was late, I became very quickly, extremely depressed, lethargic, dizzy, nauseous and irritable. I was having shooting lightening like feelings in my brain that would cause me to stop dead in my tracks and look pretty crazy.\"',\n",
       "       '\"About two-three months ago I was prescribed Cymbalta for my anxiety problems (EXTREME NERVOUSNESS, nervous habits, and constant worrying). I took Cymbalta for about three-four weeks and absolutely HATED it! It made me feel horrible so I asked the doctor to prescribe me something different. He started me off on 35 mg of Effexor. I have to say, this medicine at first wasn&#039;t all that great either. For the first four to five days I was extremely angry and annoyed about EVERYTHING! I thought it was going to be hopeless but finally the Effexor got better and now I&#039;m on 75 mg a day. My mind is not constantly racing nearly as much as it used to. Every now and then when I start to have panic attacks I will have to take either o.5/1 mg of Ativan to calm me.\"',\n",
       "       '\"I had been on Zoloft (50mg/day) for depression for 8 years. Following a major chronic health condition, a medical specialist was concerned the Zoloft was no longer effective. Increasing to 100md/day was disastrous - head spins, dry dry mouth, vertigo - so a psychiatrist recommended Effexor. Initial 75mg/day then 150mg/day after a fortnight. Initially I was unable to orgasm but this lasted only about a month (same when I started Zoloft). Main concern is weird dreams most nights. The only thing I can tie this to is the Effexor. Have been researching online and it seems I&#039;m not the only one. What a relief to discover - I was becoming quite concerned (and irritated). But hey, I feel soooo much better that I can live with it. I&#039;m smiling again.\"',\n",
       "       '\"Not perfect but pretty close. Switched from Paxil(no emotions)-&gt; Wellbutrin(aka severe anorexia)-&gt;Effexor. Basically all medications were pretty decent at anxiety coverage. I found Paxil to be the best without thinking of anything but anxiety attacks. Wellbutrin to be the least effective. Effexor was somewhere in the middle while still letting me enjoy life with an occasional anxiety attack. Since I&#039;ve been on Effexor I&#039;ve had maybe 3-4 small anxiety attacks in the span of 2-3 years.\"',\n",
       "       '\"I have been having depression for about 10 years. It took a long time to get the right one. Eventually I was put on Effexor XR. Started from 37.5 then finally 300mg per day. Effexor gave me a lot of side effects but I found it to be very good making me feel myself again. There was only one major problem, I got addicted to GAMBLING even from the day I started with 37.5. I was in major dept. I am now trying other medicines (Seroquel) but I am not the same anymore, very lazy, no motivation. Since I have stopped Effexor I have stopped gambling. And as for the depression, I am on trial with Seroquel. Wish me luck!!\"',\n",
       "       '\"Overall, I would say good but there are noticeable side effects; \\r\\r\\n- Dermatographic urticaria which became chronic (now prescribed Phenergan to cope with this)\\r\\r\\n- Trouble swallowing at times; feels stuck throat and chest\\r\\r\\n- Body jolts (like falling off a cliff/bike in dream) a\\r\\r\\n- Body aches (like day after the gym)\\r\\r\\nIt took me a while to associate these with the pills but no doubts about it now\\r\\r\\nNeed to be disciplined to take everyday, same time.  Otherwise the jolts and aches kick in.\"',\n",
       "       '\"I had a lot of side effects on Effexor 37mg- dry mouth, constipation, increased heart rate and blood pressure, ringing in ears, nausea, shakiness, more anxiety and so on. I don&#039;t remember having all these with Lexapro or Zoloft a few years ago. At least not to the same degree as Effexor and if there was any side effects they went away after a few weeks. I switched back to Zoloft 25mg after 3 weeks and 3 days in I already feel better - no more feeling wired or jittery. Effexor is not the med for me. It did help the depression, but the crazy side effects aren&#039;t worth it to me. I do have a friend that&#039;s been on it awhile and it work great for her.\"',\n",
       "       '\"I am extremely disheartened in reading the negative reviews.  I have taken Effexor since 1993.  I began taking 37.5 mg and later lived for one year in a private psychiatric hospital for a suicide attempt. My psychiatrist, then the President of the American Psychiatric Association, increased my dose to 600 mg per day.  This miracle drug kept and still keeps me alive some 23 years later.  I have experimented with not taking this or any medication.  I never presented with any withdrawal symptoms.  However, like clockwork, on the 3rd day w/o it I begin to cry tears over nothing.  By the 4th day I find myself in the midst of severe depression.\\r\\nwithin an hour of beginning my regimen again, I am back to my normal.\\r\\nDo not be afraid to try this medicati\"',\n",
       "       '\"I&#039;ve been taking antidepressants for about 15 years, due to panic attacks, general anxiety, and situational depression, and they have worked well. Additionally, for 10 years I have had very severe leg pain, seeming to be sciatica/nerve pain and muscle pain, from hips to feet. I was told by two orthopedists that, &quot;You&#039;re just old (59) so live with it.&quot; \\r\\r\\nIt&#039;s been only a month since I changed to SNRIs--namely Venlafaxine--and since the very first day, I have been pain free. I can walk again with long strides and quickly. I can stand for long periods. I can take hikes. I hadn&#039;t been able to do that for 10 years.. My life is no longer dictated by how much pain I can endure. I don&#039;t know how it works, but I wish I&#039;d known about it years ago.\"',\n",
       "       '\"Overall venlafaxine did what it was supposed to do, it kept my moods level, however; the withdrawals from having to stop it after becoming pregnant were horrible. Even with titrating off of it my brain and body felt like they were going to explode. The brain shivers landed me in the hospital (hyperemesis gravidarum didn&#039;t exactly help). The withdrawals alone will stop me from ever taking venlafaxine again.\"',\n",
       "       '\"I took this for six months, I felt great, then my doctor took me off it because he said I shouldn&#039;t take it for too long, this was 4 years ago, now for the past year my anxiety is horrible. I wish he hasn&#039;t taken me off out and now I&#039;m going to talk to my new doctor about it.\"',\n",
       "       '\"I was prescribed Effexor XR about 2 years after my mom passed away and it was the like the miracle drug for me.  Then about 9 months ago I received the generic substitute for Effexor (Venlafaxine) and I had this debilitating nausea and threw up every single time I took it.  Feeling this daily wiped me out and it caused problems for me at both of jobs.  I am highly upset about this change and want my EFFEXOR back.  I hear that I am not the only one this generic &quot;substitute&quot; has affected this way.\"',\n",
       "       '\"I have been on Effexor XR 150mg for 3 months, it has helped me face social interaction at work and calmed my negative thoughts, I am the happiest I can ever remember, totally changed my outlook on life, mild side effects of constipation and I noticed I have gained about 7 lbs but I also recently quit smoking so I don&#039;t know how much to attribute to the med.\"',\n",
       "       '\"2 weeks now and no improvement. Fingers crossed going forward! Feel tired and no energy...\"',\n",
       "       '\"4 week on 37.5mg and my irritability and anxiety is so much better. My horror week before periods - is no more. The PMDS was well treated as was the mild underlying anxiety felt during rest of month. Side effects for me were headaches for first week, visual change (2 weeks) and feeling tired (lasted a few days). None of which would make me stop given positive benefits.\"',\n",
       "       '\"I&#039;ve been on tons of antidepressants and anti-anxiety medications throughout the years.  When I started taking Effexor XR, I was thrilled- I felt so much better... minus all of the side effects.  The side effects are just awful.  I sweat constantly, I have awful headaches, no sex drive, and I gained 15 pounds.  And now the medication has stopped working sort of... I don&#039;t feel sad or happy... I just kind of feel here.  I&#039;ve tried to get off of Effexor but I get those brain zaps/vertigo feelings and vomit so I stop and keep taking it.  I guess it helps some people but if I can ever get off of it, I will be going back to another medication.\"',\n",
       "       '\"I took this pill once at 37.5mg to start my regimen. I got serotonin syndrome and was hospitalized. Steer clear from this medicine.\"',\n",
       "       '\"Find another medication. This caused me horrible memory problems, I have been out of work for the last 9 months because of it. My lying psychiatrist told me the side effects were minimal, even though I specifically asked her to tell me the side effects before I agreed to take the medication.\"',\n",
       "       '\"It was the worse experience ever. I took it and couldn&#039;t sleep all night. I cried for hours and even called the emergency hotline. I had muscle stiffness, excessive yawning, nausea, and twitching. So far the worse medication I&#039;ve ever taken\"',\n",
       "       '\"I have taken this medication for over 4 years and my life has changed dramatically since then. I take 75mg doses 3 times a day and my days are so much better now compared to over 4 years ago when I would have panic attacks and anxiety attacks. I would recommend this to anyone who has depression or anxiety/social anxiety disorders. The only downfall is if you run out of your prescription the withdrawal symptoms can be intense after about 2 days. Make sure your refills are ready and not about to expire because it can cause you a lot of problems such as it has been in my case. Other than that it is a great medication to help you get back to your normal self again.\"',\n",
       "       '\"I was given this medication after a major panic episode and I noticed a good change a few weeks after taking it. It helps your mind wander and not focus on the bad things. It also just made me a generally happier person. However, I skipped a few days (I&#039;m on the 75mg) and the side effects were terrible. I got hot flashes, awful nightmares, I was so dizzy I could barely walk, I was disoriented and couldn&#039;t focus on anything, and I was absolutely exhausted. I started taking it normally again but it makes me a little nervous to stop taking it permanently...\\r\\nBefore taking this medication I would definitely weigh &quot;do I want to be on this for a really long time?&quot; Or &quot;I can tough this out.&quot;\"',\n",
       "       '\"I&#039;ve been on 75mg of Effexor XR for about 3 weeks. I still have some anxiety but I can tell it is helping. I was very afraid of sexual side effects when taking this medicine but I&#039;m happy to report that overall its not been a problem. 70% of people do not have sexual side effects. \"',\n",
       "       '\"I was prescribed this medication when Celexa wasn&#039;t working. My doctor put me on 75mg to start and that night I took my first dose at 9:30pm and by 11pm I was a total wreck. I became super nauseous and began throwing up quite a bit. My my body was restless and my arms and neck were numb and tingly. I managed to get a bit of sleep but the next morning was a write off - I felt completely disabled and lethargic. I was so weak, I could hardly hold my cell phone. I could hardly walk I was so dizzy and the brain zaps were fierce. I immediately visited my doctor and he prescribed me something else. 75mg to start was way tooooo strong for me. I can&#039;t believe the side effects I&#039;ve suffered after 1 dose. My advice would to please try another option.\"',\n",
       "       '\"Ineffective. Shouldn&#039;t have been prescribed as I am bi polar, diabetic and in dire need of anger management.  I wasn&#039;t 100% honest with the doctor. Therefore the drugs prescribed for me, erroneously,were my fault.  Thanks for understanding, &quot;my bad&quot;.  :(  :(\"',\n",
       "       '\"Absolutely effective. Had been having hot flashes for about 6 months and they were increasing not only in intensity but also in frequency. The final straw came when I was out with my daughter, 19, and she said &#039;your face is all sweaty.&#039; Since I have started taking Venlafaxine, I can say the hot flashes have almost completely disappeared. I feel so much better. I do have a problem sleeping and am not sure if that is related to the medicine.\"',\n",
       "       '\"Barely took the edge off of my anxiety AND made me severely depressed. After a week of trying to consult a doctor about the depression I gave up and quit cold turkey. The withdrawal symptoms were bad. Never again.\"',\n",
       "       '\"I have been on Effexor for over 5 years now and I cannot imagine life without it.  I was crying all the time for no reason....my dr. Put me on 75 mg a day and it made me extremely anxious.  He then upped it to 150 mg per day and I have no side effects and function great!  The only side effect I have noticed is:  if I forget to take it I start to feel dizzy after a few hours and by night am crying.\"',\n",
       "       '\"Please please please.......If your doctor suggests this drug to you, do your research. I am 18 and just put full trust in my doctor when she told me to take it. 7 months later and I wish I never ever took it. I usually take my 150mg dose when I wake up in the morning and now I cannot even go until 11 pm at night if I forget to take it without having withdrawals. I experience nausea and feel uneasy on my feet as well as shakiness. It is ridiculous and  I write this to stress that this is not a light topic. BE CAREFUL!!!!!\"',\n",
       "       '\"Been on this         Generic XR capsule 150 mg.just 4 days and have nausea, shakiness, blurry vision, insomnia, crying spells.\\r\\nThis is awful and getting off this right away!\\r\\nWas on just before I started taking this was just 2 tablets, twice a day 75mg.\\r\\nNo problems of side effects.\\r\\nJust wasn&#039;t working much anymore.\\r\\nThere is a difference on side effects!\"',\n",
       "       '\"There is a light at the end of tunnel. Have been taking Effexor XR 75 for almost 25 days. Initially felt miserable and had side effects (nausea, stomach upset and increased in anxiety). But today when I woke up I feel myself again, the real me - this drug has been a savior for me. Trust me this is awesome. Give it some time and it will give you your life back. I was really disappointed by taking Citalopram for almost 5 months it didn&#039;t get me feeling any better and even increased my anxiety but this drug is a miracle for me. Those thinking to quit, hang in there give it sometime and you will be back to normal :-)\"',\n",
       "       '\"Effexor might have saved my life because at the time I was given it I had damn near given up hope.  Paxil and Zoloft did nothing. Depakote attacked my liver. Lexapro made me numb. Then Effexor was given to me. 2 weeks after taking it I felt better. 4 weeks later, I was back doing things again. Within a year I had all my interests and hobbies back. \\r\\n\\r\\nCons:\\r\\n\\r\\n1.  Withdrawal is terrible. When I miss a dose I feel it. Neck pain. Headache. \\r\\n2. I&#039;ve found that I had to increase the dose after two years of usage 75 mg 3x times a day holds me.\\r\\n3. Not really a con, but when more stress then usual I relapse for a few days with depression but it goes back to normal if you increase dose for awhile.\"',\n",
       "       '\"Starting of i was hesitant because nothing really happened i just felt blah the first two days on 75mg, than i started feeling the posotive effects! It was amazing, i havent felt like this ever before on an antidepressant! Im now on 150mg and just livin life depression free. If you have tried prozac, celexa, brintellix, and they havent worked for you give this a shot... Sometimes the risk is worth it!\"',\n",
       "       '\"Started off really well, 4 - 5 months down the line, have started to binge now and again but desire to purge is much less than before, only twice in 3 months.\"',\n",
       "       '\"I took remeron (mirtazapine) for about a year until I decided I needed something to give me more energy. I started 75 mg in the morning after eating. In a week I could already feel a difference in my mood and energy. Even my friends and family have noticed a difference in me. I didn&#039;t realize how numb I had been on remeron. I&#039;m finally getting back to myself and I couldn&#039;t be happier. My depression and anxiety has been getting better thank God. The only complaint about this medicine is that if you forget to take it, even just one day, you get headaches, feel nauseous, or dizzy.\"',\n",
       "       '\"Venlafaxine didn&#039;t work well for me, although I was no longer anxious, I did feel like I was a zombie. \\r\\n\\r\\nMy message to anyone trawling the internet for answers &amp; hope.  YOU WILL GET BETTER!\\r\\n\\r\\nIt may take time and trial/ error with your treatments, but every human being is different so if one treatment worked for someone and not you, then there are a whole host of other treatments &amp; combinations. \\r\\n\\r\\nTalk to people whether family, friends, support groups, online forums.  Go to your doctor or consultant and take all the help you can.  If you are not happy with your treatment, ask for a different healthcare professional. \\r\\n\\r\\nAs I write, I am in recovery on Sertraline.  I have agorophobia, but am starting to get back to a somewhat normal life.\"',\n",
       "       '\"I suffer from chronic pain from degenerative disc disease, fibromyalgia, arthritis and depression. Doctor put me on this for my fibromyalgia. I found it has done wonders for my depression (got off Prozac), PMDD and fibromyalgia pain. I&#039;m only 42 yrs old and suffer everyday of my life. This has given me some of my life back. As an added benefit I lost some weight.\"',\n",
       "       '\"Was given this for depression and had no idea it would transform my life. After taking for just 1 day I noticed my pain was almost gone after suffering for years. I can&#039;t believe that only the day before I started venlafaxine I had to use crutches to go shopping because the pain in my legs and back when walking was excruciating. I&#039;ve noticed I feel so much more relaxed than I have in years, my mood has improved, I feel almost excited that I can now get my life back. I am 45, have Ehlers Danlos Syndrome and fibromyalgia and wish I had known about venlafaxine years ago.\"',\n",
       "       '\"I was started on 75 mg Effexor and then increased to 150 mg.  I felt much better overall.  Anxiety was about gone, I could think through my thoughts.  However, I was not happy with the sexual dysfunction I experienced on the 150 mg dose. My doctor lowered my dose back to 75 mg and the sexual dysfunction resolved and my generalized anxiety disorder is within tolerable limits.  I recently added Vitamin D and B12 to my daily regimen with my Effexor 75 mg ER dose and noticed a huge lifting of the mental fog that I had known for so long. This combination has been keeping my thoughts from racing, my hope from tanking and my perspective in a good and positive place. It works for me.\"',\n",
       "       '\"I&#039;ve been on this medication only one week but am cautiously very optimistic. Prior to this I was on citalopram but still feeling very low and sleeping poorly, feeling like I needed to be in bed 12-16 hours a day. Now I am waking naturally after only 8 hours sleep and finding it much easier to concentrate at work. I can hardly believe it is working so quickly but I feel so much better. I&#039;ve had no side effects.\"',\n",
       "       '\"I started with Prozac and could not sleep at all.  With Effexor 150mg, I could sleep standing up and was so sedated that I could not function.  Withdrawal from 150mg to 75 to 37.5mg was OK, but after that withdrawal was hell with dizzyness and nausea.  Changing back to 75mg, I still slept well, had a good sense of well being and could still function. With it 20 years now\"',\n",
       "       '\"I was prescribed effexor for anxiety which interfered with sleeping - worry about getting to sleep meant that I wouldn&#039;t sleep which made me feel exhausted, depressed and useless. I&#039;ve also tried Zoloft and Luvox which didn&#039;t do anything. CBT and mindfulness were also pretty useless - just made me slightly more obsessive about my weird problems with getting to sleep. \\r\\r\\n\\r\\r\\nEffexor has been amazing. Apart from some insomnia and lightheadedness during the first week I don&#039;t have any side effects. I don&#039;t have the same obsessive and weird anxious thoughts over getting to sleep or other minor things which preoccupied me and made me feel dreadful. I sleep well and my head feels so clear.\"',\n",
       "       '\"Found this medication excellent with my depression recovery. However when you do start to feel better, the medication makes me feel lazy at times and has made me put on about 3kgs.\"',\n",
       "       '\"I suffered from depression and anxiety all through university. Effexor helped me finish my degree and I couldn&#039;t be happier. Everyone can react differently, just pay attention to your body.\"',\n",
       "       '\"I used Effexor XR for depression and anxiety for almost two (2) years. Effexor has terrible anxiety and nausea first several days. I started 37.5 with .5 Clonazepam in the morning and before night, then upped to 75mg. Clonazepam was removed once my sleep was restored.\\r\\n\\r\\nGreat Drug gave me life and energy. Side effects lowered erection, sex drive and orgasm.\\r\\n\\r\\nKept me going well, gave much more energy comparing to Lexapro. Getting off after 2 years was not a problem. I was slowly reducing dose each 2-3 weeks.\"',\n",
       "       '\"Lifted me out of a deep, dark depression at 450 mg/day combined with Remeron 45 mg/day.\"',\n",
       "       '\"This is the only medicine that totally helps me.  I seldom have to take Alprazolam or Valium with the Effexor.  I tried switching to Cymbalta for nerve pain..what a mistake.  I am back on Effexor. \"',\n",
       "       '\"This drug has been a God-send for me! I have had depression since the birth of my second child, 7 years ago. I was on Zoloft for years which worked well. However, after  a series of troubling situations, I developed anxiety and panic. The panic attacks were so bad that I kept ending up in the hospital thinking I was having heart attacks, even though my heart is completely healthy. I went to an amazing doctor who worked with me to find the right medication, and since starting Venlafaxine, I have been panic free!!! For those who suffer from panic attacks, you know what an amazing feeling this is. I didn&#039;t know I could have my life back, but I do! I feel more like myself now than I have in years!\"',\n",
       "       '\"I was on Effexor XR for about 4 years (started at age 18, weaned off at 22). Over the years, my dosage fluctuated between 37.5 and 300 mgs. \\r\\nIt helped immensely throughout the first year. I was still feeling lethargic and such, but no longer had suicidal thoughts. \\r\\nThe only side effects I had were ones that appeared when I&#039;d miss a dose. Night sweats, weird dreams, headaches. Annoying, but basically harmless.\\r\\nAfter three years of being on this medicine, I realized it was no longer doing things for me that I couldn&#039;t do myself. I was supposed to be taking 37.5 mgs daily, but weaned myself off of it over a course of several months (check with your doctor first). I had little to no withdrawal symptoms and no major signs of a returning depression.\"',\n",
       "       '\"Just started taking it and I feel so sick and wanna vomit\"',\n",
       "       '\"Brilliant\"',\n",
       "       '\"Nearly all of my life, now retired, in spite of being a high achiever, confident (on the surface) and skilled, I have fought against depression, anxiety, self harm, a lack of connection. I have hidden it well, feeling ashamed of not being happy inside. Tired of the fight I finally saw my doctor and tried several different tricyclics, SRIs, but all gave me unwelcome symptoms. We agreed to try Venlafaxine, and within a fortnight I was feeling so much better. I then started CBT, was diagnosed with delayed trauma, which surprised me but as we worked through it, made sense.  My drug dose was doubled and I&#039;m feeling even better. I am so relieved. This drug works for me, no side effects, and I feel so much calmer and able to cope.\"',\n",
       "       '\"Started out on 300 mgs 1 x per day. Can&#039;t say it helped or didn&#039;t. The dose was lowered to 75 mgs at one point to see if it was the reason for my memory loss. Supposedly I had an acute stroke with partial blockage in my neck. I have been on it 15 years doctors recomendations. Last 7 years have been on 150 mg&#039;s 1 x per day. Mind comes and goes. Sometimes I can&#039;t remember my husbands name. I had no visual signs of stroke. They said it was an old stroke I never noticed. I also take xanax 2 mgs per day. Gabapentin 300 mgs per day. Geodon 40 mgs per day. Bisoprolol 10 mgs 1 x a day. Diabetic. Take insulin. Anxiety is gone. I do need to figure out what is causing my memory to come and go. Wondering if anyone else has this problem on Effexor ER.\"',\n",
       "       '\"originally on seroxat (paxil) for 17 years. felt so good on 20mg that after having my child I thought I would come off it as thinking of having second baby. I was put on prozac to help with withdrawal.  after 4 months on prozac I was an absolute mess so Dr put me on effexor. I&#039;ve been on this now for 6 months. I cry literally every day. it has created obsessional and horrible thoughts, I am constantly tired.  I have anxiety and panic. I feel it has actually created new symptoms that I never had. I do not like this drug and am coming off it as soon as I get an appointment with the psychiatrist\"',\n",
       "       '\"My doctor started me out on the 37.5 and now I am on 75 mg.I love my venlafaxine and I love my doctor. For the first time I feel hopeful I don&#039;t feel stuck in my head all the time. Most of all don&#039;t sit around with my body all tensed up jaws clenched.I used to stay sore from tensing up. Not waking up scared and wired anymore I am getting my life back if I stay on this for life I am good with that.\"',\n",
       "       '\"Although Venlafaxine doesn&#039;t get rid of the pain, my life has improved immensely now that the depression is controlled.\"',\n",
       "       '\"I spent several years taking Citalopram, which I found to be very good, until it stopped working. I was then prescribed Venlafaxine. I started off on 225mg daily, but it was not controlling my anxiety and I became depressed on it.. I was then told to up the dosage to 300mg daily by my Psychiatrist. Several months on, and I can firmly say this medicine has turned me into the same state I was in prior to ever taking any medication. My anxiety has increased, and I now suffer with depression and suicidal thoughts which I never had before. I have had no appetite, which can be a side effect for some people. have lost a lot of weight. Food and drink tastes strange, my skin has developed pimples.\"',\n",
       "       '\"I was prescribed effexor on Monday and I have had the worst experience with it.  Its now Saturday and I can&#039;t sleep for more than like 2 hours at a time I can&#039;t eat and I feel so foggy worst experience ever\"',\n",
       "       '\"I have been on Effexor for awhile now I would guess three years. I don&#039;t know if it works or not, to be honest. The passed few years have not been normal by any means. I had a lower back fusion in 2009 but bounced back fast and continued my life. Missed a year though of baseball. Then while playing I broke my neck, yes my neck. That ended up also getting fused. My ill advised comeback resulted in three shoulder surgeries and a broken arm. I didn&#039;t handle my dreams of being crushed well. Super depressed that I was no longer an athlete. I have bad bad pain every day. I am married with two little kids and I became anxious every morning not knowing if I could play with my kids or not. still have bad anxiety and moderate depression.\"',\n",
       "       '\"I took it for 2 weeks. Started 75mg first week and went up to 150mg the second. Several days after I increased the dosage, I lost all sex potency and sex drive completely. I&#039;m a 25 year old man and I was not able to orgasm at all.\\r\\n\\r\\nAfter I stopped I have VERY SEVERE withdrawal symptoms. I had to lose work for several days and was very close to being sent to a hospital.\\r\\n\\r\\nAt NO POINT did my doctor warn me of any of these symptoms.\\r\\n\\r\\nIt&#039;s very important to understand that this drug is that this drug CAN cause permanent damage and that it is highly addictive even after a short time.\\r\\n\\r\\nI&#039;d rather take a bullet to my head than take this pill ever again.\"',\n",
       "       '\"Effexor was better for fibromyalgia when you could control dosage and take more if needed.\"',\n",
       "       '\"Made depression worst ,was not effective even at 150 mg. I got an understanding of why people become alcoholics or drug abusers on Effexor/Venlafaxine. I would lay in bed all day waiting for life to pass by. I never had feelings of despair so severe. If I mised a dose or waited for an hour later to take Effexor I had an intense &quot;Rush&quot;. I would pace around like on cocaine or speed. You cannot stop taking this medication. I am still trying to get off it!  When I reduced my dose I had a drunk effect with nausea I just felt so awful. I consider this to be a drug that shoudnt be prescribed. Celexa and zoloft &quot;robot drug&quot;worked well on me for anxiety and depression but I do NOT recommend this medication.  Going back to Elavil\"',\n",
       "       '\"I am 40 years old and I have never taken a AD in my life, however I should have! I have a hip injury and picked up a addiction to opiates along the way! Luckily effexor has helped with the psychological effects of getting off of opiates! I know about all of the horror stories of AD but for me it was the best choice I could have made! I just returned to a very stressful job after a 2 year absence and I don&#039;t think my return to work would have been as successful without AD! During my 2 year slump I never used to leave the house, I slept all the time, used to cry at the thot of doing the dishes.....insanity! Luckily the only side effects that I had was the dry mouth and slight headaches in the beginning which went away!\"',\n",
       "       '\"Was put on a high dose of 375mg and find it overestimulating not good for my anxiety\"',\n",
       "       '\"I&#039;m 17, about 125 pounds, female and a senior in high school. I&#039;ve had depression for a while and started taking Effexor. I strongly encourage trying this medicine for any teens or college students who deal with depression. Helps me concentrate and feel all together in a stable and happy mood. I&#039;ve had weight loss also only thing that makes me nervous is the withdrawal effects I&#039;ve read about.\"',\n",
       "       '\"Ineffective for me. I had to stop taking it twice and the withdrawal was AWFUL! It was like what I would imagine heroin withdrawal from heroin. I highly suggest NO one use this drug for that reason.\"',\n",
       "       '\"I&#039;ve struggled with GAD, social anxiety, depression issues since I was 15. Lets just say I get easily nervous. I am now 27 as I type this ,and let me just say I&#039;ve tried every single antidepressant out there. This one has really worked for me it boosted my mood. I&#039;m more social. I don&#039;t do anything socially awkward around new people anymore. And I keep losing a lot of weight even though I&#039;m very active. So that&#039;s a plus!\"',\n",
       "       '\"After I started taking this medicine I got Restless Leg Syndrome - when I went off of the medicine it went away.\\r\\nI was always tired while taking the medicine. When I quit, I got dizzy twice and fell within the first week after I stopped taking it.\"',\n",
       "       '\"I had a major breakdown and was hospitalized. My psychiatrist put me on effexor. I took it before bed and by 2 am I was running fever and felt like I had the flu. It was by far the worst medicine I have ever tried. EVER. I woul never take this again. I felt horrible all day the next day and wouldn&#039;t get out of bed. It was a nightmare.\"',\n",
       "       '\"Brilliant medication. I know Venlafaxine is contraindicated in people who experience mania and I have had some issues with that but overall, with other medications that stabilise my mood, I have found Venlafaxine to be a life saver. I am 23, been hospitalised before for a long time and it was the first med I agreed to go back on after a period of desperation following a year of refusal to take meds due to extreme anti-psychiatry views. Now my anxiety is massively decreased, I feel much more on a level, less irritable, far less lethargic. This medication has done so much for me. No side effects apart from the initial week or two of starting it I got some insomnia and occasionally I get a very dry mouth. Sometimes a bad tremor.\"',\n",
       "       '\"This medication has helped me out very much.  I used to get anxiety attacks often about school or work, a couple times a week but now I rarely get them at all.  I also used to just &quot;blow up&quot; in arguments with my wife but now I feel in control of my actions and speech.\"',\n",
       "       '\"I started taking Effexor at age 19 after about 2 1/2 years on Prozac. The reason for the switch was that I developed anxiety problems at that age in addition to depression, and the Prozac was not treating the anxiety. Effexor works very well to treat both anxiety and depression but if I stop taking it for even 1-2 days (which is often because I am very forgetful) I become extremely depressed for the next 1-2 days. Right now I am in one such down swing after taking my Effexor for the first time in about 5 days. If you avoid doing that though you should be fine, the medication does help a lot.\"',\n",
       "       '\"My diagnosis: MDD. It is more of a situational depression. I can be ok for years, but as a single mom, business owner and a few family struggles, the stress sneaks up on me and before I know it, there&#039;s anxiety, loss of interest, agitation, guilt, shame and some paranoia. I Tried Zoloft and it was ok. Tried cetalophram and couldn&#039;t tell if it was working. A doctor gave me venlafaxine a few years ago. I took it for a year and almost took for granted how absolutely life changing this medication was. I lost my insurance when the prescription ran out, so I went without it for a few years. I went back on it last week and it worked again almost instantly. No side effects here just peace!\"',\n",
       "       '\"I have been on this medication for over 15 years. I can tell you that this is the absolute best medication for panic attacks, the problem is that I never had any panic attacks until I quit taking the pill after a year of use. I was prescribed this when I was 18 after being hospitalized as the result of several traumatic events. I started on 32 mg and eventually was bumped up to 150mg and then 225 mg. I weened off and survived the withdrawals and felt amazing seriously felt like the best moment of my life but about a year after I stopped taking it, the depression came back twice as bad. \"',\n",
       "       '\"This medication gave me back my life. I take 75mg twice daily of the XR and for me it&#039;s the perfect dosage. I wake up every day feeling hopeful and great. I used to suffer horribly with stress and anxiety it was crippling. Thank goodness for this medication cause other meds didn&#039;t help but this medication did.\"',\n",
       "       '\"I have been on Effexor for the past 10 years - I started having panic attacks as a child although I didn&#039;t know at the time what was going on - when I was 17 the doctor prescribed Valium that I took periodically when my anxiety got really bad - finally when I was 40 the doctor suggested I go on a very low dosage of Effexor (37.5mg) because he was sure I had generalized anxiety disorder - what a difference this has made in my life - felt&quot;weird&quot; the first few weeks but now I have very little anxiety and really no side effects except maybe lower libido. I had no idea how much anxiety I had been living with all my life.\"',\n",
       "       '\"Love, love, love this drug. Spent seven months in total depression and attempted suicides.  Tried four other antidepressants which didn&#039;t help. Effexor saved my life literally. Started working within 3 days at a dose of 300mg. I&#039;m now happy, not anxious, not depressed, not suicidal. I&#039;m back to being me.   No nausea or major side effects, apart from low libido which is common for this class of medication and insomnia.  Works for those who genuinely need serotonin to be be restored to their brain.  Worth a shot, if other medications have failed.\"',\n",
       "       '\"I have had fibromyalgia since I was 10 years old have been on every medication doctors can think of. Iam now in my 40s and my fibromyalgia has got worse of time, I was on Cymbalta for years but it stopped working so yesterday my doctor prescribed Effexor XR I took it and this mornings I was not stiff, not moody and slept good last night , I am hoping this will help me in long term.\"',\n",
       "       '\"I had suffered from extreme anxiety and depression for a few years and countless prescribed anti-depressants prior to trying Effexor. I suffered anxiety so bad that it was hard to do daily tasks such as driving and going to the grocery store. I went through countless jobs because a panic attack would strike at work and I would have to rush out of the situation and never return because the fear of it happening again would haunt me. The very first day being on Effexor, I felt like a different person. For the first time in years, I wanted to venture out into the world and be around people. After a week of being on 75 mg, I landed a job and now, two years later I am still symptom free and off the medicines. I give this medicine a big 10!\"',\n",
       "       '\"I&#039;ve only started this medication about 3 weeks ago, I take 75mg/day. I&#039;ve noticed a big difference when I exercise now. Normally a walk around the track or using my elliptical would have me in a ton of pain for the rest of the day. Now I can exercise without the all day pain anymore.\"',\n",
       "       '\"I wouldn&#039;t try this or Lyrica again.  I have had fibromyalgia since before the doctor knew what it was.  No drug has been worth taking because of the side effects.  They eventually lose some effectiveness, then the doctors want to up the dosage or give another.  I&#039;ve gained 100 pounds.  I&#039;m sick all of the time.  The depression does not go away.  I think the added weight is worse on my body than the original symptoms.\"',\n",
       "       '\"I&#039;ve been taking Effexor XR for 15 months for treatment of depression.  Initially, I wondered if there was a point and if it was making a difference.  I was very skeptical when I ran out during a storm, didn&#039;t receive mail, and my mail service pharmacy prescription arrived late. I felt like my head was &quot;sloshing&quot; and I was very sick to my stomach.  Missing a dose was awful.  But about a year after I began taking it, I noticed that I was back in control of my life and I felt like me but better than I remembered.  My friends say they saw a difference much sooner.  I don&#039;t know if the passage of time, monthly therapy, or the medicine is what helped me get my depression. I&#039;m giving credit to Effexor XR.\"',\n",
       "       '\"I was on 300mg. Of Effexor XR for 3 years and did not realise what it was doing to me until I weaned myself off it.  I had constant suicidal thoughts and attempted suicide several times.  I had severe alcohol craving and was labelled an alcoholic and had several very expensive stays in re-hab.  I suffered horrific nightmares, paranoia and at times had difficulty rationalising what was reality.  I lost all ability to handle my finances.  My relationships were severely damaged because of this and I almost died 4 times.  I have now been off it for 4 months and I am a different person.  I no longer have nightmares, suicidal thoughts or crave or drink alcohol. This is an extremely dangerous drug!  Avoid it completely!  My story is not unique.\"',\n",
       "       '\"I feel the need to write a review of this medication as I am currently experiencing severe withdrawal symptoms from missing one dose. There was a mix up with a new insurance company and I unfortunately had to miss yesterdays dose. I have never felt this way after missing one dose of a medication and I have taken several different antidepressants over the last 10 years. I have the sweats, nausea, vomiting, diarrhea and I have been crying uncontrollably all day. I did have benefits from taking this medication for the past three years but I worry about continuing to take it any longer.\"',\n",
       "       '\"An increase in suicidal thoughts and depression.\"',\n",
       "       '\"Been on effexor xr for approximately 25 years....150mg...but still getting horrific night sweats...has  anyone else suffered this long...or...been on effexor xr longer\"',\n",
       "       '\"I have been on Effexor for 15 years 150MG per day except for a 1 year period ending about 6 months ago.  It is very effective for me.  It made me tired when I first started it, but it was worth sticking through that.  For my time not taking it, I was on Zoloft which didn&#039;t work as well.  Effexor has kept me from depression but it does other things for me.  First, it reduces my inattentiveness to near nothing.  Therefore, I am very productive at whatever I do.  Second, it greatly reduces anxiety.  Stress does not cripple me any longer while on this medication.  \\r\\n\\r\\nGoing off the medication has a weird withdrawal symptom that isn&#039;t painful, it&#039;s just odd.  Do not go off the medication without a doctor assisting.\"',\n",
       "       '\"If my comment helps anyone not to take this drug Effexor then I will have helped many people. I have been on and off Effexor for 10 years I&#039;m currently off Effexor I weaned myself over 6 months. I have not read any where and I have done a lot of research that anyone has written if they have successfully stayed of this drug for more than 12 months. So hear I am to tell you it&#039;s been 9 months and once the side effect of the brain buzzes nauseous aching bones itchiness have gone away\\r\\r\\nLife does begin to feel better I caught myself laughing and not feeling it was fake and crying at Tv shows Effexor gives you a fake feeling of happiness/sadness but after being on it for to long you just feel numb I believe this is why people end up wanting to come off it cause you have no emotion that and the amount of weight you will gain. 9 months and I&#039;m probably back to where I began in needing this medication but I am trying everything I possibly can to stay of it \\r\\r\\nThis includes:\\r\\r\\nFree hypnosis apps \\r\\r\\nFree mediation apps\\r\\r\\nSelf help quotes\\r\\r\\nVitamin b12\\r\\r\\nIron tablets \\r\\r\\nThe biggest one is when I mentally feel myself thinking negative I tell myself to stop and think of my daughters smiling face \\r\\r\\nI&#039;m not cured I&#039;m far from it but I will never take this drug again I was worse with it than without it \\r\\r\\nIf I help one person not to take this drug the I will be a better person good luck\"',\n",
       "       '\"This medication worked wonders for me. I suffer from panic disorder for a long time. I had been under control with Paxil, having no panic attack for over 8 years. Though I was cured. Suddenly it started to hit again and it was hell. My doctor said Paxil was not working any more and tried another medication. For 2 months the attacks wouldn&#039;t stop. I thought I was going to die. She decided to change the medication again and prescribed me Effexor 75. In less than a week the attacks were gone and I was back to normal. Now I&#039;m slowly quitting Paxil. She says it will be at least 6 months until I&#039;m totally off of Paxil. The protocol I follow to quit Paxil is that I alternate dosages, one day I take 12,5 and the other day I take 25. Working fine.\"',\n",
       "       '\"I had very little side effects, yawned a lot and dry mouth but the difference in my mind and wellbeing was significant.  I am so much better, I have hope, enthusiasm, my concentration is back, I am sleeping all night now, rarely wake up and if I do I can get back to sleep.  I really appreciate what this drug has given me back.\"',\n",
       "       '\"I have been taking this medicine for 6 years and am very happy with it.  It is the first medication that has helped me to feel what I would guess is normal.  I am able to enjoy things in my life that are good.  My anxiety is less and my paranoid obsessive thoughts are much more in control.  I feel like it gets my brain in the right place to where I can think clearly.\"',\n",
       "       '\"Increase dose more slowly than the doctor says. I was convinced I was actually in hell for a week after increasing my dose for one single day. It helps my situation, but it ruins my memory, kills motivation, kills desire or will to do anything. A cool and crisp morning loses that good feeling and your sleep sucks causing you to be tired all day. I would recommend to take a dose only on days you feel awful. Maybe 15mg. I regret taking this every day. The withdrawal is worse than alcohol, tobacco and other SSRIs combined.\"',\n",
       "       '\"I&#039;ve been on this medication for awhile now, it was originally just for my chronic migraines, but it never ended up working for my migraines, but I&#039;ve had a history of anxiety and Effexor seemed to solve my anxiety problems so my doctors have kept me on it all this time. I&#039;ve noticed if I go even a little over 24 hours since I&#039;ve taken my last dosage, my anxiety comes back worse than ever and I constantly throw up due to withdraw... and that&#039;s only a day of not taking it!!\"',\n",
       "       '\"I suffered depression and anxiety at a very difficult time in my life 5 years ago and have been on efexor 75mg since then... it took the edge off highly stressful situations and helped me to cope in a calm and positive way :)  Life has been good since then, even though family problems have endured (thankfully to a lesser extent)... side effect of nausea was to be expected during first few weeks but after that no problems at all... effexor has been a wonder for me... :):):)\"',\n",
       "       '\"I am a female senior and started taking this drug about 8 months ago, so far it works well for the depression at 150mg.   I missed taking the drug for 2 days and as a result I had terrible symptoms when I went to bed, my muscles felt like they were tensed and shaking, could not go to sleep but must have at some point and had terrible dreams, now I feel quite ill, stomach upset, gut upset,  sweating, horrible.  Had to take some pepto bismol tabs to try to settle my stomach.  Took my pill at lunch today, waiting to see if I start to feel better.  Surely there must be a drug that can do the same job without the necessity to take it with food and won&#039;t send you body into a tizzy if you miss a dose or 2.\"',\n",
       "       '\"Effexor XR 300 mg has really worked well for me.  Although, I am gaining weight.  I previously lost 50 lbs and now it is coming back on.  My doctor thinks it has something to do with all my medicines that I am on for depression, PTSD, anxiety disorder, just to name a few.  I am hesitant of trying a different medicine, but I can&#039;t keep on gaining the weight.  It is too hard on my back.\"',\n",
       "       '\"Venlafaxine can give you a false positive on a drug test. I&#039;m in the military going on 17 years and I failed a drug test because of this medication. The military made me aware of my positive drug test and I gave them a list of all my medications. They were able to reevaluate my positive drug test and break it down further which showed it was in fact venlafaxine and not ampthetimines, like cocaine or meth. As for your job, I&#039;d take them documentation and show them were venlafaxine can give a false positive and demand a review or ask to do another drug screening and have them do a full panel work up. Good luck. Hate that happened to you. Don&#039;t stop fighting till you get your job back.  That&#039;s discrimination if nothing else!\"',\n",
       "       '\"It&#039;s literally saved my sanity!!! Haven&#039;t had a hot flush since I commenced Efexor, and I was getting at least 12 to 16 daily.\"',\n",
       "       '\"It has definitely helped with depression and anxiety. But the withdrawal effects are horrible. If I forget to take a dose, I wake up SO groggy and out of it. I have these electric-like pains through my body, my vision becomes wavy, and I get a migraine.\"',\n",
       "       '\"Are these outlandish reviews of whole years being forgotten solely due to Venlafaxine, actually serious? That seems ridiculously unrealistic.\\r\\r\\n\\r\\r\\nI am on 225mg per day and if I&#039;m late taking a dose I get the weird zaps and dizziness etc. But it does do a pretty good job on very severe anxiety and depression.\\r\\r\\n\\r\\r\\nComing off it will be hard but I have been recommended a good 3-month plan for it. \\r\\r\\n\\r\\r\\nI have noticed that not all actual packs of tablets are as good as others though, I don&#039;t know how this can be!?\"',\n",
       "       '\"Initially helped with lethargy and apathy, never got over 150 mg or 3 months, began having electric shock like feelings, tingling.  Had to discontinue.\"',\n",
       "       '\"Changed to Effexor XR 75mg about 2 months ago from Celexa 20mg.  Having some dizziness and tiredness, maybe not feeling quite myself, so experimentation with the dosage is probably in order.  Otherwise no problems.  Serious diarrhea side effect from Celexa stopped immediately upon changing treatment.  But I am disturbed by some of the comments on this site about withdrawal from this medication. I have had no problem drinking in moderation while on this drug.\"',\n",
       "       '\"I have been on this medication for over 6 years now, 150 dose although it does help quite a bit if you&#039;re forgetful like me and miss a dose you&#039;re going to be in a world full of trouble even one day will make you feel sick although I still get panic attacks now and then. I find it does really help.\"',\n",
       "       '\"The first two months of Effexor Xr 37 mg were great, I felt good. But that apparently is just the start up. The first couple days of taking it I felt an awesome  euphoria and a high like I was on cocaine.  I was a little restless,  had a hard time getting to sleep, had  diarrhea . The doctor bumped me up to 75 mg one week ago, the first day was awesome I felt like I was on cocaine again. after that first day I felt nothing  other than an overbearing fact that I wanted to get off of the shit. I feel like complete trash.  I feel emotionless but reaally down  I don&#039;t know if I can make it another week on this medication . I&#039;ve been on 4medications and none of them have help so far. This was my last hope for medication\"',\n",
       "       '\"It made my &quot;down side&quot; not go as deep, but I felt like I could not leave the house - I didn&#039;t want to.  No visitors - didn&#039;t want any. Since I&#039;m a very social person my friends and family were concerned. My &quot;up side was better - I wasn&#039;t POed all the time and the thought racing slowed way down. Not the best experience, but better than the whole trip down the rabbit hole it would have been.\"',\n",
       "       '\"I had a hysterectomy over 25 years ago and was on HRs since then.  However, I am on medicare and they don&#039;t easily cover HR prescriptions for women over 65.  I quit taking them last summer and since have suffered with hot flashes, night sweats...waking up every 2 hours drenched with sweat.  I went back to my doctor to ask about getting back on HRs and she suggested that I try Effexor 37.5mg for a month to see if it would help.  Well, the first couple of weeks my hot flashes disappeared.  But as my body adjusted to the medication, the hot flashes started coming back.  I now have 2 or 3 during the day and sometimes 1 at night but I find that is tolerable.  My doctor said she could up the dosage if I wanted but I said no, I was fine with it.\"',\n",
       "       '\"I was on citalopram but this was changed to venlafaxine. At first it was rough till I had been on it about 4 weeks then it helps just try and not miss doses as that can cause really bad headaches\"',\n",
       "       '\"Year 1 no effect on my weight, years 2 &amp; 3 I experienced steady weight gain (15kg / 33 pounds). Other main side effects were: somnolence, swearing, electric-shock sensations in my brain and my body, twitching. \\r\\r\\n\\r\\r\\nHowever, SSRIs had never worked well for me, and venlafaxine was a fantastic alternative. I became very complacent in general on this drug.  \\r\\r\\n\\r\\r\\nThe withdrawal symptoms I had were horrendous - it was like coming off narcotics. . Vomiting, shaking, muscle spasms, everything hurt. At one point drifting in and out of consciousness. But if I hadn&#039;t taken venlafaxine I probably wouldn&#039;t be here today. I would take it again if I had to. \\r\\r\\n\\r\\r\\nDose 150mg. Female, I was 27 when I went on Effexor XR and 30 when I stopped. I turn 31 next week.\"',\n",
       "       '\"I am 24 years old, female, 5&#039;1, 130 lbs. Treated for major depression and anxiety. I have aversions to junk food (I am normally health conscious unless I am really depressed), weight loss (12 lbs), dry mouth, lighter mood, easier to focus, more motivated, mountains turn into anthills, lower sex drive, sometimes get headaches. For me, the pros overwrite the cons - I went off of this for 6 months with no problems. No addiction or sickness. I am back on it and boy am I glad to feel happy again.\"',\n",
       "       '\"This medication is an selective reuptake inhibitor for both serotonin and norepinephrine. I found it to increase my anxiety by a million due to the norepinephrine release. I don&#039;t understand how in the world this works for anxiety...it didn&#039;t for me. Good luck and for those it works for, God bless\"',\n",
       "       '\"Effexor has worked at times for me for my panic disorder, but has not gotten rid of my panic attacks. I&#039;ve been tapering off it for months 150 to 37.5 ... Remember with Effexor almost everyone is going to suffer from discontinuation syndrome... or as many know it the &quot;zaps&quot;.  Effexor&#039;s lowest dose was 37.5 mg now they make a 25 mg to help. I understand that getting off it is possible, but the reason for the discontinuation syndrome is due to the short half life of the medicine. Prozac at a low dose around 10 mg does help because of its long half life.  \"',\n",
       "       '\"After very unsuccessful attempts with Lexapro and Prozac, I started on Effexor XR 2 months ago. Really suffered a lot to have my system adapted to it in the first 5 days. After that I had 2 wonderful weeks.  It has helped me a lot with panic attacks I used to have (specially dizziness and balacing issues),  butI have started suffering with huge stomach pains. I thinks those are related to effexor.\"',\n",
       "       '\"I took Effexor for 10 years and found it highly effective controlling anxiety/panic attacks.  After deciding to stop [with Doctor&#039;s approval], I reduced my dosage gradually, and am discontinuing it.  Withdrawal has been rough - like the worst hangover - and I&#039;m into the 5th day but getting better.  However, my mood is still good compared to 10 years ago, and I would like to be medication-free.  Effexor allowed me to control my anxiety/moods through some tough times and through it, I learned new ways to deal with such.  I highly recommend it.\"',\n",
       "       '\"I have tried at least a dozen different psychiatric drugs, and Effexor XR works better for my depression than anything else has, and it does not make me at all manic. \\r\\n\\r\\nI also had a positive side effect it made me lose weight! I was very pleased.\"',\n",
       "       '\"I&#039;ve battled with anxiety for 10 plus years, was on medication 6 years ago for it then stopped.  I was having intense TMJ because I was constantly clenching my jaw as a coping mechanism for my anxiety. I finally decided to go on medication. My Doctor first put me on Celexa. I felt actually MORE anxious. Though it helped with my negative thoughts. I switched to Effexor. I started at 37.5 mg. I definitely feel a positive difference and my jaw clenching has completely stopped. Now I am up to 75 mg. I just feel very blah. Kind of numb, kind of &quot;dissociative&quot; like I&#039;m not present in my own body. I feel better, but I want to FEEL. I am not sure if I should up my dosage and then I&#039;ll feel &quot;normal&quot; or ween myself off.\"',\n",
       "       '\"29Year Old Male -\\r\\r\\n\\r\\r\\nQuite a bubbly person really but suffer with bad periods of Anxiety and Depression with a lot of Self Confidence issues. I have tried all types of SSRI\\r\\r\\n\\r\\r\\nFluoxetine, Citalipram, Escitalopram, Propranolol (Beta- Blocker) and none of them seemed to work or do anything about the anxiety. \\r\\r\\n\\r\\r\\nSuffered with Dizzyness Lack of motivation breathing problems, twitches and emotional problems. \\r\\r\\n\\r\\r\\nWithin a week of taking venlafaxine I felt brilliant with hardly any side effects. Little bit sweaty during the day and a slight headache at first but they really do make an impact. I have heard a lot about coming off them but I will take each day as it  comes and stay on these for as long as advised. \\r\\r\\n\\r\\r\\nDefinitely rate these tablets.\"',\n",
       "       '\"This medicine did not work well for me.  I was on it for a total of three months and it did not make me feel any better.  The side effects were not fun.  I had trouble sleeping and almost no energy.\"',\n",
       "       '\"I started this medication for my social anxiety an mood swings. I was on the medication for 3 days. On day three I went to bed an stopped breathing as I slept as a side effect of the medication. Doctor told me to immediately quit taking the medication so I did I quit an had shortness of breath for about 2 days after an increased anxiety even worse panic attacks . hope this helps.\"',\n",
       "       '\"Being depression one of the most  misunderstood and stigmatized diseases of the world there&#039;s no wonder why suicide is already one of the leading causes of death worldwide.\\r\\nI&#039;ve been struggling with this silent killer associated with panic attacks for so long that I actually thought no medicine would ever help me.\\r\\nI was so dissappointed about antidepressants that I was already planning a painless way to suicide by the time my doc prescribed me Venlafaxine. The first two weeks seemed like I was on any other antidepressants that I&#039;ve had tried before (zoloft, imipramine, Paxil). Then, as a miracle: there was this day when I woke up from a (finally) great night of sleep, feeling myself really better, free of those continuous headaches and anxiety\"',\n",
       "       '\"I&#039;ve been on 75mg of venlafaxine for 6 or 7 years. It is good for me. Before Effexor, my emotions felt like being hit by a truck. After Effexor, it gives me a moment to THINK about things, rather than just disintegrating into a puddle on the floor. I still have feelings, but they&#039;re not as overwhelming and I don&#039;t feel like I HAVE to react to them. \\r\\nSide effects: sweating and tiredness. I take a lot of naps!\\r\\nMissing a dose: About an hour or two after my time to take my pill, if I forget to, I&#039;d get tingly and dizzy.\\r\\nWithdrawal: I recently tried to stop taking Effexor cold turkey. I lasted 6 days. Intense anger, bursting into tears, a static feeling in my head, like a TV set on no channel, and a tingly feeling in my lips.\"',\n",
       "       '\"I&#039;ve been on this for about 6 months now. I usually get really tense being in stores or in public for that matter. Now I can go out and play ball with my son at the park, go into any store and be relaxed and so far there&#039;s been not one side effect. I would definitely recommend this to anyone.\"',\n",
       "       '\"I&#039;ve been taking this medication for several weeks now (Effexor XR 37.5mg daily) and it has helped me a lot more than the Celexa I was on. \\r\\n\\r\\nAlthough recently (within the last 10 or so days) I have experienced very mild headaches that last a long time and feeling fatigued all day. Caffeine doesn&#039;t help and extra sleep doesn&#039;t help. \\r\\n\\r\\nI&#039;ve had problems with fatigue all my life but this feels different. I am not sure if this is related to the medication because I have not had any side effects and I&#039;ve been on this medication for almost a month now.\"',\n",
       "       '\"It gave me my life back. I would have panic attacks that lasted for hours, always anxious, work was crippling. After one year no side effects. Now I feel normal, confident - it&#039;s something I&#039;ve waited on for 26 years!\"',\n",
       "       '\"I started on Venlafaxine several months ago -- went from 37.4 to 75 to150mg. This was situational, as we had lost our 34-year old daughter several years ago in an extremely traumatic accident.   When I was taking 150 mg., I felt less anxious and depressed but foggy-headed, and my emotions have been blunted.  Over a short period of time, I experienced excruciating headaches, sleepiness, dry mouth, constipation, bizarre dreams, and felt detached from myself.  Under the guidance of my APRN, I&#039;ve been decreasing the dosage.  The weaning process has been difficult, and my memory is terrible.  I have now weaned to 37.5 mg. and will stay at this dose for a while. I have always been extremely sensitive to prescription meds; lower dose makes sense.\"',\n",
       "       '\"Only take Effexor if you want to be on it for life. The withdrawal lasted 3 months for me. I think my body and mind are permanently damaged from this drug. It helped anxiety by numbing me but at the same time, made me more depressed at times.\"',\n",
       "       '\"You know, I wasn&#039;t sure what to rate this. In terms of effectiveness, definitely very much so. But in terms of the quality of life after taking this for a year and a half, I&#039;m not sure it&#039;s worth it. It acted as a number for me. I don&#039;t remember many months of my life while taking this pill. The memory loss scares me sometimes. But I like to think I was just coasting, softly through time. Maybe that&#039;s what I needed from this pill during that time of my life, however. Anyway - I don&#039;t take this anymore. I have been switched to Lithium, which has been my slow but sure savior. Overall, Effexor XR is a strong medication for strong emotions, but you lose a part of who you are along with it.\"',\n",
       "       '\"Venlafaxine is great!  I have been on it for 3 years with good help for my depression and anxiety.  Sometimes it makes me a bit jumpy, but not often.  The hardest part is finding the right dose.  I am now of 250mg in 3 doses and it works great.  I need more in the winter and roughly 175mg in the spring and summer.  Can&#039;t say enough good things, I have a better outlook and interested in living life.  Hope this helps.\"',\n",
       "       '\"I use to have panic attacks everyday for three years. I was scared to go to sleep. I&#039;ve tried so many antidepressant and effexor was the only thing that worked with little to no side effects. My Dr. started me on 75mg, then increased it two wks later to 100mg. I&#039;ve been on 100mg for almost a yr and I still haven&#039;t had a panic attack or anxiety.\"',\n",
       "       '\"29/f with anxiety and depression, I have only taken this medicine once, I took it at night as prescribed by the doctor, woke up at 3 a.m. crawling out of my skin! I threw up twice, my pupils were dilated I was sweating, shaking uncontrollably and couldn&#039;t sleep. I imagine this is what meth feels like?! I started to have incredibly bad anxiety bad thoughts and images, my brain felt like it was screaming. this medicine is awful. It&#039;s now 10am, I&#039;m still jittery, i feel super sick, can&#039;t eat, I feel awful.\"',\n",
       "       '\"I started experiencing depression and anxiety attacks at around 19 years old. At the time, I didn&#039;t quite realize what was wrong with me, I just knew something was horribly wrong. I have tried every medication known to man; celexa, Prozac, cymbalta, pristiq, viibryd, Wellbutrin... And nothing. The emptiness, emotional turmoil, and suffocation I felt was ruining my life. Then in 2011, I started Effexor. I feel alive again, and I never thought I would feel normal again. The one thing I will warn about is the dependency. If you miss one pill, you will think you are coming down with the flu. If you ever decide to stop, you will have to taper off. Adverse effects: constipation, weight loss, vivid dreams, insomnia, sexual dys.\"',\n",
       "       '\"I&#039;ve been on Effexor for quite a few years now taking 112.5mg.  I didn&#039;t have any problems with this med but have been wanting to simplify my regime.  So 112.5 to 75mg saw no real withdrawal or return of depression or anxiety.  But, 75mg to 37.5mg, I cannot bear.  I feel awful, irritable, nasty, and even aggressive at times.  Imagine waking up every morning for 2 weeks being 50 Shades of Pissed! My personality changed if feels like. Wondering if anyone has experienced this.  It would appear that Effexor is effective for my anxiety.\"',\n",
       "       '\"I began on a low dose of the ER 37.5 &amp; immediately noticed the dry mouth, headaches and burning pit in my stomach 24/7.  Then came the blurry vision, urinary issues &amp;  by day 10, the most debilitating stiff &amp; painful back you can imagine. I knew it had to be related to the meds since this is NOT a Fibro symptom (at least for me) nor did I do anything to injure  myself. Before I discovered it was the meds I had gone to a walk in clinic (or hobble in clinic) &amp; was given muscle relaxers. Nothing worked. Not ibuprofen, hot or cold compresses or muscle relaxers. After researching further I found that this medication can cause severe muscle stiffness.  I then asked my Dr.&#039;s nurse if this was true and she said yes, she experienced it herself.\"',\n",
       "       '\"I just dropped in on the internet to see if their was something &quot;better&quot; or maybe &quot;newer&quot; than my Effexor, but after several sites I know I&#039;m still in good hands. I&#039;ve been on 150mg Effexor, or venlafaxine, for more than ten years and I&#039;ve lived a normal life since the right-medication-finding game. Yes, the withdrawals within 24 hours are dizziness so bad you shouldn&#039;t drive, but I&#039;ve asked my doctor to write a second prescription for the non-xr version in half strength and I keep that filled for emergencies, or it&#039;s open to fill in another city if I have to fill it unexpectedly. Or if I miss my dose and need it to kick in immediately\"',\n",
       "       '\"I began taking Effexor after coming off of Paxil. I did not like the weight gain and sexual side effects from the Paxil. The Effexor does not do either of those to me even though I have heard some people complain about it. It has also vastly improved my mood and depression. I have been using it combined with Depakote for the past few months and I feel much better then I have in years. My current dose is 150mg a day.\"',\n",
       "       '\"I really want to get off this drug I never get headaches but since taking this drug I have been getting them, severe heartburn and nausea, overall feeling really bad every day. Had the worst anxiety attack I have ever had scared the hell out of me. I have never felt so hopeless, worst drug I have ever used never again.\"',\n",
       "       '\"Took first dose of 75mg before bed. Fell asleep at 1030 and slept well, actually. Woke up at 530 with eyes wide open as if i just had 10 espressos. It&#039;s now 630 and I don&#039;t have to be out of bed until 7. Can&#039;t sleep anymore.  Feeling jittery with jaw clenching and teeth chattering when I open my mouth a little. Hands are sweating. I feel a little emotionally numb. Slight ringing in ears and slight headache with slight nausea. I feel peaceful but dull. Not sure if I will take again.\"',\n",
       "       '\"This medication is the only thing that managed to keep me functional as a human being. Panic attacks, and severe depression...this seems to do the trick for both problems, and does wonder for my IBS as well! I have started and stopped multiple times (usually just because of the &quot;I feel fine, why bother with it?&quot; syndrome) but the last time, the doctor told me, &quot;Consider yourself like a diabetic; they need insulin because their body doesn&#039;t regulate it correctly. You need this because your brain doesn&#039;t regulate serotonin correctly. Don&#039;t feel ashamed! The choice is to lie around and do nothing all day because you hate pills, or take the pills and live your life.&quot;  Effexor XR allows me to live normally.\"',\n",
       "       '\"Best antidepressant I&#039;ve tried. On 225mg, also on 5mg Olanzapine for BPD (helps with mood &amp; anxiety). Best combo I&#039;ve had to date, but doesn&#039;t make me energetic, but alleviates the C-PTSD, BPD and IBS, so it&#039;s a winner.\"',\n",
       "       '\"I had a friend tell me about Venlafaxine and how it helped her hot flashes. I&#039;m so happy I took her advice! Not only did it eliminate my hot flashes it improved my mood and took away the irritability  I had. My husband calls it my happy pill. It&#039;s so nice to not have the hot flashes and feeling so irritable.  This was a much better choice for then taking hormones! I&#039;ve had to increase the dosage over the last year to 150 mg.\"',\n",
       "       '\"I take 75mg daily! Took a good two full weeks to adjust! Will experience weird dreams, insomnia and sweats the first two weeks! Hang in there, for me it was a lifesaver!\"',\n",
       "       '\"I took this medicine about 6 years ago for depression and PTSD . This is a horrible medication, doctor I saw told me it was a magic drug for depression. Magic as in the sense it is god awful and turned me into a monster. I went from being depressed to being super depressed. I think I suffered from all of the side effects listed, and now that I had a genetic test to find out why medications didn&#039;t work on me , I know why. Being a poor metabolizer made it so the medications build up in my system and I get the horrible side effects, and this one was no different. The withdrawal from this was god awful almost unbearable, from the brain zaps, to the uncontrolled crying, all the way to a 1 day hospital stay. Stay away\"',\n",
       "       '\"One of the best medications I have taken for depression, one warning is do not run out of this medication, because you will experience terrible withdrawals, and when you re-take it the nausea is terrible. If I can stay on this medicine for a long time, I will be happy, never had better control of my depression than I do on Effexor.\"',\n",
       "       '\"I&#039;m a 27 yr old female with ADD, generalized anxiety (including morbid thoughts, OCD behaviors, hypochondria and depression). Effexor has basically fixed me. I used to be irritable, negative, overwhelmed and chronically fatigued to a disabling capacity and now I&#039;m evened out and confident, positive, patient and kinder. My head feels clearer than it ever has. The only issue is that this medication causes some sweating and raises my blood pressure so I&#039;ve had to have that stabilized with blood pressure medication.\"',\n",
       "       '\"I have been taking citalopram for about 6 years and not really noticed any difference in my life. I was switched to venlafaxine yesterday and after 1 dose and a good night&#039;s sleep I jumped out of bed this morning to answer the telephone. I did not realize it until later, but I normally sleep through the phone ringing or just ignore it and go back to sleep. I am very very impressed with the results already and feel like a new person and so full of energy. Thank you, thank you is all I can say!\"',\n",
       "       '\"I have been on this medicine since I was 13. I&#039;m 17 now I&#039;m on 225mg it helps my generalized anxiety disorder the most my other disorders not so much. I like this medicine more than any other, I have been on all of the ones you can be on under the age 18. I say 6 out of 10, I would tell anyone to try this first it will help.\"',\n",
       "       '\"I am 56 and still hot flashes. Over 2 years I have increased dosage several times. \"',\n",
       "       '\"I&#039;ve been using 75mg Effexor for 9 weeks now and it has changed my life. I wake up looking forward to the day and can remain focused throughout. I woke up on my 30th Birthday feeling very depressed and could not believe that&#039;s how I felt everyday before taking Effexor.\\r\\r\\nMy libido is back to where it was a year ago and the only side effect I experience is an upset stomach during very intense work outs. I see a therapist and that too has helped. My wife says I&#039;m now a different person.\"',\n",
       "       '\"Been on this for a few years now, taking 225mg/day. The side effects are unpleasant, but have abated greatly thankfully. When I started there was the WORST DRY MOUTH EVER. Persistent and I couldn&#039;t go five minutes without drinking something.\\r\\r\\nHad sleep problems with it, including ridiculous night sweats where I&#039;d wake up with a body imprint in my sheets (gross, yes) almost every night. Couldn&#039;t sleep more than 2-4 hours at a time. But trust me when I say these things were nothing compared to what I was feeling before (we&#039;re talking 0.5 on a scale of 1-10) and while I&#039;m not 100% it is certainly the single thing keeping me from killing myself, which is nice.\\r\\r\\nI can now sleep about 6 hours at a time and only have night sweats if I DON&#039;T take it.\"',\n",
       "       '\"I have been taking Effexor XR for almost two years and I love it.  I take it for anxiety, stress, and depression.  I have taken Wellbutrin and Paxil and found a little relief but nothing compared to Effexor.  After 10   years of emotional eating I have started losing that weight, 40 lbs in the past year and I haven&#039;t dieted, I still eat the foods I love but now I stop when I&#039;m no longer hungry and I feel no guilt when I eat a cookie or two or go out for an indulgent dinner.  Another plus, I actually want sex now.  For years my anxiety kept me from having any desire but now I can&#039;t get enough.  YAY!\"',\n",
       "       '\"I have used this anti-depressant at varying dosages over the past 5 years and it has proved to be very efficient at managing my depression. I do wish to highlight the intense physical withdrawal symptoms I experience if I miss even one dose (flu-like symptoms). This is an excellent medicine but when you choose to lower your dosage, only do it in conjunction with a medical professional as it can be quite physically demanding.\"',\n",
       "       '\"Started at 25mg a day, and eventually got up to 75mg a day.  Rather than make me feel more expansive and energized this drug made me feel super lethargic and even more depressed.  I also experienced loss of appetite on this drug.  \\r\\n\\r\\n1/10 would punch Pfizer CEO in the face.\"',\n",
       "       '\"I took Effexor XR 150mg for a good 10 years for depression.  Then, I switched to Zoloft due to what is considered a side-effect of Effexor:  elevated liver enzymes.  On Zoloft, I felt more anxious than I did on Effexor, but not overly so.  It was tolerable.   I continued to have same liver enzymes while on Zoloft.   It turns out the enzyme issue is not related to the medication alone, if at all.  I had a stressful life changing event and felt very anxious.  I know I felt much less anxious on Effexor so I asked to be switched back and I was.  The doctor made a general statement that he wants me on what works best for me.  However, I&#039;m pretty sure he didn&#039;t buy my anxiety theory. \"',\n",
       "       '\"I attempted suicide 23 yrs ago and I tried several medications for the first 3 or 4 yrs.  They did little to help my depression and then a psychiatrist prescribed Effexor first @ 75mg daily and then at 150mg daily.  I have used it for about 20 yrs and there have been no side effects like the others. It has truly been a life saver.\"',\n",
       "       '\"I cannot describe how life changing this medication has been for me. I&#039;ve been suffering from anxiety/depression, specifically social anxiety and low self esteem, my whole life. It was at a point where I thought it was normal to be negative, pessimistic, anxious and depressed all the time. I tried EVERYTHING including therapy, exercise, diet and an array of medicines and nothing worked. I nearly developed an addiction to Xanax just trying to combat the anxiety. Prozac, lexapro, Concerta, stratera; Nothing worked. Finally got introduced to Effexor XR. Started on 75mg for 2 months, I wasn&#039;t that satisfied. I got put on 150mg for 2 months then. CANNOT BELIEVE THE DIFFERENCE. I&#039;m happy, confident and positive. AMAZING. Long may it last.\"',\n",
       "       '\"Trying to come off Effexor is hard its like withdrawal effects.\"',\n",
       "       '\"Was taking two 37 mg per day but made me nauseous so kept missing the second dose &amp; wasn&#039;t working .  Now taking 75mg slow release per day. Was completely spaced out for a few days..zoning out!  but after 10 days I feel great. Loads of energy. Depression easing off. Impressed but hope it lasts . Side effects were dry mouth but this has now gone. Sex drive has also plummeted but I do have a baby so could be down to that. In any case I&#039;d rather have my old self back than a sex drive so not too bothered.  Have tried prozac and citaloplam in the past until they stopped working. I&#039;d say this is just as good if not better. Fingers crossed x\"',\n",
       "       '\"I have been taking Effexor for hot flashes for 4 years now. While it did relieve the flashes I must tell you about a devastating experience I had this week. The Effexor caused  me to have a false positive reading for PCP on a pre employment drug screen. I will NEVER take this medication again and am on a mission to let everyone know about this problem.\"',\n",
       "       '\"I have been on Effexor XR for years.  I have been on several other SSRIs through the years that eventually stopped working.  Effexor has been the most successful in the long term.  I take 150mg of the XR and 37.5 three times a day of the regular Effexor.  The regular was recently added as my depression has worsened due to additional stress at work.  I have not had any major side effects, even on this high of a dose.  I do agree that withdrawal is serious.  If I miss a dose, I have a buzzing feeling, crying and increase in depression almost immediately.  This is one medication that I do not go without--ever.  I am a bit worried about ever going off of it for these reasons.  I believe that this can be done safely with the help of a physician.\"',\n",
       "       '\"I started Effexor after the birth of my first child due to post-partum depression. I have never been severely depressed prior to this. My doctor first prescribed Zoloft which did not help at all. After two weeks, I was put on Effexor and started feeling better within a few days. The only side effect that I ever noticed was having no sex drive at all. I stopped taking it after a year (I tapered so I did not notice any withdrawal symptoms everyone talks about) and was recently put back on it due to some family issues pushing me back into a depression. The first few days are rough but I&#039;ve been on it for a week now and I do feel a difference. My anxiety and mood has improved and I can actually function. This medicine works great for me.\"',\n",
       "       '\"I have only been taking this drug for two weeks but I believe it has saved my life. I have taken so many drugs that did not work I could hardly believe this began working in just over a week. My severe depression has not gone completely but the change is huge in such a short time. I think the doctor will probably increase my dose, only on 75mg daily, and I am hopeful I will be in total remission quite soon. \"',\n",
       "       '\"Effexor is the only medicine that helps my depression. Only side effect, was sexual dysfunction but now that is completely gone. I take 187.5mg a day.\"',\n",
       "       '\"Not as many side effects as other antidepressants, such as Celexa.\"',\n",
       "       '\"I have been on effexor xr for 11 years now and it works wonderfully for me. The only side effect was dry mouth and constipation. It.s not for every patient. Always contact your doctor if your symptoms worsen.\"',\n",
       "       '\"I have been taking Effexor XR for about 3 weeks now for depression and generalized anxiety disorder. For the first three days I felt a little dizzy but continued with the medication and the dizziness went away once my body got used to it. I get a dry mouth and have lost interest in sex and cannot reach orgasm. I do feel a lot more focused at work and can think more clearly. I do find if I don&#039;t take the medication right on time around 9am every morning I get a headache and agitated so I try to take it the same time everyday. Despite the dry mouth and loss of sex drive I will continue with it for another month or two and see what happens when I see my doc again.\"',\n",
       "       '\"I may have had good experiences with Effexor the first six months or so. But, without a mood stabilizer, I soon went into a hypomanic stage. At times, on the medicine, I went into an full-blown manic phases. Once again, without a mood stabilizer.\\r\\n\\r\\nThe most challenging part about this medicine, (or the generic venlafaxine which I took) is quitting it. Now, I am a poster child for doing it wrong, no doubt.\\r\\n\\r\\nThat is, it is extremely challenging to quit this medicine going Cold Turkey. You will read online where people will tell you point blank, &quot;Do not quit this medicine cold turkey.&quot; Listen to them.\\r\\n\\r\\nIt took at least five months to feel like this medicine was totally out of my system.\"',\n",
       "       '\"I take 4-75 mg pills 2x a day. So I am on the maximum dosage. It has does wonders for me. Through my Doctor&#039;s office I get a discount on medication so this is super cheap for me since I don&#039;t have insurance at this moment. I was on Cymbalta and it worked exactly the same but was WAY to pricey.\"',\n",
       "       '\"This medication is very scary to take. I was only on 37.5mg for one day and my pupils dilated and one eye was bigger then the other. It felt like I had taken some illegal drug. I felt dopey and after stopping it from one day I still felt high days later. Told my doctor and was prescribed escitalopram and took only 5mg same thing happened with my pupils again and made my out of reality feelings worse. I honestly think medication is only good if you actually have a full on disorder that is bad.. but taking this to get a relief from anxiety it just masks it. It made me feel numb to my emotions.. I don&#039;t want to be masked and not feel happy or sad..\"',\n",
       "       '\"You have to keep taking this medicine forever. The withdrawl is awful after a day. However, once you find your dose everything is fine. I don&#039;t recommend this medicine because its like a marriage with a messy long divorce. Its better to stay on it once youre on it. I am on 150 mg and it works for me. Don&#039;t try and go off\"',\n",
       "       '\"I have been taking Effexor since it first came out.  It is the only drug that has helped me, life has been good.\"',\n",
       "       '\"I have had some level of depression for decades.  Also have some form of anxiety I have never understood as to why, PG calls it social anxiety. After being prescribed a series of anti-depressants for years I landed on Venlafaxine and have been taking it for 20 years 150 mg by GP  Tried to stop gradually as GP required but found I must need it due to a chemical imbalance rather than a life situation.  Only one minor side effect is dizziness. Can avoid this by eating something and drinking a full glass of water when taking it.  Drink minimum 6-8 glasses of water a day, more if needed as this will also alleviate dizziness.  I don&#039;t know how helpful it would be if my life fell apart completely.  But it has worked fine for me all these years.\"',\n",
       "       '\"Effexor is awesome for depression.\"',\n",
       "       '\"I have been on Effexor XR 75mg for two months now, after previously being on Zoloft and Celexa. The two other medications were not effective for my anxiety and depression, and they tended to make me either tired or foggy regardless of the time of day that I took them. I expected the tiredness to wear off, but the foggy feeling never did. My doctor prescribed Effexor XR, and it has been very effective for both my depression and anxiety symptoms. I am not 100% perfect, and I still have anxiety, but in the appropriate moments. The moments of unreasonable anxiety attacks are fewer and far between since starting the medicine. I had no negative side effects, and I take it every morning at 9am.\"',\n",
       "       '\"I couldn&#039;t understand where all this bloating was coming from. Along with joint pain and blurred vision since my hypertension has been treated and under cover for years.  Well, I found out that the generic version of venlafaxine ER included a hydrochloride extended release that was also in the brand.  Thought I was in menopause - but I&#039;m not.  The increase in my blood pressure is causing quite a bit of other problems.  I don&#039;t know which is worse, uncontrollable hypertension with complications for my thyroid medicine because of the iodine from the sodium or the depression from the hypothyroidism.  Either way - my doctor is working on the problem because I just can&#039;t take myself off my medicines.\"',\n",
       "       '\"I had developed severe anxiety and depression in my late teens/ early 20&#039;s and like many before me I have tried wellbutrin, paxil, lexapro etc. This is the only medicine that has shown significant improvement on both my depression and anxiety. I can be myself again. Don&#039;t be ashamed to talk to your doctor or family member. Get help as soon as possible.\"',\n",
       "       '\"I am a 33 yr old woman with Anxiety, irritabilty, ocd \\r\\n. I have been on many different medications since i was 18. My new doctor finally sent me to a psychologist to see if effexor was the right drug for me after being on it for 18 months with some improvement but not great improvement. At the time I was on 75 mg a day. The psychologist upped my dosage to 200 mg a day. Since then I have had very slight anxiety, and only when even a normal person would have a panic attack. My OCD is manageable. And I no longer wish everyone dead. I have had 0 side effects what so ever.  Only thing I have noticed is when i miss a couple days, (mom of 3 it happens), all my problems come back 100%. I never take my meds at the same time and have never had withdrawal.\"',\n",
       "       '\"I was taking effexor for depression. I found that my hot flashes went away. I love this medicine. It helped all of my menopause symptoms. The down side is I can&#039;t miss one! The hot flashes comes back with worst sweats than I had before. I now sleep very well at night.\"',\n",
       "       '\"I was prescribed this for onset of anxiety and possible hormonal mood swings. I was not told by my doctor how it would make me feel or how hard coming off of it would be. I took one 37.5 mg capsule and was horrified that I was given this. I woke up at 2am with an anxiety attack for about the first hour. It then went into being wired, nauseous, shakey, weak, chills and sweating. 11 years ago I quit using meth and this was awful that I felt like I was on it again. I laid in bed the entire day, wide awake and ill. I never took another dose! And even one pill took at least another full day to leave my system. My nervous system is obviously sensitive and I could not handle this medication at all.\"',\n",
       "       '\"My doctor put me on 37.5 mg regular (generic brand) for about 2 weeks and I was so tired and still depressed. So she upped my dosage to 75 mg XR. And after 2 days my anxiety was out of control and depressed so I had be watched 24/7. So I finally got off it after I switched backed to 37.5 before going cold turkey. I didn&#039;t  have any withdrawal symptoms. Good luck to anyone on this medication.\"',\n",
       "       '\"I&#039;m 45 years old and have lived a pretty normal life except for my occasional heightened anxiety. Recently, my anxiety and panic attacks had escalated out of control. I was feeling out of touch with reality and having multiple panic attacks a day. Unfortunately for me, after 2 doses the Effexor caused mild hallucinations; light pixelating and things moving in fast motion. It was adding to my anxiety so I went off immediately and the hallucinations went away.\"',\n",
       "       '\"I always read reviews about meds but never share my expierence. SO, \\r\\r\\n\\r\\r\\nI am 22 years old and have always struggled with depression and anxiety, but this past May (May of 2016) I ended up admitted myself to an in-patient psychiatric ward due to suicidal thoughts which led me to cutting myself for the first time in my life. The psychiatrist decided to put me on venlafaxine 75 mg 1x a day.. The only side effects I had was dry mouth, minor insomnia, and a little weigh gain; besides that, I have not experienced any horrible side effects like I have with so many other medications. I take venlafaxine for depression and generalized anxiety. I take 75mg 2x a day now and I am calm, collected, and happier than ever. I plan to stay on this forever.\"',\n",
       "       '\"I have been taking Effexor XR for about 8 years after suffering a serious mental breakdown. This medicine has given me back my life.  Having said that the UK government have recently told all doctors to prescribe the generic version. THERE IS A HUGE DIFFERENCE, I began suffering terrible headaches, and anxiety again. After speaking to my Consultant Psychiatrist I am now back on Effexor with all the nasty symptoms gone. There really is no substitute for the real thing.\"',\n",
       "       '\"I&#039;ve been on Effexor XR for about 9 years now (150mg once a day). I originally started taking it for A.D.D. and mild depression. It has worked incredibly for me. I went from no attention span to extremely focused. I also went through some events that increased my depression, and by upping the dosage, I was fine. The only side effects I&#039;ve had are extreme withdrawal symptoms if I miss a dose (severe headaches and jitters), and a decreased sex drive. I would strongly recommend this drug.\"',\n",
       "       '\"HI , dz .\\r\\nI wanted to share my expirience with effexor ( flaxyne)  for anxiety , panic attack  disorder and depression I m a 28 old girl I have been taking effexor  75 mg for years but no result at all then my ps augmented the dose to 225mg which works greatly now with all my disorders and I m also on 100mg sulpiride which blocks perfectly black persecutive ideas and help reduce my anxiety too but here is the prblm I faced an important lack of libido and anorgasmia  and a delayed period due to high dose flaxyne probably , but after months I m taking an infusion of Fenugreek seeds I m not drinking every day but at least twice in 28 days and it really helped with the side effects of effexor .\"',\n",
       "       '\"I have been on Effexor XR for over 15 years. I take a daily dosage of 300mg. It has been the most significant thing in my life! I am able to function normally, hold down a sometimes stressful job, be a great parent and most of all be the best me possible. I have a hormonal imbalance which causes my depression and no amount of psychological intervention was ever going to change that. Effexor XR did. Whilst there are side effects, my body has become accustomed to them and believe me they are nothing in comparison to the dreadful depression. I believe that it has saved my life and ensured that the life I lead is a good one. A couple of tablets a day, some minor side effects and I can get on with a wonderful life.\"',\n",
       "       '\"18 year old female and have been on it for 5 months. Just recently quit taking it and had horrid withdrawal symptoms. I don&#039;t recommend quitting cold turkey. Talk to the doctor and formulate a titration schedule to wean yourself off. Worked to help lessen my depression, though I am not sure it helped as much as Prozac did.\"',\n",
       "       '\"I have been on venlafaxine for almost 10 years. After being diagnosed with severe depression when I was in my twenties, I was prescribed Prozac on which I couldn&#039;t function, and then Paxil which worked okay at first.  Several years later after years of both manic and depressive episodes,  the worst  full-blown manic episode got me re-diagnosed as bi-polar. I was prescribed venlafaxine, a very small dose which made me violently ill for over 2 weeks, but after that, it improved and I felt better. My dosage has been upped numerous times. I am now at 225 mg and have been for a couple of years. It has been a life saver. I feel like I have a new life; one without rages, anxiety, and depression. My family is much more stable now that I am stable.\"',\n",
       "       '\"I was diagnosed with GAD with symptoms including general fatigue, anxiety, panic and insomnia. Started off at 35mg but now on 150mg in morning and 75mg at night which seems to be keeping me pretty stable. However the withdrawal is horrendous. If I miss a couple of doses I get brain zaps, I can hear my eyeballs moving in my head, very anxious and panic. It works but this is some seriously messed up stuff...I can see I may have to be on this forever wheras I gave up prozac cold turkey with no problems at all.\"',\n",
       "       '\"To Socanxiety. I have been on EffexorXR for over 10 years. (I also have short term memory loss so my doctor put me on Concerta, 36 mgs, which is the lowest dose and it is helping!) I am 59 years old and am happy and less anxious with taking effexor 225 mgs a day. I take 75mg pill before bed and am less anxious when I get up. Then I take the 150mg capsule in the morning. I still have times that I have anticipatory anxiety and use 10 mgs of Valium which helps. I am hoping when we retire and move south that I can lower the Effexor. Great med and I have tried many over the last 20 years!!\"',\n",
       "       '\"In one sense it handled many of my symptoms, but I became a completely different person. I was no longer myself at all. I made many, many horrible decisions affecting my family friends, business, etc. I adopted a whole new set of values - i just wasn&#039;t myself anymore. When I finally decided to go off it I spent 9 months of withdrawal symptoms, splitting capsules every day and gradually reducing the amount of grains. \"',\n",
       "       '\"This medication has worked well for me in terms of controlling my anxiety and fear of having a panic attack.  However the side effects I have had to endure are not so pleasant.  I&#039;m always tired and can sleep all day long.  As well, I have gained weight on this medication and trying to lose it is very hard.  It&#039;s like my metabolism has stopped working. I&#039;ve been on this medicine for about 3 years now and considering weening off to try something else.\"',\n",
       "       '\"This is the only anti depressant I&#039;ve ever been on and I&#039;ve been on it for about 4 months now I&#039;ve had about 4 seizures and I twitch as I&#039;m falling asleep and in my sleep I shake uncontrollably, I&#039;ve read a few reviews similar to mine only theirs were worse and have been hospitalized. I am a normal 20 year old healthy female I only suffer from depression and I&#039;m on suboxone I am switching this weekend to Zoloft I put it off for so long because when I don&#039;t have these pills I feel extreme withdrawal and my head feels crazy and brain zaps all weird I can&#039;t handle being off it so I was scared to switch. But to each their own my personal experience with it wasn&#039;t good other than twitching it works.\"',\n",
       "       '\"Effexor XR works great for hot flashes, not to mention it elevates your mood as a bonus.  I do recommend the extended release as the side effects are fewer.  I have no hot flashes now at all.  I recommend it to anyone who does not want to take hormones.\"',\n",
       "       '\"I started Venlafaxine at 37.5mg and gradually increased to 150mg over a period of four weeks. I noticed a small improvement in mood, but I discontinued due to sweating which became unbearable and embarrassing. I came off cold turkey and experienced restlessness and additional anxiety as a result. As for my anxiety, it didn&#039;t really improve really whatsoever throughout, but I had only been taking 150mg for less a week. I am still experiencing fairly mild withdrawal symptoms (one week later).\"',\n",
       "       '\"I am 46 yrs old and have taken Effexor since 2000. It helps me balance myself. It really works and it calms myself down and relax. But never miss it for a day or so it will give you dizziness or nausea. I would let the people out there know that Effexor is the best antidepressant. It makes me focus my life on everything. Thank you for saving my life Effexor.\"',\n",
       "       '\"I&#039;ve struggled with depression since I was a teenager (and attempted suicide then). In college I started having panic attacks. A few years later I was put on this new medicine called Effexor (after getting no relief from Paxil nor Zoloft) and for the first time in my life I felt relatively normal!  I&#039;ve been on Effexor - 150 mg/day for 20 years now and it has REALLY helped me to function at a high level.  I have gone off it several times - VERY slowly, but each time, a few months after being completely off, BANG - unbelievable depression, and I&#039;d go back on. I&#039;m at peace knowing I&#039;ll most likely be on it form the rest of my life.  Helps with depression AND anxiety.  No problems drinking while taking it, had three healthy kids while on it.\"',\n",
       "       '\"I have been taking Venlafaxine for 4 months. It does the job, but its effects have diminished. I am now on 300mg. It sometimes gives me a mild headache. Also, its effects are so deep, that it tends to turn me into another person.\\r\\n\\r\\nI cannot understand why my doctors want me to experiment with this type of relatively new medicines which have a list of secondary effects long like the Wall of China. \\r\\n\\r\\n\"',\n",
       "       '\"I found this medicine, along with therapy,  to have helped me a great deal. I was originally given Prozac, and it made me more anxious than I was to begin with. A friend of mine told me about Effexor, and I asked my Psychiatrist to switch medications. Thank God. Effexor was a God send for me.\"',\n",
       "       '\"I&#039;m 25 years old and have been depressed for the past few years. The first medication I tried was fluoxetine, which did absolutely nothing for me. When the dosage was increased from 20 to 40mg I had extreme itchiness of the skin all over my body at night and didn&#039;t sleep for a week. About 6 months ago I was put on venlafaxine at 150mg a day after a suicide attempt. It really helped a lot and I felt a lot more balanced. The effects were fairly slow to come on and it did suppress the libido and make it almost impossible to have an orgasm. After a few months the medicine seemed to wear off and I don&#039;t really feel much different now I&#039;m not on any medication. Having said that, I would definitely recommend it as it got me out of a very dark place.\"',\n",
       "       '\"Good but created impotence.\"',\n",
       "       '\"After years of Social Anxiety/Panic attacks I had to sort myself out. I did some research into SNRIs/SSRIs and like many, was fearful of the side effects described by others and how bad it made people feel.\\r\\n\\r\\nI went to the GP who prescribed Venlafaxine/Effexor.\\r\\n\\r\\nThe first few weeks I felt a little nausea, increased anxiety/panic attacks, delay in ejaculation. It never felt unmanageable. After 6 weeks all had gone.\\r\\n\\r\\nI feel 80% less anxious in social/all situations, I feel calm and very much unphased by most things. I feel more confident, my mind is clearer and it is physically impossible to dwell on negative thoughts. Haven&#039;t had a panic attack!\\r\\n\\r\\nEveryone reacts differently. I believed it a risk worth taking and I feel it has paid off!\"',\n",
       "       '\"I HAD BEEN ON SEVERAL DIFFERENT MEDS FOR DEPRESSION &amp; ANXIETY.  STARTING WITH PAXIL, PROZAC AND OTHERS I CAN&#039;T REMEMBER THE NAMES OF. I STARTED EFFEXOR A YEAR AGO AND IT CERTAINLY WORKS FOR ME, FOR BOTH DEPRESSION &amp; ANXIETY.  REMEMBER TO TAKE IT EVERYDAY. ALL SSRIs CAUSE SEVERE WITHDRAWAL SYMPTOMS. IF YOU WANT TO DISCONTINUE USE, TELL YOUR DR.  COLD TURKEY IS NOT ONLY DEBILITATING IT IS DANGEROUS. I AM SO THANKFUL I HAVE BEEN PRESCRIBED EFFEXOR. FINALLY RELIEF FROM THINGS THAT ARE NO BIG DEAL! WHERE AS BEFORE IN MY HEAD, IT WAS SO EXAGGERATED. I LIKE MANY OTHERS HAVE STATED, I WISH THIS WAS AVAILABLE IN MY TEEN YEARS. I AM ENJOYING LIFE AND AM EXTREMELY HAPPY!\"',\n",
       "       '\"I had a nervous breakdown when I was 38, I literally felt as if I was going out of my mind. I had gotten pregnant when I was 21 and had terminated the pregnancy. I had a few years of depression with no meds . I left my Husband and two children and went and stayed with my Sister. She promptly took me to a Psychiatrist that put me on Effexor Xr 75 mg twice a day. He also gave me Xanax to help me with the breakdown. Effexor and my Dr.  saved my life. I have been on Effexor for 22 years. I sometimes feel the depression coming back and I now still have lots of Anxiety. but I take my Xanax and it helps. I have switched to Prozac, Brintellix, Lexapro . None of them work. I always go back to Effexor. I pray daily that God will heal me .\"',\n",
       "       '\"I went thru a horrible domestic violence issue with someone I loved very dearly in the end I lost my home and everything  in my life it left my daughter and I homeless. I felt soooo lost , hopeless , emotions all over the map and  The depression  I was experiencing was soooo severe  and the anxiety was at a whole new  height thru the roof this medicine saved my life I wanted to die the pain and emptiness  I  felt inside was like nothing I have ever felt before.  I have battled depression my whole life nothing  ever worked but this medication  was prescribed  to me along with Buspar and it has helped me tremendously It levels me out and I dont feel sooo hopeless  . My emotional  state has improved tremendously\"',\n",
       "       '\"I started this medication a month ago for anxiety and depression.  Immediately I started feeling different during the first few days of taking this medication. But once i started taking the medication,  I started feeling better.  I still had episodes of anxiety, stress, and depression,  but they were more manageable.  The only negative side effects were yawning,  dry mouth and inability to remain asleep during the night. My GP decided to have me switch over to sertraline this past weekend due to the trouble of sleeping. I am currently on day 3 of sertraline,  and I don&#039;t feel quite like I was when taking venlafaxine. Need to give it more time. At least I know this one will work if need to switch back.\"',\n",
       "       '\"Overall I have found this the best for me. I can have a normal life which enables me to work full time and support myself no major side effects except I have to watch my diet.\"',\n",
       "       '\"Disclaimer: This is only general information. Consult a doctor before making any changes to your medications.\\r\\n\\r\\nIf you&#039;re trying to get off antidepressants, it may be easier to FIRST switch to an antidepressant other than venlafaxine. A different antidepressant may be easier to withdraw from. Some doctors will allow you to switch antidepressants in a process that does not require a full withdrawal from the first drug, before starting the next one . My doctor allowed this and it was relatively easy, but it can be dangerous if not done properly.\\r\\n\\r\\nI&#039;m currently giving venlafaxine a second try. It worked well but i switched drugs because of side effects.\"',\n",
       "       '\"The absolute worst drug I have ever been on. Caused physical illness and a state of mania for a week straight - a week from hell.\"',\n",
       "       '\"I started Effexor at my lowest dose, 37.5mg and then was bumped up to 75XR and now 75XR twice a day. I can honestly say it&#039;s been life changing. Not only did my anxiety go away, but I sleep better and I can function. I used to wake up at 11-12:30pm in the morning/afternoon now I can wake up at 7am without a problem. I am really happy with this medication. Before I was hazardous, suffering from anxiety after a terrible accident. I couldn&#039;t even drive now I can. And also, it helped tremendously along with Adderall for my GPA. Went from a 2.4 to a 3.6 GPA and deans list! My life changed.\"',\n",
       "       '\"This is the best medicine I have been on in years. It gives you a continued feeling not a low or uncaring feeling.\"',\n",
       "       '\"It caused a severe reaction for me. I started going into hyper-mania with racing thoughts, anxiety, trembling and upset stomach.\"',\n",
       "       '\"Good results but I have hot flashes when I take it.\"',\n",
       "       '\"After dealing with PPD for over a year, I began taking Effexor XR about 3 years ago. I&#039;m sorry that I waited so long! I had been dealing with panic attacks, inability to sleep restfully, and various other issues during my daughter&#039;s first year. After taking Effexor XR (initially I was tired and feeling sort of sluggish) for about 2 months, I felt 150% better! I was moving around a lot more, wanted to be out and about, playing with my daughter more. It was a miracle, for me. It also took my mind off of dealing with depression, and focusing on being able to function. Actually being able to feel BETTER, and to deal with things that had been seriously affecting my overall happiness all along. It gave me strength to make life changes.\"',\n",
       "       '\"I entered the beginning stages of menopause and my mood changed dramatically.  I was getting very concerned as I had never felt so sad and hopeless.  I could not stop crying and things that  normally I would not let bother me were becoming huge issues.  I did not recognize myself.  I am known as glass half full kind of person so the change was dramatic.  I was put on 35mg of Effexor and wow - what a difference.  Surprise, surprise my hot flashes stopped, ( I have since read it helps with that)  mood back to normal and strangely my joints don&#039;t hurt so much and I have more energy.  The few negatives are I yawn a lot and though I still enjoy sex I can not have an orgasm.  I consider both minor due to feeling so much better.\"',\n",
       "       '\"I rate this a 5 because this worked for me 3 years ago. I originally started taking it for fibromyalgia and it essentially took away my pain in a week or two. I stayed in it for about a year and a half and noticed how less anxious I felt. I tapered off over 6 months which has its side effects,  but nothing like others have reported. I write this review though in case someone has had a similar experience. I went back on about a month ago, this time solely due to anxiety. I took two pills and started have burning on my tongue and lips. I will also mention that I took Xanax these two days as well so I can&#039;t be certain it was the venaflaxine. I then started having 24/7 panic, lost 12 lbs in 2 weeks and blood pressure went really high.\"',\n",
       "       '\"If you are thinking about taking this, do not do it. Ask your doctor for something else, anything else. Effexor is horrible. I was put on it due to Depression and Generalised Anxiety. Within the first few weeks I was emotionally numb, I wasn&#039;t sad anymore but I couldn&#039;t feel happiness. Six months later, while still on this I became suicidal and self harming, my heart rate started increasing due to my anxiety to the point where I was hospitalised. After that it was decided I was so come off it, now coming off it is even worse then being on it, shaking, dizziness, headaches, puking, sweating. I&#039;ve only been off it a week and already I can feel my mental health calming down. Avoid this drug. Please. For your own safety.\"',\n",
       "       '\"I have been taking venlafaxine for almost a year now and my life has changed for the better in so many ways. I have BPD and the mood swings, constant anxiety, depression, anger, stressing over the smallest things and overthinking everything always got in the way of living a normal life, I also struggled with an eating disorder due to comfort eating and weight gain with other anti depressants. I have lost weight and don&#039;t binge anymore, have much more energy, sleep well, less stressed and my moods are much calmer and less irrational. I didn&#039;t score it a ten as the first few weeks of side effects were pretty rough - constant dry mouth, excessive sweating, nausea, dilated pupils but didn&#039;t last long! Everyones experience is different\"',\n",
       "       '\"I was on Effexor XR for 8 years and I recently went off. I gave the drug 8 out of 10 because overall my anxiety and depression were greatly improved. I didn&#039;t have any sexual side effects and only felt dizzy when I did not take the medication at exactly the same time every night. I did lose a lot of my energy and was prescribed Wellbutrin to help out with that. However, the withdrawal, as others have mentioned, is terrible. My doctor prescribed a low dose of prozac (20mg) to ease the withdrawal and it really helped. If you are going off effexor, do it with prozac. I tried without it twice before and it was such a horrible experience that I went right back on.\"',\n",
       "       '\"I take 300 mg of time released effexor, a day and it has changed my life 100% \\r\\r\\nIt has helped me to not worry about rejection if things don&#039;t go right and to give a speach in front of a audiance had always been frightning as well as any crowds with others. Or being preccupied with possible rejection every minute. I did not relize how much joy of life i was misssing,\"',\n",
       "       '\"Changes my life for the better!\"',\n",
       "       '\"I have multiple health issues and am very anxious about them. Have been on and off Effexor 75mg twice now (going off when felt better) over 3 years and just started again with anxiety of upcoming surgeries. Going on I experience nausea and can only eat dry biscuits for about 2 weeks. Going off them 1st time no withdrawals...2nd time was suicidal as I stupidly went &#039;cold turkey&#039; - not recommended.  Pupils dilated and some dizziness and sexual dysfunction (I think due to MS though) otherwise great. Day 4 now and already feeling less &#039;freaked out&#039; about everything but complete loss of appetite this time  - not a bad thing after the summer indulgence. Have experienced insomnia this time which I had not previously. Female 37.\"',\n",
       "       '\"Though the medication helped my depression, I  (a 20 year old female) started having incredibly painful acid reflux and heartburn after just a month or 2 of taking it. The acid reflux has dissipated since switching to different medication, but I still have bouts of it from the harm it caused to my stomach. I had never experienced any type of heartburn or acid reflux before being prescribed this drug.\"',\n",
       "       '\"this med did its job reasonably. Didn&#039;t necessarily keep me out of the dumps all of the time,  but I could cope with life better. Started with 37.5mg ER, then switched to sertraline for 2 weeks due to insomnia. Went back on Ven but now 75mg immediate release for 1 month, then 75mg ER for another, then 150 mg ER after feeling like 75 wasnt enough. Was only on 150 for 2 weeks after realizing I gained 15 lbs!! WTF?? I didn&#039;t eat a lot because it did suppress my app. But I was constipated all of the time. Just wanted to lay in bed most of time. Moved on to Bupropion, but thanks venlafaxine for being there I guess? You&#039;re like the brother who kept me company but never cleaned up after yourself.\"',\n",
       "       '\"I&#039;m on 75mg venlafaxine but I&#039;m going up another 37.5mg I&#039;m scared is this ok to do as my psych said that 75mg is too low.\"'],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 131,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "nlp_drug['review'].unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 134,
   "id": "79f88faf-760e-474c-b1d8-9ea0a46c298b",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "<>:1: SyntaxWarning: list indices must be integers or slices, not list; perhaps you missed a comma?\n",
      "<>:1: SyntaxWarning: list indices must be integers or slices, not list; perhaps you missed a comma?\n",
      "/var/folders/z4/y29hfzpj47dd0krx452vm5940000gn/T/ipykernel_10417/1568366645.py:1: SyntaxWarning: list indices must be integers or slices, not list; perhaps you missed a comma?\n",
      "  nlp_drug=[nlp_drug['rating']=='10'][['condition']]\n",
      "/var/folders/z4/y29hfzpj47dd0krx452vm5940000gn/T/ipykernel_10417/1568366645.py:1: SyntaxWarning: list indices must be integers or slices, not list; perhaps you missed a comma?\n",
      "  nlp_drug=[nlp_drug['rating']=='10'][['condition']]\n",
      "/var/folders/z4/y29hfzpj47dd0krx452vm5940000gn/T/ipykernel_10417/1568366645.py:1: SyntaxWarning: list indices must be integers or slices, not list; perhaps you missed a comma?\n",
      "  nlp_drug=[nlp_drug['rating']=='10'][['condition']]\n",
      "/var/folders/z4/y29hfzpj47dd0krx452vm5940000gn/T/ipykernel_10417/1568366645.py:1: SyntaxWarning: list indices must be integers or slices, not list; perhaps you missed a comma?\n",
      "  nlp_drug=[nlp_drug['rating']=='10'][['condition']]\n",
      "/var/folders/z4/y29hfzpj47dd0krx452vm5940000gn/T/ipykernel_10417/1568366645.py:1: SyntaxWarning: list indices must be integers or slices, not list; perhaps you missed a comma?\n",
      "  nlp_drug=[nlp_drug['rating']=='10'][['condition']]\n",
      "/var/folders/z4/y29hfzpj47dd0krx452vm5940000gn/T/ipykernel_10417/1568366645.py:1: SyntaxWarning: list indices must be integers or slices, not list; perhaps you missed a comma?\n",
      "  nlp_drug=[nlp_drug['rating']=='10'][['condition']]\n",
      "/var/folders/z4/y29hfzpj47dd0krx452vm5940000gn/T/ipykernel_10417/1568366645.py:1: SyntaxWarning: list indices must be integers or slices, not list; perhaps you missed a comma?\n",
      "  nlp_drug=[nlp_drug['rating']=='10'][['condition']]\n"
     ]
    },
    {
     "ename": "TypeError",
     "evalue": "list indices must be integers or slices, not list",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mTypeError\u001b[0m                                 Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[134], line 1\u001b[0m\n\u001b[0;32m----> 1\u001b[0m nlp_drug\u001b[38;5;241m=\u001b[39m[nlp_drug[\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mrating\u001b[39m\u001b[38;5;124m'\u001b[39m]\u001b[38;5;241m==\u001b[39m\u001b[38;5;124m'\u001b[39m\u001b[38;5;124m10\u001b[39m\u001b[38;5;124m'\u001b[39m][[\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mcondition\u001b[39m\u001b[38;5;124m'\u001b[39m]]\n",
      "\u001b[0;31mTypeError\u001b[0m: list indices must be integers or slices, not list"
     ]
    }
   ],
   "source": [
    "nlp_drug=[nlp_drug['rating']=='10'][['condition']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 123,
   "id": "3e6ef67e-40c6-437e-9742-a85e611bc085",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(320, 7)"
      ]
     },
     "execution_count": 123,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "nlp_drug=nlp_drug.dropna(subset=['review'])\n",
    "\n",
    "nlp_drug.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 128,
   "id": "97148bbd-4e7f-44f5-91ab-caf6f5f06ba8",
   "metadata": {},
   "outputs": [],
   "source": [
    "substitute_no_space=re.compile(r\"[.;:!\\'?,\\\"()\\[\\]]\")\n",
    "substitute_with_space=re.compile(r\"(,br\\s*/><br\\s*/.|(\\/))\")\n",
    "\n",
    "def clean_text(review):\n",
    "    review=re.sub(substitute_no_space, \"\", review)\n",
    "    review=re.sub(substitute_with_space, \" \", review)\n",
    "    doc==spacy_nlp(review)\n",
    "    lemmas=[]\n",
    "\n",
    "    for token in doc:\n",
    "        if not token.is_punct and not token.is_space and not token.is_stop:\n",
    "            lemmas.append(token.lemma_.lower())\n",
    "    return lemmas\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 130,
   "id": "6b52894e-67ed-4a23-8b14-0d34f3e157b2",
   "metadata": {},
   "outputs": [
    {
     "ename": "KeyError",
     "evalue": "1",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mKeyError\u001b[0m                                  Traceback (most recent call last)",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.11/site-packages/pandas/core/indexes/base.py:3791\u001b[0m, in \u001b[0;36mIndex.get_loc\u001b[0;34m(self, key)\u001b[0m\n\u001b[1;32m   3790\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[0;32m-> 3791\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_engine\u001b[38;5;241m.\u001b[39mget_loc(casted_key)\n\u001b[1;32m   3792\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mKeyError\u001b[39;00m \u001b[38;5;28;01mas\u001b[39;00m err:\n",
      "File \u001b[0;32mindex.pyx:152\u001b[0m, in \u001b[0;36mpandas._libs.index.IndexEngine.get_loc\u001b[0;34m()\u001b[0m\n",
      "File \u001b[0;32mindex.pyx:181\u001b[0m, in \u001b[0;36mpandas._libs.index.IndexEngine.get_loc\u001b[0;34m()\u001b[0m\n",
      "File \u001b[0;32mpandas/_libs/hashtable_class_helper.pxi:2606\u001b[0m, in \u001b[0;36mpandas._libs.hashtable.Int64HashTable.get_item\u001b[0;34m()\u001b[0m\n",
      "File \u001b[0;32mpandas/_libs/hashtable_class_helper.pxi:2630\u001b[0m, in \u001b[0;36mpandas._libs.hashtable.Int64HashTable.get_item\u001b[0;34m()\u001b[0m\n",
      "\u001b[0;31mKeyError\u001b[0m: 1",
      "\nThe above exception was the direct cause of the following exception:\n",
      "\u001b[0;31mKeyError\u001b[0m                                  Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[130], line 1\u001b[0m\n\u001b[0;32m----> 1\u001b[0m text\u001b[38;5;241m=\u001b[39mnlp_drug[\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mreview\u001b[39m\u001b[38;5;124m'\u001b[39m][\u001b[38;5;241m1\u001b[39m]\n\u001b[1;32m      3\u001b[0m \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mafter cleaning: \u001b[39m\u001b[38;5;124m'\u001b[39m, clean(review))\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.11/site-packages/pandas/core/series.py:1040\u001b[0m, in \u001b[0;36mSeries.__getitem__\u001b[0;34m(self, key)\u001b[0m\n\u001b[1;32m   1037\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_values[key]\n\u001b[1;32m   1039\u001b[0m \u001b[38;5;28;01melif\u001b[39;00m key_is_scalar:\n\u001b[0;32m-> 1040\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_get_value(key)\n\u001b[1;32m   1042\u001b[0m \u001b[38;5;66;03m# Convert generator to list before going through hashable part\u001b[39;00m\n\u001b[1;32m   1043\u001b[0m \u001b[38;5;66;03m# (We will iterate through the generator there to check for slices)\u001b[39;00m\n\u001b[1;32m   1044\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m is_iterator(key):\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.11/site-packages/pandas/core/series.py:1156\u001b[0m, in \u001b[0;36mSeries._get_value\u001b[0;34m(self, label, takeable)\u001b[0m\n\u001b[1;32m   1153\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_values[label]\n\u001b[1;32m   1155\u001b[0m \u001b[38;5;66;03m# Similar to Index.get_value, but we do not fall back to positional\u001b[39;00m\n\u001b[0;32m-> 1156\u001b[0m loc \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mindex\u001b[38;5;241m.\u001b[39mget_loc(label)\n\u001b[1;32m   1158\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m is_integer(loc):\n\u001b[1;32m   1159\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_values[loc]\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.11/site-packages/pandas/core/indexes/base.py:3798\u001b[0m, in \u001b[0;36mIndex.get_loc\u001b[0;34m(self, key)\u001b[0m\n\u001b[1;32m   3793\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(casted_key, \u001b[38;5;28mslice\u001b[39m) \u001b[38;5;129;01mor\u001b[39;00m (\n\u001b[1;32m   3794\u001b[0m         \u001b[38;5;28misinstance\u001b[39m(casted_key, abc\u001b[38;5;241m.\u001b[39mIterable)\n\u001b[1;32m   3795\u001b[0m         \u001b[38;5;129;01mand\u001b[39;00m \u001b[38;5;28many\u001b[39m(\u001b[38;5;28misinstance\u001b[39m(x, \u001b[38;5;28mslice\u001b[39m) \u001b[38;5;28;01mfor\u001b[39;00m x \u001b[38;5;129;01min\u001b[39;00m casted_key)\n\u001b[1;32m   3796\u001b[0m     ):\n\u001b[1;32m   3797\u001b[0m         \u001b[38;5;28;01mraise\u001b[39;00m InvalidIndexError(key)\n\u001b[0;32m-> 3798\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mKeyError\u001b[39;00m(key) \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01merr\u001b[39;00m\n\u001b[1;32m   3799\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mTypeError\u001b[39;00m:\n\u001b[1;32m   3800\u001b[0m     \u001b[38;5;66;03m# If we have a listlike key, _check_indexing_error will raise\u001b[39;00m\n\u001b[1;32m   3801\u001b[0m     \u001b[38;5;66;03m#  InvalidIndexError. Otherwise we fall through and re-raise\u001b[39;00m\n\u001b[1;32m   3802\u001b[0m     \u001b[38;5;66;03m#  the TypeError.\u001b[39;00m\n\u001b[1;32m   3803\u001b[0m     \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_check_indexing_error(key)\n",
      "\u001b[0;31mKeyError\u001b[0m: 1"
     ]
    }
   ],
   "source": [
    "text=nlp_drug['review'][1]\n",
    "\n",
    "print('after cleaning: ', clean(review))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 108,
   "id": "d4812fb2-4ada-427c-95c1-1c760608f3fa",
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "from collections import Counter\n",
    "import spacy\n",
    "\n",
    "def count_tokens(text):\n",
    "    spacy_nlp = spacy.blank(\"en\")\n",
    "    text=re.sub('[^A-Za-z0-9.,!?/:;\\\"\\'\\s]+',' ',text)\n",
    "    doc = spacy_nlp(text.lower())\n",
    "    out = Counter([tok.text for tok in doc])\n",
    "    total_tokens = len(out.keys())\n",
    "    return total_tokens, out"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "id": "6c677479-96b7-4176-8d86-812976ddd15e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "79       (92, {'\"': 2, 'i': 14, 'was': 7, 'first': 3, '...\n",
      "81       (79, {'\"': 2, 'i': 8, 'took': 1, 'effexor': 1,...\n",
      "223      (97, {'\"': 2, 'horrible': 1, 'side': 2, 'effec...\n",
      "586      (61, {'\"': 2, 'i': 6, '039;ve': 1, 'been': 2, ...\n",
      "712      (69, {'\"': 2, 'i': 5, 'suffered': 1, 'with': 1...\n",
      "                               ...                        \n",
      "52286    (8, {'\"': 2, 'changes': 1, 'my': 1, 'life': 1,...\n",
      "52683    (106, {'\"': 2, 'i': 5, 'have': 3, 'multiple': ...\n",
      "52904    (57, {'\"': 2, 'though': 1, 'the': 3, 'medicati...\n",
      "52953    (99, {'\"': 2, 'this': 1, 'med': 1, 'did': 2, '...\n",
      "53618    (26, {'\"': 2, 'i': 3, '039;m': 3, 'on': 1, '75...\n",
      "Name: tokens_count, Length: 320, dtype: object\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/z4/y29hfzpj47dd0krx452vm5940000gn/T/ipykernel_10417/2936175458.py:1: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  nlp_drug[\"tokens_count\"]=nlp_drug[\"review\"].apply(count_tokens)\n"
     ]
    }
   ],
   "source": [
    "nlp_drug[\"tokens_count\"]=nlp_drug[\"review\"].apply(count_tokens)\n",
    "print(nlp_drug[\"tokens_count\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 110,
   "id": "dbb97e7e-5f54-43f9-8963-327f8ca751e2",
   "metadata": {},
   "outputs": [],
   "source": [
    "text=nlp_drug[\"tokens_count\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 111,
   "id": "e5902061-599f-4a7b-98ba-0994455a7e52",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "79     (92, {'\"': 2, 'i': 14, 'was': 7, 'first': 3, '...\n",
       "81     (79, {'\"': 2, 'i': 8, 'took': 1, 'effexor': 1,...\n",
       "223    (97, {'\"': 2, 'horrible': 1, 'side': 2, 'effec...\n",
       "586    (61, {'\"': 2, 'i': 6, '039;ve': 1, 'been': 2, ...\n",
       "712    (69, {'\"': 2, 'i': 5, 'suffered': 1, 'with': 1...\n",
       "Name: tokens_count, dtype: object"
      ]
     },
     "execution_count": 111,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 112,
   "id": "c455eddd-eb22-4333-b9f0-f870224c33b5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "79       (92, {'\"': 2, 'i': 14, 'was': 7, 'first': 3, '...\n",
      "81       (79, {'\"': 2, 'i': 8, 'took': 1, 'effexor': 1,...\n",
      "223      (97, {'\"': 2, 'horrible': 1, 'side': 2, 'effec...\n",
      "586      (61, {'\"': 2, 'i': 6, '039;ve': 1, 'been': 2, ...\n",
      "712      (69, {'\"': 2, 'i': 5, 'suffered': 1, 'with': 1...\n",
      "                               ...                        \n",
      "52286    (8, {'\"': 2, 'changes': 1, 'my': 1, 'life': 1,...\n",
      "52683    (106, {'\"': 2, 'i': 5, 'have': 3, 'multiple': ...\n",
      "52904    (57, {'\"': 2, 'though': 1, 'the': 3, 'medicati...\n",
      "52953    (99, {'\"': 2, 'this': 1, 'med': 1, 'did': 2, '...\n",
      "53618    (26, {'\"': 2, 'i': 3, '039;m': 3, 'on': 1, '75...\n",
      "Name: tokens_count, Length: 320, dtype: object\n"
     ]
    }
   ],
   "source": [
    "#â€ o tokenize text\n",
    "def to_lowercase(text):\n",
    "    return text.lower()\n",
    "\n",
    "print(text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 113,
   "id": "7dc744d9-6af6-43b8-b6ce-087ba76995b5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "79       (92, {'\"': 2, 'i': 14, 'was': 7, 'first': 3, '...\n",
      "81       (79, {'\"': 2, 'i': 8, 'took': 1, 'effexor': 1,...\n",
      "223      (97, {'\"': 2, 'horrible': 1, 'side': 2, 'effec...\n",
      "586      (61, {'\"': 2, 'i': 6, '039;ve': 1, 'been': 2, ...\n",
      "712      (69, {'\"': 2, 'i': 5, 'suffered': 1, 'with': 1...\n",
      "                               ...                        \n",
      "52286    (8, {'\"': 2, 'changes': 1, 'my': 1, 'life': 1,...\n",
      "52683    (106, {'\"': 2, 'i': 5, 'have': 3, 'multiple': ...\n",
      "52904    (57, {'\"': 2, 'though': 1, 'the': 3, 'medicati...\n",
      "52953    (99, {'\"': 2, 'this': 1, 'med': 1, 'did': 2, '...\n",
      "53618    (26, {'\"': 2, 'i': 3, '039;m': 3, 'on': 1, '75...\n",
      "Name: tokens_count, Length: 320, dtype: object\n"
     ]
    }
   ],
   "source": [
    "def remove_numbers(text):\n",
    "    pattern=r'[^a-zA-z.,!?/:;\\\"\\'\\s]'\n",
    "    return re.sub(pattern, '', text)\n",
    "print(text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 114,
   "id": "61b5d821-1a9f-4dd6-bfc3-a233a02f6bd2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "79       (92, {'\"': 2, 'i': 14, 'was': 7, 'first': 3, '...\n",
      "81       (79, {'\"': 2, 'i': 8, 'took': 1, 'effexor': 1,...\n",
      "223      (97, {'\"': 2, 'horrible': 1, 'side': 2, 'effec...\n",
      "586      (61, {'\"': 2, 'i': 6, '039;ve': 1, 'been': 2, ...\n",
      "712      (69, {'\"': 2, 'i': 5, 'suffered': 1, 'with': 1...\n",
      "                               ...                        \n",
      "52286    (8, {'\"': 2, 'changes': 1, 'my': 1, 'life': 1,...\n",
      "52683    (106, {'\"': 2, 'i': 5, 'have': 3, 'multiple': ...\n",
      "52904    (57, {'\"': 2, 'though': 1, 'the': 3, 'medicati...\n",
      "52953    (99, {'\"': 2, 'this': 1, 'med': 1, 'did': 2, '...\n",
      "53618    (26, {'\"': 2, 'i': 3, '039;m': 3, 'on': 1, '75...\n",
      "Name: tokens_count, Length: 320, dtype: object\n"
     ]
    }
   ],
   "source": [
    "def lemmatize(text, nlp):\n",
    "    doc=nlp(text)\n",
    "    lemmatized_text=[]\n",
    "    for token in doc:\n",
    "        lemmatized_text.append(token.lemma_)\n",
    "    return \" \".join(lemmatized_text)\n",
    "print(text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 115,
   "id": "bbf99cf7-fd81-42e6-9620-2383035c57a9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "79       (92, {'\"': 2, 'i': 14, 'was': 7, 'first': 3, '...\n",
      "81       (79, {'\"': 2, 'i': 8, 'took': 1, 'effexor': 1,...\n",
      "223      (97, {'\"': 2, 'horrible': 1, 'side': 2, 'effec...\n",
      "586      (61, {'\"': 2, 'i': 6, '039;ve': 1, 'been': 2, ...\n",
      "712      (69, {'\"': 2, 'i': 5, 'suffered': 1, 'with': 1...\n",
      "                               ...                        \n",
      "52286    (8, {'\"': 2, 'changes': 1, 'my': 1, 'life': 1,...\n",
      "52683    (106, {'\"': 2, 'i': 5, 'have': 3, 'multiple': ...\n",
      "52904    (57, {'\"': 2, 'though': 1, 'the': 3, 'medicati...\n",
      "52953    (99, {'\"': 2, 'this': 1, 'med': 1, 'did': 2, '...\n",
      "53618    (26, {'\"': 2, 'i': 3, '039;m': 3, 'on': 1, '75...\n",
      "Name: tokens_count, Length: 320, dtype: object\n"
     ]
    }
   ],
   "source": [
    "#remove stopwords\n",
    "def remove_stopwords(text,nlp):\n",
    "    filtered_sentence=[]\n",
    "    doc=nlp(text)\n",
    "    for token in doc:\n",
    "        if token.is_stop==False:\n",
    "            filtered_sentence.append(token.text)\n",
    "    return \" \".join(filtered_sentence)\n",
    "nlp=spacy.load(\"en_core_web_sm\", disable=[\"parser\", \"ner\"])\n",
    "\n",
    "print(text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 116,
   "id": "be3b9076-dea9-47b4-939c-83fd9621edc2",
   "metadata": {},
   "outputs": [],
   "source": [
    "#from collections import Counter\n",
    "#import spacy\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e71b2ecc-6063-42e1-a0c4-7ae81da4405d",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 117,
   "id": "a3c16a16-8471-4b01-bac0-7dd76f0030c2",
   "metadata": {},
   "outputs": [],
   "source": [
    "#token_list=[]\n",
    "#for token in my_doc:\n",
    "    #token_list.append(token.text)\n",
    "\n",
    "#print(token_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 118,
   "id": "9456797d-7352-4627-b31a-eb4ef6ed31ff",
   "metadata": {},
   "outputs": [],
   "source": [
    "#from collections import Counter\n",
    "#import spacy\n",
    "\n",
    "#spacy_nlp=spacy.blank(\"en\")\n",
    "#doc=spacy_nlp(\"this is text, this is text\")\n",
    "#out=Counter([tok.text for tok in doc])\n",
    "#out.keys()\n",
    "#len(out.keys())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 119,
   "id": "5117d8d7-d957-4624-976a-c6f0ce8358e5",
   "metadata": {},
   "outputs": [],
   "source": [
    "#def count_tokens(text):\n",
    "#   spacy_nlp = spacy.blank(\"en\")\n",
    "#  doc = spacy_nlp(text.lower())\n",
    "#   out = Counter([tok.text for tok in doc])\n",
    "#    total_tokens = len(out.keys())\n",
    "#    return total_tokens, out"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6c8f52d6-644a-4ff8-8747-54a043fbd9a4",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 120,
   "id": "d5bb4fa7-5ba3-4c33-8348-336e5acda041",
   "metadata": {},
   "outputs": [],
   "source": [
    "#drug_data_df.head(2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "37f0ad24-1b77-4115-85c4-9b9504459bac",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 121,
   "id": "4682aee5-209f-4d0d-bf34-d749eeb0056c",
   "metadata": {},
   "outputs": [],
   "source": [
    "#drug_data_df[['total_tokens', 'tokens']]=drug_data_df['review'].apply(count_tokens)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e27088d0-73ed-493e-a27c-56062fff01b0",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
